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To my beloved family, who have always stood by me 
If  there  is one  way better than  another,  it is the  way of  nature.  
(Aristotle) 
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ABBREVIATIONS AND SYMBOLS 
ACE Angiotenzin I Converting  Enzime 
ACHC 2-aminocyclohexane-1 -carboxylic acid 
ACPC 2-aminocyclopentane-1 -carboxylic acid 
AIBN azoisobutyronitrile 
BINOL 1,1' -binaphthyl-2,2' -diol 
Boc ieri-butyloxycarbonyl 
Bom benzyloxymethyl 
Bu3SnH tributyltin hydride 
CAL-B lipase from Candida Antarctica  fraction B 
CDI l,l'-carbonyI  diimidazole  
CSI chlorosulfonyl  isocyanate  
DBU l,8-diazobicyclo[5.4.0]undec-7-ene 
DCM dichloromethane 
DIFFNOE NOE Difference Spectroscopy 
DHAA (+)-ira«j-2,3-dihydro-3-hydroxyanthranylic  acid  
DMF W,W-dimethylformamide 
DMPU N,N'-ûimethyl  propylene urea 
DPPA diphenylphosphorylazide 
ee enantiomeric  excess  
Fmoc 9-fluorenylmethoxycarbonyl 
IPC2BH diisopinocamphenyl  borane  
KHMDS potassium hexamethyldisilylazide  dimer  
LiHMDS lithium  hexamethyldisilylazide  
MCPBA m-chloroperbenzoic  acid  
Ms mesyl 
NBS W-bromosuccinimide 
NIS V-iodosuccinimide 
NMO V-methylmorpholine  oxide  
NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
NOESY two-dimensional  nuclear Overhauser  spectroscopy  
ORTEP oak ridge thermal ellipsoid plot program 
PLE pig liver esterase 
r correlation coefficient 
T temperature 
TBHP terr-butyl-hydroperoxyde 
TBS CI tributylsilyl  chloride  
TFA trifluoroacetic acid 
THF tetrahydrofurane 
Ts toluenesulfonyl 
8 chemical shift 
+ a Hammett-Brown  parameter  
Z benzyloxycarbonyl 
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1.  INTRODUCTION  AND  AIMS  
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Alicyclic  /J-amino  acids  play  important  roles  in chemistry  and  biology.  In  1989,  
(l/?,2S)-2-aminocyclopentanecarboxylic  acid  (cispentacin)1'2  an  antifungal  antibiotic,  
was  isolated  from  Bacillus  cereus]  and  Streptomyces  setonii;3  it  is  also  a component  of  
the  antibiotic  amipurimycin.  An  antifungal  antibiotic  BAY  y  9379  and  the  
hydrochloride  salt  of  (lS,6./?j-6-anfino-3,4-dimethylcyclohex-3-ene-l-carboxylic  acid,  
which  were  originally  designed  at  Bayer  AG  as pyridoxal  phosphate  suicide  inhibitors,  
turned  out  to  have  activity  against  Candida  albicans  as  well.5  (li?,2S)-2-Amino-4-
methylenecyclopentanecarboxylic  acid  (BAY  10-8888)  is  currently  under  investigation  
in  phase  II  clinical  trials  as  a  novel  antifungal  for  the  treatment  of  yeast  infections  
(Scheme  1).  
NH 2  NH2  
O  ""COOH  H2C  "COOH  C  J ; „  
cispentacin  BAY  10-8888  BAY  y 9379 
Scheme 1  
2-Aminocycloalkanecarboxylic  acids,  important  non-proteinogenic  /?-amino  
acids,  have  many  applications  in  the  syntheses  of  natural  products,6  biologically  active  
7  8  •  
compounds,  heterocycles  and  peptidomimetics.  The  synthesis,  stereochemistry  and  
transformations  of  cyclopentane-,  cyclohexane-,  cycloheptane-  and  cyclooctane-fused  
1,3-oxazines,  1,3-thiazines  and  pyrimidines  have  been  reviewed.  Many  of  these  
syntheses  started  from  cyclic  2-aminocycloalkanecarboxylic  acid  or  their  derivatives  
O  Q  
and have already been reviewed.  '  
Particularly  since  their  oligomers  were  demonstrated  to  fold  into  stable  helical  
conformations,  /Tamino  acids  have  been  the  subject  of  much  synthetic  effort  in  recent  
years.10"12 
In  spite  of  the  publication  of  several  different  methods  for  the  preparation  of  
racemic  and  enantiopure  cyclic  hydroxy-/?-amino  acid  derivatives  in  the  past  two  
decades, these methods  have not  yet been reviewed.  The  aim  of the  literature  part  of  my 
thesis  is to summarize  the results  in this  intensively  developing  field  of research. 
My PhD work  was focused on the  syntheses  of new y3-amino acids: the  synthesis  
of  all  four  enantiomers  of  l-aminoindane-2-carboxylic  acid,  a  new  cispentacin  
benzologue  [III],  and  the  preparation  of  cis-  and  7rara--2-amino-4-  and  -5-
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hydroxycyclohexane-carboxylic  acids  [VI]  and  3-amino-5-  and  -6-
hydroxybicyclo[2.2.1]heptane-2-carboxylic  acids  [VII]  by  stereoselective  and  
regioselective  functionalizations  of  cis-  and  trara-2-amino-4-cyclohexenecarboxylic  
acid  and  if/e«<fo-3-aminobicyclo-[2.2.1]hept-5-ene-2-carboxylic  acid  derivatives  via  
1,3-oxazine  or y-lactone  intermediates  (Scheme  2).  
H2  r T V  N H 2  
HO—  (  T  
COOH  ^ " ^ C O O H  
cis, trans  cis, trans, diendo 
Scheme  2  
A  further  aim  was  a  comparative  study  of the  ring-closure  reactions  of  cis-  and  
frvms-2-amino-1  -cyclopentanecarboxylic  acid  derivatives  [II],  cis-  and  trans-1 -
aminoindane-2-carboxylic  acid  derivatives  [V]  and  V-ureido-  and  thioureido-1,2,3,4-
tetrahydro-/?-carboline-l-carboxylic  acid  esters  [IV],  and  the  ring-enlargement  of  
norbornane-  and norbornene-fused azetidinones  [I] (Scheme  3).  
All  compounds  investigated  in  the  Results  part  of  my  thesis  were  racemates,  
except  for  97-104  [III],  The  Schemes  depict  only  one  of  the  enantiomers,  except  in  
Scheme  22,  where  optically  active  compounds  are  discussed  and  the  absolute  
configurations are  shown.  
The  publications  on  which  the  thesis  is  based  (listed  on  page  5)  are  given  in  
square brackets,  while  other references are given  as  superscripts.  
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2.  LITERATURE  
2.1.  Importance  of  hydroxylated  f-amino  acids  
Hydroxy-/?-amino  acids  constitute  an important  class  of  amino  acids,  because  of  
their  occurrence  in  many  biologically  relevant  compounds.'1  Paclitaxel  (Taxol®)  and  
docetaxel  (Taxotere®)  are  amongst  the  most  effective  chemotherapeutic  agents  for  the  
clinical  treatment  of  ovarian  and  breast  cancers  today.14"17  Representative  examples  are  
the  aminopeptidase  inhibitors  bestatin18'19  and  amastatin20  and  the  ACE  inhibitor  
9 1  99  
microginin,  '  'which  contain  aliphatic  derivatives  (Scheme  4).  Some  cyclic  derivatives  
9"}  9f\  •  97  9R  •  
have  antibiotic  (oryzoxymycin)  "  or  antifungal  activities,  '  or  are  building  blocks  
for pharmaceutically  important  natural  substances  such  as  fortamine,6 '29  chryscandin,30  pentopyraneamine,31  gougerotin,"  and  blasticidin.  
AcO^  o  
NHR  O  Me,  
32 
OH 
33 
H,N 
OBz 
Me 
O  Me  
O  COOH  
R = Bz;  Taxol  
R = CO,But;  Taxotere3  
Me 
Me 
H2N 
Me  Me  
O  Y  O  
0 X 
COOH 
OH 
N  COOH  
Q  ^  H  Me  
Me  Me  
amastatin 
OH 
bestatin 
Me  Me  
O  Y  Me  O  
eVr% 
'  o  A  Me  O  
NH  Me  Me  
Me 
microginin 
Scheme  4  
Hydroxylated  /?-amino  acids  function  as  precursors  for  the  synthesis  of  /?-
lactams34'35  and heterocyclic  compounds/6  
It  has  been  demonstrated  that  oligomers  composed  of  /?-amino  acids  can  fold  
stable  secondary  structures  similar  to  those  of a-peptides,  helices,  sheets  and  turns.10'37  
It  was  most  intriguing  discovery  that  only  6  /?-amino  acid  residues  are  enough  for  the  
OO  QQ  ,  
formation of a stable helix,  '  whereas  an a-amino  acid  oligomer  normally requires  15-
20 residues.  The formation of the helical  structure of//-peptides was  strongly  influenced  
by  the  nature  and  stereochemistry  of  the  amino  acid  side-chains  at  both  the  a -  and  /?-
positions.  In 2001,  Tromp  et  al.  prepared  a-hydroxylated  //-oligopeptides  in  solid-phase  
syntheses. NMR  studies  on the resulting  a-hydroxylated  /Fhexapeptide  indicated  that  in  
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pyridine no helical  structure was formed.40 In contrast, in 2002, Woll et al. reported that 
oligomers  composed  of  3-methoxy-  or  3-phenoxy-substituted  ACPC  residues  maintain  
the  I2-helical  conformation  displayed  by  the  non-substituted  analogues.41  These  facts  
reveal  that the presence  of the unprotected  a-hydroxy  group exerts  a great influence on 
the formation of the secondary  structure.  
2.2. Syntheses  of  hydroxylated  alicyclic /3-amino acids  
2.2.1.  Natural  hydroxylated  alicyclic  fi-amino  acids  
In  1961, McCormick  et  al.  isolated  a new amino  acid  from the fermented  mash  
of a Streptomyces  aureofaciens  mutant.42  This substance was characterized  as (+)-trans-
2,3-dihydro-3-hydroxyanthranilic  acid  (1,  DHAA)  via  its  elemental  analysis,  its  
ultraviolet  and  infrared  absorption  spectra,  and  its  chemical  transformations.  The  
conversion  of DHAA to  anthranilic  acid (3) under vigorous  acidic conditions  and to  m-
hydroxybenzoic  acid  (2)  under  vigorous  alkaline  conditions  confirmed  the  structure.  
Catalytic  hydrogenation  of DHAA  led to  3-hydroxyanthranilic  acid  (5) and  hexahydro-
3-hydroxyanthranilic  acid  (4)  (Scheme  5).  At  that  time,  no  conclusive  evidence  was  
found  for  the  configurational  relationship  of  the  amino  and  hydroxy  groups,  but  the  
vigorous  conditions  required  for  the  acidic  dehydration  of  DHAA  to  anthranilic  acid  
strongly suggested  that these  groups  are  trans  to each other. No  evidence  was  obtained  
either  for  the  configuration  of  C-l  in  4  relative  to  the  other  two  asymmetric  centres.  
However, the reduction was shown to be stereoselective by the isolation of 4 as a single 
substance in high yield.43  The complete stereochemistry  of DHAA was proved by  Teng  
and  Ganem,  who  established  the  absolute  configuration  of  DHAA  as  (25,3S)  and  
prepared  its N-Boc  and ester derivatives  (6a-d).44 Policastro  et al.  prepared  the  (55,65)-
6-amino-5-[(l -carboxyethenyl)oxy]-1,3-cyclohexadiene-1 -carboxylic  acid  derivative  
(6a)  and  described  its  biochemical  transformation  to  anthranilic  acid  (2)  with  pure  5.  
marcescens  AS I enzyme.45  
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OH OH 
NaOH  / A 
COOH 
OH 
à " 
NH2 
COOH 
10%Pd/C 
A 
HC1/A 
OH 
I 
COOH 
NH, 
COOH 
+  4  
CH2 
A 
NH2 
COOH 
OR' 
i X 
6a-d 
, R2  =  H, R3  =  H a  :  R1  
"COOH 
b:  R1  =  H, R 2  =  Boc,  R3  =  H  
c:  R1  =  H, R2  = B o c , R 3 =  Me  
CH2 
^  COOH  
R2  =  Boc,  R3  =  Me  
Scheme  5  
From  a  soil  sample  of  a  Streptomyces  strain  Hashimoto  et  al.  isolated  a  novel  
metabolite,  oryzoxymycin  7,  which  exhibited  moderate  in  vitro  activity  against  
Xanthomonas  oryzae  23,24 Oryzoxymycin  was  readily  converted  to  an  inactive  
crystalline  dimerization  product  8. Hydrolysis  of  oryzoxymycin  gave  iMac tic  acid  and  
(25',35)-6-amino-rrara-5-hydroxy-l,3-cyclohexadiene-l-carboxylic  acid  (1),  which  was  
converted  through  atmospheric  catalytic  hydrogénation  on Adams  platinum  oxide to  the  
hexahydro-hydroxyamino  acid  9  (Scheme  6).  The  melting  points  and  the  optical  
rotation  data  for  9  and  4  were  identical,  and  the  two  compounds  were  therefore  
presumably  the  same.  Esterification  of  9  with  hydrogen  chloride  in  methanol  at  room  
temperature  afforded ester  derivative  10.25  The  absolute  configurations  of  7  and  9  were  
determined  by NMR  spectroscopy  and  the copper  complex  (TACu)  method.  From  these  
data,  the  absolute  structure  of  7  must  be  (2i?,5S',6S)-2-[6-amino-5-hydroxy-l,3-
cyclohexadiene-l-carbonyloxy]propanoic  acid,  while  the  absolute  configuration  of  9  is  
(\R,2S,3S). 
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OH 
,0 K J ^ o  +  k j y >  
OH 
< A y N H 2 
0 
OH 
dimerization 
HO 
H2N 
O^Me 
COOH 
natural  oryzoxymycin  
NaOH 
OH 
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OyMt 
COOH 
N H 2 
0 
O  Me  
COOH 
OH 
U 
PtO, 
COOH a N H 2 MeOH/HCI COOH 
Scheme 6  
OH 
C T 
COOMe 
10 
In  2003,  Steel  et  al.  reported  an  asymmetric  synthesis  of  putative  (-)-
oryzoxymycin  (23)  and  an  asymmetric  synthesis  of the  dihydroxyanthranilate  core.  In  
the  first  step, the  Diels-Alder  reaction  of furan with  nitroacrylate  12 occurred  rapidly  to  
give  a  mixture  of  cycloadducts  favouring  the  expected  endo  nitro  isomers  14  (4:1).  
Subsequent  selective  conversion  to  the  anthranilate  ester  16  was  achieved  through  the  
protected  amino  ester  15.  Hydrolysis  of  16  and  its  reaction  with  mesylate  17  gave  the  
desired  lactate  product  18  as  a  mixture  of  two  diastereomers.  Separation  of  the  
diastereomers  proved  impossible;  accordingly,  the  authors  developed  an  
enantioselective  preparation  of  ester  15.  The  PLE-catalysed  selective  hydrolysis  of  
bicyclic  ester  15  gave  the  enantiomer  ester  19  and  acid  20.  With  the  chiral  esters  
available,  the  synthesis  was  repeated  starting  from  enantiomer  19,  and  putative  (-)-
oryzoxymycin  23  was  obtained.  
The  optical  rotations  of  the  natural  7  and  synthetic  23  oryzoxymycins  were  
different (23:  [cr]21  = -199 (c =  1, H20);  7: lit24  [a £  = +349 (c =  1, H20))  and in the  IR  
spectrum  revealed  significant  differences  both  in  the  carbonyl  region  and  in  the  
characteristic  bands  of  the  fingerprint  region.  The  authors  suggested  that  the  correct  
structure  of  oryzoxymycin  may  be  the  isomeric  C-5  lactate  ester  24  and  promised  to  
prepare  this compound  to verify this hypothesis  (Scheme  7).  
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Scheme  7  
In  2004,  the  same  research  team  reported  the  synthesis  of  3-hydroxy  and  3,4-
dihydroxy  derivatives  of  ACHC.46  Under  Diels-Alder  conditions  two  isomers  were  
isolated, which were  easily  separated  by column chromatography.  Nitro  group  reduction  
and  protection  of  the  resultant  amines  gave  carbamates  15  and  25.  Subsequent  ¡3-
elimination  of  the  oxygen  bridge  of  carbamates  15  and  25  gave  dihydroanthranilates  16  
and  26.  Acylation  and  reduction  of  these  acetates  afforded  3-hydroxy-ACHC  
derivatives:  trans-trans  27  from  16  and  cis-cis  28  from  26  (Scheme  8).  The  relative  
stereochemistry  of  carbamate  15  was  confirmed  by  X-ray  crystallography,  and  the  
structures  of the other derivatives  were confirmed by 2D NMR  spectroscopy.  
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The  preparation  of  3,4-dihydroxy  derivatives  of  ACHC  was  possible  via  
reductive  opening  of  epoxide  intermediates  derived  from  cyclohexadienes  16  and  26  
(Scheme  9).  Treatment  of  16  with  m-chloroperbenzoic  acid  in  dichloromethane  gave  a  
separable  mixture  of  epoxides  29:30  =  9:1  (method  A).  Repetition  of the epoxidation  of  
16  in  acetonitrile  instead  of  dichloromethane  preserved  the  stereoselectivity  and  gave  a  
2:1  mixture  of  the  isomers  favouring  the  cis  epoxy  alcohol  30  (method  B).  Reductive  
opening  of  the corresponding  epoxides  in the presence  of Pd-C  in hydrogen  atmosphere  
gave  the  all-trans  31  and  trans-trans-cis  32  dihydroxy  ACHC  derivatives  as  the  only  
isomers.  The configurations of 31  and  32  were confirmed by NOESY  experiments.  
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Scheme  9  
Epoxidation  of  26  by method  A afforded epoxide  33  as  the  only  product  in  high  
yield.  All  attempts  with  the  use  of  polar  solvents  or  starting  from  acetate  26a  failed  to  
give  the  trans  epoxy  alcohol.  Reduction  of  epoxide  33a  afforded the  all-cis  isomer  34  
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(Scheme  10).  It  is pertinent  to note  that the  combination  involving  the  above-mentioned  
9 f\ 
PLE-mediated  kinetic  resolution  method  is  applicable  for  the  preparation  of  the  
enantiomers  of derivatives  28, 31, 32  and  34.  
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Scheme  10  
Couche  et  al.  reported  on the  synthesis  of  enantiomerically  enriched  2-amino-3-
hydroxycyclohexanecarboxylic  acid  derivatives,  starting  with  an  asymmetrization  
step.47  Enantiomerically  pure  (ee  >  98%)  mono  ester  35,  obtained  by  PLE-catalysed  
hydrolysis  of  the  corresponding  meso  diester,  was  activated  by  mixed  anhydride  and  
treated  with  sodium  azide  to  afford  the  desired  acyl  azide  36.  Subsequent  Curtius  
rearrangement  and  trapping  of  the  intermediate  isocyanate  with  methanol  gave  the  
bicyclic  amino  compound  37.  Basic  ring  opening  of  the  bicycle  37  proved  fairly  
sensitive  to  the  reaction  conditions,  due to  side-reactions  involving  either  epimerization  
of  the  carbomethoxy  group  (37—+39)  or  an  intramolecular  reaction  leading  from  37  to  
the  oxazolidinone  40.  Under  the  best  conditions  (LiHMDS  2.2  equivalents,  THF,  -10  
°C)  the  reaction  proceeded  without  any  by-product  formation  but  the  conversion  was  
incomplete  and  the cyclohexene  derivative  38  was  formed in low yield  (41%).  Catalytic  
hydrogenation  of  the  double  bond  of  38  resulted  in  the  single  diastereomer  of  41  
(Scheme  11).  
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2.2.2.  Synthetic  a lieye lie  hydroxy  fi-amino  acids  
2.2.2.1.  By functionalization  of ring  double  bonds  
Gellman  et  al.  reported  on  the  stereoselective  synthesis  of  3-substituted  2-
aminocyclopentanecarboxylic  acids  and  their  incorporation  into  short  12-helical  /?-
peptides  that  fold  in  water.41  The  phenoxy  and  methoxy-substituted  monomers  (48a,b)  
were  prepared  enantioselectively,  starting  with  the  alkylation  of  sodium  
cyclopentadiene  (Scheme  12).  The  resulting  diene  42  was  then  converted  to  the  cis-
epoxide  45.  Epoxide  ring  opening  with  sodium  azide,  followed  by  alcohol  activation  
with  mesyl  chloride,  yielded  a 2:3 regioisomeric  mixture  of  azido-mesylates,  which  was  
converted  to  46  by azide  reduction  and concomitant  ring-closing  mesylate  displacement.  
The  ring-opened  47a  and  47b  were  converted  to  their  respective  V-Boc-/?-amino  acids  
48a  and  48b  by  removal  of  the  benzyl  protecting  group,  followed  by  oxidation.  A  
protecting  group  change  from Boc  to Fmoc  afforded /7-amino acid  derivates  suitable for  
solid-phase  synthesis.  Their  circular  dichroism  signatures  and  NMR  analysis  data  
demonstrated  that  the  hexamers  composed  of  the  3-substituted  ACPC  residues  (48a,b)  
maintained  the  12-helical  conformation  previously  shown  for  the  non-substituted  
analogue.  3-Substituted  ACPC  residues  allow  the  arrangement  of  specific  functional  
groups  in  a  geometrically  defined  fashion,  which  should  facilitate  the  design  of  /?-
peptides  for biological  applications.48'49  
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Twenty  years  ago,  Kobayashi  et  al.  reported  that  the  PLE-catalysed  hydrolysis  
of  the  meso  diester  49  quantitatively  furnished  the  monoester  50  with  an  excellent  
enantiomer  excess  (ee  >  96%).50  The  chiral  monoester  50  was  then  converted  to  the  ¡3-
amino  ester  51,  which  was  hydrolysed  with  trifluoroacetic  acid,  and  the  resulting  
carboxylic  group  of  52  was  subjected  to  iodolactonization  in  a  two-phase  system,  
yielding  the  iodolactone  53.  Dehalogenation  of  53  with  DBU  afforded  the  bicyclic  
lactone  54.  V-Methylation  of  54  to  55  was  cleanly  achieved  through  the  use  of  methyl  
iodide  and  silver  oxide.  Methanolysis  of  the  lactone  55  gave  the  allyl  alcohol  56.  This  
compound  was  the  key  intermediate  in  the  enantioselective  synthesis  of  (-)-fortamine  
(57) (Scheme  13).  6,29 
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Masemune  et  al.  prepared  hydroxy  amino  aciu  derivative  60  starting  from  
anhydride  58  according  to  Scheme  14/ '  The  anhydride  58  was  converted  to  the  
iodolactone  59  in  five  steps,  similarly  to  the  method  of  Kobayashi  et  al  e  The  
iodolactone  59  was  reduced  with  tributyltin  hydride,  followed  by  treatment  with  boron  
trifluoride  etherate  and  tributylsilyl  chloride  to  give  hydroxyamino  ester  60.  This  
compound  was  utilized  in  the  diastereoselective  synthesis  of  hapten  61  and  its  
inhibitor.51 
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Wipf  and  Wang  elaborated  three  efficient  stereocontrolled  Diels-Alder  
52 
approaches  towards  dihydroxylated  cis-  and  tram-aminocyclohexanecarboxylates.  
Starting  from A-benzyloxycarbonyl-protected  aminodiene  62,  using  Kobayashi's  chiral  
scandium  catalyst  for  the  Lewis  acid-mediated  reaction  with  acyl-l,3-oxazolidin-2-one,  
they  isolated  the  cis  product  in  high  yield  (92%)  and  good  ee  (90%).  After  the  
saponification  of  63  and  benzyl  ester  formation,  dihydroxylation  proceeded  to  give  the  
desired  diol  65.  
An  alternative  route  to  the  synthesis  of  65  was  the  addition  of  phenylalanine-
derived  imidazolidinone,  as  a nucleophilic  catalyst  to  a  mixture  of  aminodiene  62  and  
acrolein.  This  method  provided  cyclohexene  derivative  64  as  a  14:1  mixture  of  the  cis  
and  trans  diastereomers,  respectively.  Pure  64  was  converted  to  65  by  oxidation,  
esterification  and  dihydroxylation.  Both  chiral  Lewis  acid-  and  nucleophile-catalysed  
asymmetric  Diels-Alder  routes provided  65 in high  ee (> 98%) (Scheme  15).  
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A  combination  of  a  titanium-catalysed  asymmetric  Diels-Alder  reaction  with  
fumarate  hemi-ester  66,  followed  by  Curtius  rearrangement  and  neighbouring  group-
assisted  alkene  functionalization,  provided  the  hydroxy  lactone  69  as  a  single  
diastereomer.  Subsequent  methanolysis  gave  the  tetrasubstituted  cyclohexane  analogue  
70 (Scheme  16).  
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2.2.2.2.  By  transformation  of other functional  groups  
A  series  of  novel  /T amino  acids,  including  cw-2-amino-4-hydroxy-
cyclopentanecarboxylic  acid  diastereomers  77,  have  been  synthetized  and  tested  for  
97  98  
their  in  vitro  antifungal  activity  against  Candida  albicans  by  Mittendorf  el  al.  '  
Compound  77  was  prepared  in  a  straightforward  manner  as  dcpicted  in  Scheme  17.  
Commercially  available  butanetetracarboxylic  acid  (71)  was  converted  in  a  four-step  
sequence  to  cyclopentanone  diester  72  as  a  mixture  of  diastereomers  (trans/cis — 5:1). 
The  next  step,  a  one-pot  sequence  of  Wittig  methylation  and  ester  hydrolysis  provided  
the  dicarboxylic  acid,  mainly  as  the  trans  diastereomer  (trans/cis  =  50:1),  which  was  
completely  isomerized  to  the  cis  meso-anhydride  73.  In  the  fey  step,  a  highly  
enantioselective  quinine-mediated  alcoholysis  of  the  weso-anhydride  73  provided  
cinnamyl  ester  74  with  ee  >  97%.  Subsequent  Curtius  rearrangement  and  Pd-catalysed  
removal  of  the  cinnamyl  protecting  group  afforded  75  with  ee  >  99  %.  4-Hydroxy-
amino  acid  diastereomers  77  were  obtained  from the  protected  /hamino  acid  76  in  four  
steps. 
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Table  1 In  vitro  activity  of /Lamino  acids against  Candida  albicans  
Compound Structure IC50  (mg/L)  
75 COOH 
H 2 C * 0 " N H 2 
0.13 
yya, b COOH 
HO  NH2.HC1  
128 
78 NIH2. HCl 
C^""COOH 
0.13 
a  R a c e m i c ;  m i x t u r e  of  d i a s t e r eomers  
Kachenko  et  al.  prepared  diethyl  6-amino-4-hydroxy-2,4-dialkyl-cyclohexane-
•  53  
1,3-dicarboxylic  acid  derivatives  82a,b  in  good  yields  starting  from  oxoesters  79a,b.  
Oxoesters  79a,b  were  reduced  in  the  presence  of  ethanolic  ammonia  solution  through  
enamino  esters  80a,b,  or  in  the  presence  of  hydroxylamine  solution  through  oxime  
intermediates  81a,b  (Scheme  18).  The  relative  configurations  of  the  starting  material,  
intermediates  and  final products  were  not  fully characterized;  the  authors  reported  only  
elemental  analysis  and  IR spectral  data.  
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In  2003,  Fringuelli  et  al.  reported  the  first  one-pot  metal-catalysed  synthesis  of  
racemic  and  optically  active  a-hydroxy-/?-amino  acids  by  azidolysis  of  the  
corresponding  a,/?-epoxycarboxylic  acids  and  the  in  situ  reduction  of  the  resulting ¡3-
azido-a-hydroxycarboxylic  acid  intermediates.34  The same  metal  catalyst  mediated  both  
the  oxirane  ring  opening  by NaNi  and  the  azido  group  reduction  processes.  The  whole  
process  was  performed  solely  in  water,  without  the  use  of  any  organic  solvents.  The  
amino  acid  derivatives  were  isolated  in excellent  yields.  The  authors  prepared  a  number  
of  open-chain  and  a  single  cyclic  hydroxylated  amino  acid  85.  The  azidolysis  of  cyclic  
epoxide  83  and  the  reduction  of  racemic  azido  compound  84  were  fast  (30  min  each)  
and  the  copper  nitrate  catalyst  was  used  in  live  cycles  without  loss  of  its  efficiency  
(Scheme  19).  
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2.2.2.3.  Miscellaneous  
An  interesting  method  was  developed  by  Hansen  et  al.,  based  on  azidoformate  
ring  closure  to  cyclobutane  (Scheme  20).55  A  mixture  of  cis-  and  trans-hydroxy  esters  
86  was  transformed  to  azidoformates  87,  which  were  thermally  cyclized  to  
oxazolidinones  88a  and  88b.  The  cis  and  trans  isomers  were  separated  by  
chromatography.  After  Boc  protection  and  careful  cleavage  of  the  carbamate  
functionality,  3-hydroxy-substituted  /Z-aminocyclobutanecarboxylate  isomers  90a  and  
90b  were  obtained.  They  were  transformed to dipeptides  and  incorporated  into  a  longer  
peptide  sequence.  
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3.  RESULTS AND DISCUSSION 
3.1. Syntheses  of  new  amino  acids  
3.1.1.  Synthesis  of  l-aminoindane-2-carboxylic  acid,  a  new  cispentacin  
benzologue 
The  reaction  of  CSI  with  different cycloalkenes  is  a  well-known  route  for  the  
synthesis  of  cycloalkane-fused  /^-lactams56"58.  There  are  several  examples  in  the  
literature for the regio- and stereospecificity of the cycloaddition, in accordance with the 
Markovnikov  orientation  of  CSI  addition.59"61  For  example,  Murray  and  Cromwell62  
reported  the  synthesis  of  cw-N-chlorosulfonyl-3,4-benzo-6-azabiciclo[3.2.0]heptan-7-
one  (91).  Hydrolysis  of  the  sulfonyl  chloride  group  with  sodium  bisulfite  in  the  
presence  of  sodium  bicarbonate  gave  /?-lactam  92  in  relatively  low  yield  (41%).  This  
compound  is a suitable precursor  for the synthesis  of  l-aminoindane-2-carboxylic  acid.  
Our  aim was the  synthesis  of all four enantiomers  of  l-aminoindane-2-carboxylic  acid,  
a new cispentacin  benzologue.  
The pathways  of the  syntheses  of the racemic amino  acids  93  and  96  are  shown 
in  Scheme  21.  Chlorosulfonyl  isocyanate  addition  to  indene  takes  places  regio-  and  
stereoselectively,  resulting  in iV-chlorosulfonyl-/?-lactam  91.  The  general  procedure  of  
Murray  and Cromwell  was modified: The crystalline V-chlorosulfonyI-/?-lactam  91  was 
dissolved  in  diethyl  ether  and  added,  with  stirring,  to  a  mixture  of  sodium  sulfite  in  
water  and  diethyl  ether.  During  the  addition,  the  aqueous  phase  was  kept  slightly  
alkaline by addition of potassium hydroxide. In this method, the yield (63%) was higher 
than  described  above.  Treatment  of  92  with  hydrochloric  acid  resulted  in  amino  acid  
hydrochloride  93,  while  treatment  with  ethanolic  hydrogen  chloride  led  to  ethyl  ester  
95.  Sodium  ethoxide  isomerization  of 95,  followed by acidic hydrolysis,  resulted  in the 
trans  amino acid hydrochloride  96. The free amino acids of 93 and  96 were liberated by 
ion-exchange  chromatography.  The  N-hydroxymethylated  /^-lactam  94,  the  starting  
compound  of  the  enzymatic  reactions,  was  prepared  from  93  with  paraformaldehyde  
under  sonication.  
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(±)-94  (±)-95  (±)-96  
Scheme  21  
The  intermediate  racemie  hydroxymethylated  /?-lactam  94  was  resolved  through  the  
lipase-catalysed  asymmetric  acylation  of  the  primary  hydroxy  group  at  the  (J?)  
stereogenic  centre.  High  enantioselectivities  (E>200)  were  observed  when  the  
enzymatic  reactions  were  performed  with  lipase  AK  or  lipase  PS  as  catalyst  and  vinyl  
acetate  or vinyl  butyrate  as  acyl  donor.  The hydrolysis  and  isomerization  resulted  in  all  
four  enantiomers  (99,  102,  103  and  104)  of  l-aminoindane-2-carboxylic  acid,  a  new  
benzologue  of cispentacin  (Scheme  22).  
X-ray  investigation  revealed  the  absolute  configuration  of  101.  Amino  ester  base  101  
was  transformed  to  the  thiourea  compound  105  by  reacting  it  with  (IS,2S)-1,3-
diacetoxy-l-(4-nitrophenyl)-2-propyl  isothiocyanate  (DANI).63'64  The  X-ray  structure  
(Fig.  1) clearly  shows the  (R,R) configuration of the  starting  101.  
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Figure  1 ORTEP plot  of the X-ray  structure  of thiourea  105  
3.1.2.  Syntheses  of  alicyclic  hydroxy-¡3-amino  acids  
In  recent  years,  a  number  of  new  syntheses  of  functionalized  cyclic  //-amino  
acid  derivatives  have  been  reported  (see  e.g.  refs.,  33,  46,  52,  54).  Among  them,  
hydroxy-substituted  //-amino  acids  are  of  considerable  importance  because  of  their  
occurrence  in  many  biologically  active  compounds  {e.g.  taxol  and  related  molecules).14"  
'7  Our  present  aim  was  to  introduce  an  extra  hydroxy  group  at  position  4  or  5  of  the  
cyclohexane  ring.  For  these  syntheses,  the  readily  available  cis-  and  trans-2-amino-4-
Page  27  
cyclohexenecarboxylic  acids  were  used.  For  the  derivatization,  we  considered  two  
strategies:  cyclization  on  an  acylamino  derivative  via  1,3-oxazine  formation,  or  
cyclization  on  a  carboxylic  acid  function  via  lactone  formation  (iodolactonization  
protocol). 
The  starting  c/'s-2-amino-4-cyclohexenecarboxylic  acid  was  prepared  by  
hypochlorite-mediated  Hofmann  degradation  of  the  carboxamide  obtained  by  
ammonolysis  of  cz's-1,2,3,6-tetrahydrophthalic  anhydride.65  The  amino  acid  was  
esterified  in  the  presence  of ethanol  and  thionyl  chloride,  then  acylated  with  /e/T-butoxy  
pyrocarbonate,  acetic  chloride  or  benzoyl  chloride,  resulting  in V-acylated  amino  esters  
106a-c,  respectively.  
With Wiodo-  (NIS) or jV-bromosuccinimide  (NBS)  (for a related  transformation,  
see  e.g.  ref.  66),  the A-Boc  derivative  106a  gave  oxazinone  107,  while the Wacetyl  and  
Wbenzoyl  derivatives  106b  and  106c  furnished  the  corresponding  methyl-  or  phenyl-
substituted  oxazines  110a,b  and  l l l a , b  regio-  and  diastereoselectively  (Scheme  23).  
Not  even  traces  of  other  regio-  or  diastereomers  were  observed  in  the  crude  product.  
Iodooxazinone  107  and  bromo-  or  iodooxazine  derivatives  110a,b  and  l l l a , b  were  
dehalogenated  with  tributyltin  hydride  under  an  argon  atmosphere,  resulting  in  
compounds  108  and  112a,b,  respectively.  Acidic  hydrolysis  of  108  gave  the  stable  
oxazinonecarboxylic  acid  derivative  109,  which  slowly  decomposed  on  further  heating.  
Hydrolysis  of  oxazine  112b  with  20%  aqeous  HC1,  and  removal  of  the  HC1  by  ion-
exchange  chromatography  led  to  the  all-cis  isomer  of  2-amino-4-hydroxy-
cyclohexanecarboxylic  acid  113.  
NH 
COOEt Bu3SnH 
— -  r  nh  
DCM  O - V  
COOEt  H C 1  COOH 
H 2 0  o ^  
o 
107 108 
O O 
109 
113 
X  =  I  :  110a,b 
X  =  Br  : 111a,b 
112a,b 
Scheme  23  
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The  corresponding  /rara-2-amino-4-cyclohexenecarboxylic  acid  was  prepared  
by Hofmann degradation  of the carboxamide  obtained  by ammonolysis  of  trans-1,2,3,6-
tetrahydrophthalic  anliydride.  The  amino  acid  was  esterified,  and  subsequent  treatment  
with  acetic  chloride  resulted  in V-acetylamino  ester  114.  By  a similar  transformation  as  
for  the  cis  isomer  106b,  the  /ra/7s-2-acetylamino-4-cyclohexenecarboxylic  acid  114  
reacted  via  the  iodooxazine  intermediate  115  to  furnish  the  corresponding  (r-l,/-2,/-4)-
2-amino-4-hydroxycyclohexanecarboxylic  acid  116  (Scheme  24).  
Me 
O^Me  , 1  HO^x-^NHj  
1  N1S  |  |  l .Bu 3 SnH/DCM  
^  ^  DCM  y  i  2.  HC1 / H 2 0  ^  COOH  
u . COOEt 
114 
COOEt  1 ) 6  
115 
Scheme  24  
For  the  synthesis  of  the  corresponding  norbornane  derivatives,  endo-3-
f\ 7 
aminobicyclo[2.2.1]hept-5-ene-2-carboxylic  acid  derivative  117  was  chosen.  When  N-
acetylamino  ester  117  was  reacted  with  NIS  or  NBS,  tricyclic  1,3-iodo-  or  
bromooxazine  derivative  118a,b  was obtained,  stereoselectively.  Iodo-  or  bromooxazine  
derivative  118a,b  underwent  dehalogenation  with  tributyltin  hydride  under  an  argon  
atmosphere,  resulting  in  compound  119.  Hydrolysis  of  oxazine  119  with  dilute  HC1 at  
room  temperature  gave  the  7V-acetyl-hydroxy  amino  acid  120.  When  V-acetyl-hydroxy  
amino  acid  120  was  boiled  in acidic  solution,  endo  exo  isomerization  took  place  and  
the  forced  conditions  resulted  in  3,5-diendo-2-exo-3-ammo-5-
hydroxybicyclo[2.2.1]heptane-2-carboxylic  acid  hydrochloride  (121)  as  the  main  
product.  The mother  liquor was treated  with  a large excess of propylene  oxide,  and after 
fractional  crystallization  compound  122  was  also  isolated  as  a  diastereomerically  
enriched  (8:2)  mixture  (Scheme  25).  The  correct  configuration  of  the  bydroxylated  
amino  acids  121  and  122  was  proved  indirectly,  the  stereostructures  of  120  and  123  
being  established  via  a  D1FFNOE  technique  and  also  by  chemical  transformation:  
esterification  of  121  led  to  hydroxylated  amino  ester  123,  while  122  after  acetic  acid  
treatment  gave  an TV-acetyl  derivative.  The NMR  spectra  of the  resulting  compound  was  
identical  with  those  of  tf//-ercJo-3-acetylamino-5-hydroxybicyclo-[2.2.1]heptane-2-
carboxylic  acid  (120).  
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Stereoselective  iodolactonization6  was  the  key  step  in  the  synthesis  of  2-amino-
5-hydroxycyclohexanecarboxylic  acid.  The  reactions  of  jV-benzoyl-  and  N-Boc-
protected  cA-2-amino-4-cyclohexenecarboxylic  acid  124a,b  with  T/KI  in  slightly  
alkaline  medium  yielded  iodolactones  125a,b  in fairly good  yields, with excellent  regio-
and  diastereoselectivity;  the  products  were  reduced  with  tributyltin  hydride  to  give  
lactones  126a,b.  The  acidic  hydrolysis  of  benzoyl  derivative  126a  did  not  give  the  
desired  amino  acid;  instead,  decomposition  took  place.  When  the  N-Boc  lactone  126b  
was  hydrolysed  after  ion-exchange  chromatography,  the  all-cis  isomer  of  2-amino-5-
hydroxycyclohexanecarboxylic  acid  127 was obtained  in 66% yield (Scheme  26).  
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X-ray  diffraction  studies  confirmed  the  structure  of  127.  All  the  bonding  parameters  
were  in  the  usual  ranges.  The  molecular  structure  and  extensive  hydrogen  bonding  
system  of  127  are presented  in Fig.  2.  
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Figure  2 Crystal  structure  of  127,  showing the hydrogen  bonding  scheme  
By  a  similar  transformation,  from  (ram-2-ter/-butoxycarbonylamino-4-
cyclohexenecarboxylic  acid  (128)  via  iodolactone  129,  the  corresponding  (r-l,t-2,c-5)-
2-amino-5-hydroxycyclohexanecarboxylic  acid  (131) was prepared  (Scheme  27).  
O^ N H B o c v 'COOH 
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Scheme  27  
By  the  same  method  the  corresponding  all-endo-3-amino-6-
hydroxybicyclo[2.2.1]heptane-2-carboxylic  acid  (135)  was  obtained  from  N-Boc-endo-
3-aminobicyclo[2.2.ijhept-5-ene-2-carbo\ylic  acid  (132)  (Scheme  28).  The  given  
stereochemistry  and  the  relative  configurations of the synthetized  compounds  (106-135)  
were proved  by using certain key vicinal couplings  and characteristic  NOEs.  
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The  syntheses  of  enantiomeric  cis  compounds  (+)-113  and  (-)-127  were  
performed  from  rac-7-azabicyclo[4.2.0]oct-3-en-8-one  by  CAL-B  treatment  with  one  
f-n 
equivalent  of  H2O  in  isopropyl  ether  as  described  earlier.  The  enantiopure  ¡3-lactam  
obtained  was  transformed  with  18%  HC1  into  the  (15',27?)-2-amino-4-
s O 
cyclohexenecarboxylic  acid  hydrochloride.  The  syntheses  of  4-hydroxy-  and  5-
hydroxyamino  acid  enantiomers  (+)-113  and  (-)-127  were  carried  out  similarly  as  for  
the  racemic  compounds  given  in  Schemes  23  and  26,  resulting  in  the  products  with  ee  
>98%. 
3.2.  Ring-closure  reactions  of  alicyclic  (3-amino acid  derivatives  
3.2.1.  Synthesis  and  mild  retro  Diels-Alder  decomposition  of  1,4-methanopyrrolo-,  
1,4-methanopyrido-  and  l,4-methanoazepino[2,l-h]-quinazolinones  
Fused  pyrimidinones  are  widely-used  sources  for the  synthesis  of new  potential  
therapeutic  agents.69"73  The  pyrrolo-  and  pyrido[2,l-6]quinazolinones  include  well-
known  alkaloids  isolated  from  a  number  of  families  of  plants.  Adhatoda  vasica  
containing  vasicine  (peganine)  has  been  used  in  Indian  indigenous  medicine  for  
centuries.  Because  of  their  therapeutic  interest,  the  syntheses  of  pyrido[2,l-
6]quinazolin-l  1-one  derivatives  and  their  ring  A  and  C  homologues  have  been  studied  
71  72  
very  thoroughly.  "  Although  numerous  papers  deal  with  the  synthesis  of  pyrido[2,l-
6]quinazolin-l  1-ones  and  their  differently  saturated  analogues  and  homologues,  the  
corresponding norbornane-  and norbornene-fused derivatives  141-144  are not  known.  
In  the  first  experiments  for  the  synthesis  of  tetracycles  141-144,  3-exo-
aminobicyclo[2.2.1]hept-5-ene-2-exo-carboxylic  acid74  or  the  corresponding  saturated  
derivative  or  either  of the  ethyl  esters  was  refluxed in  chlorobenzene  with  2  equivalents  
of  lactim  ethers  137-140,  as  described  for  the  synthesis  of  cis-  and  trans-
ne 
decahydropyrido[2,l-6]quinazolin-l  1-one.  After  re fluxing  for  24  h,  the  starting  
materials  were  recovered  unchanged.  When  azetidinones74'76  136a  and  136b  were  
reacted  in  chlorobenzene  with  lactim  ethers,  a very  slow  transformation  was  observed,  
and the reaction  mixture turned  deep-brown.  
On melting  of the azetidinones  136a  and  136b  with  2 equivalent  of lactim  ethers  
137-140  at  80  °C  for  8-10  h,  the  desired  tetracycles  141a,b-144a,b  were  obtained.  The  
first  step  of  the  reaction  is  the  formation  of  an  amidine  intermediate  which,  after  
77  •  •  
transamidation,  results  in  the  ring-enlargement  products  141a,b-144a,b.  On  increase  
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of the  temperature,  the  colour  of  the  reaction  mixture  becomes  deeper,  and  in the  series  
136a  the  smell  of  cyclopentadiene  is observed.  Following  the  melting  of  136a  with  138  
at  100  °C,  6,7,8,9-tetrahydropyrido[l,2-a]pyrimidin-4-one  (146)  was  isolated  in  low  
yield  through  the  splitting-off  of  cyclopentadiene.  Retrodiene  decomposition  under  
similarly  mild  conditions  was  described  only  recently  for  the  synthesis  of  monocyclic  
1,3  derivatives.78  The  bicyclic  hetero  compounds  pyrimido[2,l-è]thiazin-6-one  and  
79 
thiazolo[3,2-tf]pyrimidin-5-one  have  also been prepared  by this  method.  
In  order  to  establish  the  scope  and  limitations  of  this  retrodiene  decomposition  
resulting  in  heterobicycles,  tetracycles  141-144  were  melted  at  100  °C.  When  141a-
144a  were  melted  for  30  min,  pyrrolo-,  pyrido-  and  azepino[l,2-û]pyrimidinones  145-
148  were  formed  in  good  yield,  by  the  splitting-off  of  cyclopentadiene.  Starting  from  
the  series  141b-144b,  the  formation  of  145-148  could  not  be  observed  under  similar  
conditions  (Scheme  29).  
Because  of  their  pharmacological  interest,  a  number  of  different  routes  have  
been  devised  for  the  synthesis  of  substituted  analogues  of  145-148.  Our  method  is  a  
new, effective procedure  for the preparation  of the  above  derivatives.  
R 
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138,142,  146  1 Me 
139,143,  147  2 H 
140,144,  148  3 H 
Scheme  29  
Sodium  borohydride  reduction  of  143a  resulted  stereospecifically  in  the  
decahydro  derivative  149  with  relative  configuration  /'-l,c-4,c-4a,c-5a,c-lla.  When  
143b  was  reduced  with  sodium  borohydride,  the  perhydro  derivative  150  was  formed  
(Scheme  30).  Their  similar  relative  configurations  were  proved  both  spectroscopically  
and  chemically:  catalytic  reduction  of  149  gave  a  compound  identical  with  the  product  
of  150.  Attempted  retrodiene  decomposition  from  both  149  and  150  was  unsuccessful.  
The  successful  and  failed  retro  Diels-Alder  reactions  show  that  a  retrodiene  
decomposition  takes  place  under  mild  conditions  only  when  the  decomposition  results  
in  a  heterocycle  with  a  quasi-aromatic  character  through  the  splitting-off  of  
cyclopentadiene. 
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3.2.2.  Synthesis  and  transformations  of  stereoisomeric  ethyl  2-isothiocyanato-
1-cyclopentanecarboxylates 
Isocyanato  and  isothiocyanato  compounds  are widely  used  for the preparation  of  
ureas,  thioureas  and  heterocyclic  derivatives,81  which  have  a  wide  range  of  biological  
activities. 
c/£-2-Aminocyclopentanecarboxylic  acid  was  prepared  from  cyclopentene  by  
addition  of  CSI  and  subsequent  ring  opening  of  the  resulting  azetidinone  with  
hydrochloric  acid.82  The  trans  isomer  was  obtained  by  the  addition  of  ammonia  to  1-
cyclopentene-l-carboxylic  acid.83  The  amino  acids were transfonned  to the amino  ester  
hydrochlorides  15184  and  1568  with  thionyl  chloride  and  ethanol.  Ethyl  cis-  and  trans-
2-isothiocyanato-l-cyclopentanecarboxylates  152  and  157  can  be  prepared  through  
reaction  of  the  ester  hydrochlorides  151  and  156  with  thiophosgene  in  the  presence  of  
sodium  hydrogencarbonate  at  40  °C  and  subsequent  column  chromatography  of  the  
crude  oily products  (Schemes  31 and  32).  
Isocyanates  152  or  157  were  reacted  with  different  amines  and,  depending  on  
the  reagents,  the  ratio  of  the  reactants  and  the  configuration  of  the  isothiocyanate,  three  
different  products  were  formed.  The  cis  152  with  two  equivalents  of  ammonia  or  
methylamine  gave  the  corresponding  2-thioxo-l,2,3,4a,5,6,7,7a-octahydro-
cyclopenta[c/]pyrimidin-4-ones  153a  and  153b,  respectively.  When  an  excess  of  
ammonia  was  used,  the  product  was  again  153a,  but with  an excess  of methylamine  the  
cis  152 gave the thiourea  155: the  ester was amidated  rather than ring closure  occurring.  
Reactions  of  substituted  amines  such  as  isopropylamine,  benzylamine,  
phenylethylamine,  aniline  and  p-toluidine  with  152  resulted  in  the  corresponding  
thioureas  154c-g.  Thiourea  154b  was  prepared  from  151  with  methyl  isothiocyanate  as  
described  earlier.86  Thioureas  154  can  readily  be  cyclized  using  either  acidic  (HC1)  or  
basic  (e. g.  NH3)  catalysts.  
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When  the  trans  157  ester  isothiocyanate  (Scheme  37)  was  reacted  with  amines,  
formation  of  the  pyrimidinone  160  was  not  observed,  even  under  forcing  conditions.  
However  the  reaction  with  ammonia  or  methylamine  led  to  the  thiourea-amide  
derivatives  158a,b.  With  aniline  or p-toluidine,  the  trans  thioureas  159a  and  159b  were  
formed  in  good  yields.  The  cyclization  of  trans  thioureas  159a  and  159b  failed  under  
both acidic  and basic  conditions.  
NH2.HC1  C S C 1 2 / 0 H ®  AY N C S  
R N H , 
H 
N ^ N H R  H C L O R  / A - L N Y S  on NH3 COOEt  o  
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R =  Ph:  a  
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Scheme  32  
It  is noteworthy  that  in the  ring  closures  of the  l,2-disubstituted-l,3-difunctional  
cyclohexane,  cycloheptane  and  cyclooctane  derivatives,  no appreciable  differences were 
found  in  the  reactivities  of  the  cis  and  trans  isomers  in  the  formation  of  six-membered  
o  on  
1,3-heterocycles  fused  with  carbocycles.  '  In  contrast,  very  striking  differences  were  
observed  in  the  cyclization  reactivities  of  the  cis-  and  trans-1,2-disubstituted  1,3-
difunctional  cyclopentane  derivatives,  such  as  2-hydroxymethyl-l-cyclanols  and  
alicyclic  2-aminomethyl-1 -amines,  or  in  the  cases  of  cis-  and  tnmyA-hydroxy-l-
cyclopentanecarboxamides  or  cis-  and  trara-2-aminocyclopentanecarboxylic  acids.  The  
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cis  isomers  react  readily,  while  their  trans  counterparts  do  not  undergo  ring  closure  in  
most  cases.  
The  differences observed  in the  present  study  may  serve  as  supporting  evidence  
for the differences in the  ring-closure  reactivities  of  cis-  and  trans-1,2-disubstituted  1,3-
difunctional cyclopentane  derivatives.  
3.2.3.  Synthesis  of  indano[l,2-d][l,3]oxazines  and  thiazines,  new  ring  systems  
With  racemic  ethyl  cis-  and  /ra«.s-l -aminoindane-2-carboxylate  (95  and  161)  
available,  our  present  aim  was  to  prepare  cis-  and  trara-l-amino-2-
hydroxymethylindane  and  to  examine  the  chemistry  and  stereochemistry  of  indane-
fused  1,3-oxazines  and  thiazines.  The  cis-  and  tram'-unsubstituted  and  c/s-X-benzyl-
substituted  1,3-amino  alcohols  163-165  were  prepared  by  LÍAIH4  reduction  or  by  
benzoylation  followed by reduction, respectively  (Scheme  33).  
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Scheme 33  
For  the  preparation  of  2-thioxo-1,3-oxazines  166  and  167  the  most  common  
method  is  the  reaction  of  the  appropriate  1,3-amino  alcohols  163  and  165  with  carbon  
disulfide,  followed  by  cyclization  of  the  resulting  thiourea  with  lead(II)  nitrate.  
Cyclization  of the  corresponding  1,3-amino  alcohol  163 with  ethyl  p-chlorobenzimidate  
resulted  in  the  dihydro-l,3-oxazine  168.  The  synthesis  of  heterocycles  171-173  started  
from  the  adducts  of  the  corresponding  amino  alcohols  163  and  165  with  ethyl  
isothiocyanate.  Treatment  of  thioureas  169  and  170  with  methyl  iodide  followed  by  
alkali  treatment  led  to  the  elimination  of  methyl  mercaptan,  resulting  in  the  oxazines  
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171  and  172  in good  yields.  Treatment  of thiourea  169 with  ethanolic  hydrogen  chloride  
under reflux, followed by treatment  with  alkali, provided  thiazine  173 (Scheme  34).  
R  S  
NHR 
OH C S 2 / K 0 H / P b ( N 0 3 ) 2 
163,  165  166,  167  
R = H 
ethyl p-chloro-
benzimidate 
/ toluene /  A  f  
N— 
R =  H,  CH2Ph 
EtNCS /  EtiO /  r.t.  
NHEt 
OH 
X = 0:  Mel /NaH  
R =  H,  X =  S:  
HCl /EtOH/A 
R  NEt  
N - < 
X 
169,170 
X  = 0:  171,  172  
X =  S:  173  
Scheme 34  
The  cis  amino  alcohol  163  was  condensed  in  methanolic  solution  with  seven  
substituted  aromatic  aldehydes  with  different  electronic  characters.  The  reactions  
reached  completion  within  a  few  hours,  even  at  room  temperature.  After  evaporation  
and  purification,  well-defined  products  174a-g  were  obtained,  which  existed  as  three-
component  tautomeric  mixtures  in  CDCft.  For  the  tautomeric  equilibria  to  be  reached,  
the  substances  were  allowed  to  stand  for  24  h  in  CDCI3  (Scheme  35).  The  relative  
configurations  of  the  various  structures  174A,B,C  were  determined  via  the  NOESY  
spectra,  on the basis  of the  observation  of NOEs between  the NH-C//Ar-0  and  the N! I-
CH-CH  hydrogen  atoms.  
N H 2 
OH 
CHO 
163 
N=CH 
OH 
174Ba-g 174Aa-g 174Ca-g 
X  = p -N0 2 :  a; m-Br: b;p-Cl:  c; H: d;p-Me:c;p-OMe:  f;p-NMe2:  g  
Scheme  35  
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Comparative  studies  were  carried  out  earlier  on the  ring-chain  tautomerism  of  a  
CO  OO  Q-y  
wide  range  of  2-aryl-substituted  tetrahydro-l,3-oxazines.  '  "  For  all  these  series,  the  
following equation  is valid: 
log Kx  = po+  + log K  x=H  (1)  
where  Kx =  [ring]/[chain]  and p i s  a constant  characteristic  of the ring  system.  In  CDCI3  
at  ambient  temperature,  p  is  0.76  for tetrahydro-l,3-oxazines.  When  eq.  (1) was  applied  
to  the  log  Kx  values,  good  linear  correlations  were  obtained  vs  the  Hammett-Brown  
parameter  (cr+)  of  the  substituent  X  on  the  2-phenyl  group  for  compounds  174a-g  
(Tables  2  and  3,  Fig.  3).  The  tautomeric  ratios  are  based  on the  integration  of the  174B  
and  174C ring form NH-C//Ar-0  and the  174A chain  form N=CH proton  singlets.  
The  linear  regression  analysis  data  in Table  3 show that,  as customary  among  2-
aryl-substituted  tetrahydro-l,3-oxazines,  the  value  of  p  is  positive  in  each  case,  i.e.  an  
electron-withdrawing  substituent  on  the  2-aryl  ring  favours  the  ring-closed  tautomer.  
The  proportion  of  the  ring  form  for the  trans-2-ary\-\  ,3-0,N  heterocycles  174C  varies  
within  a  somewhat  wider  range  (10.7-54%)  than  that  for  the  corresponding  cis-2-aryl-
1,3-0,N  heterocycles  174B  (9.2-41.7%).  The  relative  configuration  of  the  ring-closed  
products  does  not  seem  to  influence  the  value  of  p:  cis-  and  trans-2-axy\-\,3-0,N  
heterocycles  have very  similar values  of p(0.78  and  0.81).  
Table  2 Proportions  (%) of ring forms  (B  and C)  in tautomeric  equilibria for 
compounds  174a-g  in  CDCI3  at 300  K  
Compound X + cr B  (%)  C  (%)  
174a p-N0 2 0.79 41.7 54.0 
174b m-Br 0.05 39.3 49.8 
174c p-CI 0.114 35.8 50.5 
174d H 0 35.1 41.5 
174e p-Me -0.31 29.6 35.9 
174f p-OMe -0.77 22.9 28.2 
174g p-NMe2 -1.7 9.2 10.7 
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Figure  3 Plots of  log  Kx  V5 a  for compounds  174a-g:  B (X),  C  (+)  in  CDC13  
Table  3 Linear regression  data for compounds  174a-g  
89 
B C 89 
Intercept 0.32 0.42 0.22 
Slope 0.78 0.81 0.72 
Corr. coeff. 0.981 0.979 0.991 
No.  of  points  7 7 6 
he data for the corresponding  cyclopentane-fused  tetrahydro-l,3-oxazines  
When  the  trans-amino  alcohol  164  was  condensed  in  methanol  with  p-
nitrobenzaldehyde,  a  well-defined  product  was  obtained,  which  exists  solely  as  the  
open,  Schiff base  form  175  (Scheme  36).  In this  case,  the  OH  group  is too  far from  the  
N=CH  bond  (4.5  A),  and  intramolecular  proton  transfer  is  not  possible  without  energy  
transfer (Fig.  4)  
N O 2 
/A 
NH, 
CHO -CH 
MeOH  /  r.t.  
OH OH 
164 N 0 2 
Scheme  36  
175 
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174Ad  175  
Figure 4 Stereoview  of typical  minimum energy molecular  structures  
for 174Ad  and  175  
When  the  iV-benzylamino  alcohol  165  was  condensed  with  aldehydes  in  
methanolic  solution  at room temperature,  only one diastereomer  176a-c was observed  in  
the  CDCI3  solution  of  the  product  at  300  K  (Scheme  37).  The  product  formed  is  
stabilized by aromatic-aromatic  interactions  (Figure 4).  
X = p-N02 :  a;  H: b; p-NMe2:  c  
Scheme 37 
176b 
Figure 5 Stereoview  of typical  minimum energy molecular  structure for  176b  
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3.2.4. Synthesis  of imidazo[r,S':l,2]pyrido[3,4-bJindole  derivatives  
The  /?-carboline  structure  is  present  in  important  natural  compounds,  and  its  
derivatives exert various pharmacological  effects on the benzodiazepine receptors in the 
mammalian  central  nervous  system.  In  1994,  in  a  programme  with  the  goal  of  
developing  new  drugs  affecting  the  central  nervous  system,  Lopez-Rodrigez  et  al.  
studied  the  possibilities  of  ring-closure  of  the  1,2,3,4-tetrahydro-/?-carboline-1 -
carboxylic  acid  (177)  with  alkyl  and  aryl  isothiocyanates  under  vigorous  conditions  
(refluxing for 40  h  in  acetone  or  DMSO).  In  their  case,  the  corresponding  hydantoin  
QO 
analogues  were  formed.  Some  further  derivatives  of  the  4-ring  hydantoins  exert  
pharmacological  effects  on  ai-adrenoreceptors.94  However,  the  synthesis  of  
thiohydantoin  derivatives  remained  unsolved  under  the  circumstances  applied:  in  the  
reactions  of  177  and  isothiocyanates,  decarboxylation  took  place,  and  open-chain  
thiourea derivatives were isolated instead of the desired thiohydantoins. 
Our  present  aim  was  to  attempt  the  synthesis  of  thiohydantoin-fused  
imidazo[ 1',5': 1,2]pyrido [3,4-6]indole  derivatives  under  mild  conditions,  based  on  the  
results  of  similar  ring  closures,8  starting  from  ethyl  1,2,3,4-tetrahydro-yff-carboline-l-
carboxylate (178). 
l,2,3,4-Tetrahydro-/?-carboline-l-carboxylic  acid  (177)  was  obtained  from  
tryptamine  hydrochloride  and  glyoxylic  acid.95  Racemic  177  was  esterified  by  two  
methods (Scheme 38): refluxing in ethanol with thionyl chloride (method A) or reaction 
with  dry  hydrogen  chloride  gas  in  ethanol  (method  B).  Besides  178,  both  methods  
resulted  in a by-product, the  hydrochloride  of  1,2,3,4-tetrahydronorharmane  (179)  as a 
consequence  of  decarboxylation.  This  side-product  could  be  filtered  off  from the  hot  
ethanolic solutions. Method A gave a somewhat higher yield (A: 76%, B: 57%). 
When the  ester  base  178 was  combined  with  alkyl  and  aryl  isothiocyanates  at  
room  temperature  in  methanol,  the  corresponding  target  thiohydantoins  180  could  be  
filtered off from the reaction mixtures after stirring  overnight. No decarboxylation was 
observed  during  the  reactions,  and  no  intermediates  or  by-products  could  be  isolated  
from  the  residues.  From  the  reactions  of  177  and  isothiocyanates  under  the  same  
conditions,  but  with  sodium  methylate  as  the  catalyst,  the  thiohydantoins  180  were  
obtained  in  rather  low yields.  The  structures  of  the thiohydantoin  compounds  180a-h,  
involving two conformers and the presence of keto-enol tautomerism, were  determined  
by NMR spectroscopy.  In the reactions  of  178 and ethyl  and phenyl  isocyanates  under  
similarly  mild  conditions,  the  corresponding  urea  derivatives  181a,b  were  formed  as  
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crystalline  products.  These  were  cyclized  by  refluxing  in  ethanol  for  1  day  under  
hydrochloric  acid  catalysis.  Hydantoin  compounds  182a  and  182b  were  formed  in  
p-tolyl:  f; p-C 1-C2H4: g; p-OMe-C2H4  : h 
Scheme 38  
3.3.  Methods  
Details  of  syntheses,  physical  and  analytical  data  on  new  compounds  described  
in  the  thesis,  and  descriptions  of  NMR  spectroscopic  analyses  of  tautomeric  equilibria  
can be found  in the Experimental  part  of the enclosed  publications.  
Page 42 
4.  SUMMARY  
Chlorosulfonyl  isocyanate  addition  to  indene  takes  places  regio-  and  
stereoselectively,  in  accordance  with  the  Markovnikov  orientation  rule,  resulting  in  
czs-A/-chlorosulfonyI-3,4-benzo-6-azabicyclo[3.2.0]heptan-7one  (91),  which  was  
hydrolysed with  sodium sulfite to /?-lactam  92. Treatment of 92 with hydrochloric acid 
resulted  in  cis-1 -aminoindane-2-carboxylic  acid  hydrochloride  (93),  while  treatment  
with  ethanolic  hydrogen  chloride  led to  ethyl  ester  95.  Sodium  ethoxide  isomerization  
of  95,  followed by acidic hydrolysis,  resulted  in the  trans-1 -aminoindane-2-carboxylic 
acid  hydrochloride  (96).  The  free  amino  acids  of  93  and  96  were  liberated  by  ion-
exchange  chromatography.  Starting  from  /J-lactam  92,  the  syntheses  of  all  four  
enantiomers  of  1-aminoindane-2-carboxylic acid  99  and  102-104 proved possible by a  
combination  of  lipase-catalysed  0-acylation,  hydrolysis  and  isomerization.  The  
absolute  configurations  of  the  prepared  amino  acids  were  determined  by  X-ray  
investigation. 
By  means  of  highly  regio-  and  diastereoselective  functionalizations of  cis-  and  
/rans-2-amino-4-cyclohexenecarboxylic  acid  derivatives,  isomers  of  new  hydroxy-
substituted  /?-amino  acids  were  prepared.  V-Acyl  derivatives  of  106  and  114  were  
transformed  to  1,3-oxazines  107,  110,  111  and  115  by  using  N-bromo-  or  N-
iodosuccinimide.  Selective  reduction  of the  halogen  group  and  subsequent  hydrolysis  
led  to  the  diastereomers  of  a//-cis-2-amino-4-hydroxycyclohexanecarboxylic  acid  
(113)  and (r-l,t-2,c-4)-116.  Iodolactonization  of //-protected  amino acids  124 and  128  
resulted  in  y-lactone  intermediates  125  and  129,  which  were  transformed  to  
regioisomeric  <z//-m-2-amino-5-hydroxycyclohexanecarboxylic  acid  (127)  and  (r-\,t-
2,c-5)-131  diastereomers  via  selective  reduction  and  hydrolysis.  The  syntheses  of  
enantiomers  (+)-113  and  (-)-127  were  carried  out  similarly  as  for  the  racemic  
compounds.  By  the  same  method,  the  corresponding  3,5-diendo-2-exo-3-amino-5-
hydroxybicyclo[2.2.1]heptane-2-carboxylic  acid  hydrochloride  (121)  and  all-endo-3-
amino-6-hydroxybicyclo[2.2.1]heptane-2-carboxylic  acid  hydrochloride  (135)  were  
obtained  from  ¿fre«£fo-3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylic  acid  derivatives  
117 and  132.  
On  melting  of  the  norbornene-  and  norbornane-fused  azetidinones  136a  and  
136b,  and  lactim  ethers  137-140,  1,4-methanopyrrolo-,  1,4-methanopyrido-  and  1,4-
methanoazepino[2,l-6]quinazolinones  141a,b-144a,b,  new  ring  systems,  were  
prepared.  The  first  step  in  the  reaction  is  the  formation  of  an  amidine  intermediate  
Page 43 
which,  after transamidation,  results  in  the  ring  enlargement  products  141a,b-144a,b.  
Norbornene  derivatives  141a-144a  underwent  retrodiene  decomposition  to  give  
pyrrolo-,  pyrido-  and  azepino[l,2-a]pyrimidinones  145-148,  respectively.  This  is  a  
new method for the synthesis of heterobicycles  145-148.  
Ethyl  cis-  and /raws-2-isothiocyanato-l-cyclopentanecarboxylates  (152 and  157)  
were  prepared  by  the  reactions  of  corresponding  alicyclic  ethyl  2-amino-l-
carboxylates  and  thiophosgene.  The  cis  isothiocyanate  152  underwent  ring  closure  
with  amines,  resulting  in  3-substituted-cw-2-thioxo-cyclopenta[fi(]pyrimidin-4-ones  
153a-g.  The  trans  isomer  155  failed  to  cyclize,  but  gave  carboxamide  158a,b  or  
thiourea  ester  derivatives  159a,b.  The  differences observed  in  the  present  study  may  
serve  as  supporting  evidence  for the differences in the ring-closure  reactivities  of  cis-
and trans-1,2-disubstituted  1,3-difunctional cyclopentane  derivatives.  
By ring-closure  reactions  of  cis-1 -amino-2-hydroxymethylindane  (163)  and  cis-
l-benzylamino-2-hydroxymethylindane  (165)  with  carbon  disulfide,  ethyl  p-
chlorobenzimidate,  ethyl  isothiocyanate/methyl  iodide,  ethyl  isothiocyanate/hydrogen  
chloride,  indano[ 1,2-<¿] [ 1,3 ]oxazinone  and  thiazine,  new  ring  systems  were  prepared.  
The  reactions  of  trans-1 -amino-2-hydroxymethylindane  (164)  with  p-nitro-
benzaldehyde gave Schiff base  175, while the reactions of TV-benzyl amino alcohol  165  
with  substituted  benzaldehydes  resulted  in  ring-closure  products  176a-c  alone.  The  
same  reactions  of  cz'.y-1-amino  alcohol  163  led  to  2-substituted-indano[l,2-
¿(][l,3]oxazinones  (174a-g),  which  at  300  K  in  CDCI3  proved  to  be  three-component  
tautomeric  mixtures  containing  C-2  epimeric  indanooxazines  (174Ca-g  >  174Ba-g),  
besides the open tautomer  (174Aa-g)  
Racemic  l,2,3,4-tetrahydro-/?-carboline-l-carboxylic  acid  (177)  was  esterified  
by  refluxing  in  ethanol  with  thionyl  chloride  or  reaction  with  dry  hydrogen  chloride  
gas in ethanol.  The reactions  of  l,2,3,4-tetrahydro-/?-carboline-l-carboxylic  acid  (177)  
and  its  ester  178 with  alkyl  and  aryl  isothiocyanatcs  under  mild  conditions  resulted  in  
the  corresponding  2-substituted-5,6,l 1,11 ¿-tetrahydro-1 -oxo-1 H-imidazo[ 1',5': 1,2]-
pyrido[3,4-6]indole-3-thiones  (180a-h).  Treatment  of  the  ethyl  ester  with  isocyanates  
furnished  ethyl  2-alkyl-  or  arylcarbamoyl-1,2,3,4-tetrahydro-/?-carboline-l-
carboxylates  (181a,b),  which were transformed to  182a,b hydantoin-fused tetrahydro-
/?-carbolines. 
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SYNTHESIS  AND M U D  RETRO DELS-ALDER DECOMPOSITION  OF  
1,4-METHANOPYRRQL©-,  1,4-METHANOPYRJDO-  AND  
1,4-METUANO AZEPINO [2,1-6] QUINAZOLINONES1 
Ferenc Fülöp*, Márta  Palkó, Gábor Bernáth and Pál  Sohár+  
Institute of Pharmaceutical  Chemistry,  Albert Szent-Györgyi Medical  University,  
H-6701  Szeged, POB  121, Hungary;  +Institute of General  and Inorganic  
Chemistry, Eötvös Loránd University, H-1518 Budapest, POB 32, Hungary 
Abstract  From  norbomcme-  and  norbomene-fused  azetidinones  la  and  lb,  1,4-
methanopyrrolo-,  J, 4-methanopyrido-  and  l,4-meihanoazepino[2,l-b]quinazo-
linones  6a,b-9a,b  were prepared  by ring enlargement.  Norbornene  derivatives  6b-
9b  underwent  retrodiene  decomposition  to  give  pyrrolo-,  pyrido-  and  azepino-
[1,2-aJpyrimidinones  10-13,  respectively.  
Fused  pyrimidinones  are  widely-used  sources  for  the  synthesis  of  new  potential  
therapeutic  agents."  The  pyrrolo-  and  pyrido[2, l-6]quinazolines  include  well-
known  alkaloids  isolated  from  a  number  of  families  of  plants.  Adhatoda  vasica  
containing  vasicine  (peganine)  has  been  used  in  Indian  indigenous  medicine  for  
centuries.  Because  of  their  therapeutic  interest,  the  syntheses  of  pyrido[2,l-i]-
quinazolin-ll-one  derivatives  and  their  ring  A  and  C  homologies  have  been  
studied very thoroughly." 
Although  numerous  papers  deal with  the  synthesis  of  pyrido[2,l-ó]quinazoün-ll-
ones and  their differently saturated  analogues  and  homologues,6  the  corresponding  
norbomane-  and norbornene-fiised derivatives 6-9 are not  known. 
In  the  first  experiments  for  the  synthesis  of  tetracycles  6-9,  3-exo-amino-
bicycIo[2.2.1]hept-5-ene-2-exo-carboxylic  acid7  or  the  corresponding  saturated  
derivative  or  either  of  the  ethyl  esters  was  refluxed  in  chlorobenzene  with  2  
equivalents  of  lactim  ethers  2-5,  as  described  for the  synthesis  of  cis-  and  trans-
195 
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decahydropyrido[2,l-Zi]quinazolin-l  1-one.8  After  refluxing  for  24  hours,  the  
starting  materials  were  recovered  unchanged.  When  azetidinones1 ,5  l a  and  l b  were  
reacted  in  chlorobenzene  with  lactim  ethers,  a  very  slow  transformation  was  
observed,  and  the  reaction  mixture  turned  deep-brown.  
On  melting  of  the  azetidinones  l a  and  l b  with  2  equivalents  of  lactim  ethers  2-5  at  
80  °C  for  8 -10  hours,  the  desired  tetracycles  6a,b-9a ,b  were  obtained.  The  first  
step  of  the  reaction  is  the  formation  of  an  amidine  intermediate  which,  after  
t ransamidation,1 0 , 1 1  results  in the  ring  enlargement  products  6a,b-9a,b.  On  increase  
of  the  temperature,  the  colour  of  the  reaction  mixture  becomes  deeper,  and  in  the  
series  l b  the  smell  of  cyclopentadiene  is  observed.  Following  melting  of  l b  with  3  
at  100  °C,  6,7,8,9- tetrahydropyrido[l ,2-a]pyrimidin-4-one  was  isolated  in  low  
yield  through  the  splitting-off  of  cyclopentadiene.  Retrodiene  decomposition  under  
similarly  mild  conditions  wcr.  described  only  recently  for  the  synthesis  of  
monocycl ic  1,3-hetero  derivatives.12  The  bicyclic  hetero  compounds  pyrimido-
[2 , l - i ] th i az in -6 -one  and  thiazolo[3,2-a]pyrimidin-5-one  have  also  been  prepared  
by  this  method . 1 3  
In  order  to  establish  the  scope  and  limitations  of  this  mild  retrodiene  decomposition  
resulting  in  heterobicycles,  tetracycles  6-9  were  melted  at  100  °C.  When  6b-9b  
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were  melted  for  30  minutes,  pyrrolo-,  pyrido-  and  azepino[l,2-a]pyrimidinones  
10-13  were  formed  in  good  yield  by  the  splitting-off  of  cyclopentadiene.  Starting  
from  the  series  6a-9a,  the  formation  of  10-13  could  not  be  observed  under  similar  
conditions. 
Because  of  their  pharmacological  interest,14-15  a  number  of  different  synthetic  
routes  have  been  devised  for  the  synthesis  of  substituted  analogues  of  10-13.  Our  
method  is  a  new,  effective procedure  for the preparation  of the  above  derivatives.  
Sodium  borohydride  reduction  of  8b  resulted  stereospecifically  in  the  decahydro  
derivative  14  with  relative  configuration  r-l ,c-4,c-4a,c-5a,c-l  la.  When  8a  was  
reduced  with  sodium  borohydride,  the  perhydro  derivative  15  was  formed.  Their  
similar  relative  configurations  were  proved  both  spectroscopically  and  chemically:  
catalytic  reduction  of  14  gave  a  compound  identical  with  the  product  of  15.  
Attempted  retrodiene  decomposition  was  unsuccessful  from  both  14  and  15.  The  
successful  and  failed  retro  Diels-Alder  reactions  show  that  a  retrodiene  
decomposition  under  mild  conditions  takes  place  only  when  the  decomposition  
results  in  a  heterocycle  with  a  quasi-aromatic  character  through  the  splitting-off  of  
cyclopentadiene. 
The  spectral  data  proving  the  expected  structures  of  the  newly  synthesized  
compounds  are  given  in  Tables  1  and  2.  They  are  self-explanatory.  Only  the  
following remarks  are  necessary.  
The  fact  that  the  diexo  annelation  of  the  starting  compounds  remains  unaltered  in  
the  products  6-9  and  12-15  is evidenced  by the  double  split  of  the  H-4a  signal.  For  
diexo  isomers,  a  further  split  to  a  double  doublet  is characteristic.17  The  ring  strain  
in  6a,b  and  7a,b  is manifested16  in  higher v C = 0  IR frequencies.  
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Table  1. Characteristic IR  frequencies  (cm-1,  in KBr) and  'H-NMR  data  (chemical  
shifts  in  6,6-tms  =  0  ppm  and  coupling  constants  in  Hz)  in  CDC13  solutions  of  
compounds 6a,b-9a,b  and  11-15 at 250.14  MHz*  
Com-
pound 
Ir  bands  
. v C = 0  vC=Nb  
NCH,(10)m 
(2H)' 
CH(1) 
- s ( l H ) 
CH(4) 
- s ( l H ) 
CH(4a) 
¿OH)" 
CH( l la ) 
dm 
6a 1710 1664 3.71 2.65' 2.43f 3.79 2.40f 
6b 1706 1670 3.75e 3.30 3.10 3.75' 2.30 
7a« 1711 1679 4.38 2.35-2.8' 3.78 2.35-2.8' 
7b 1710 1666 4.42 3.31 3.09 3.73h 2.30 
8a 1674 -3.65 ' 2.66 2.43 3.68' -2 .5 
8b 1666 -3 .7 ' 2.29 3.11 3.62' 2.38 
9a 1664 3.72'  4.00  2.67 2.44f 3.69' 2.46f 
9b 1667 3.80  4.02  3.28 3.11 3.62 2.33 
10 1658 1588 4.16 - - 7.86 6.28 
11 1685 1597 4.82 - - 7.84 6.27 
12 1667 1514 3.97 - - 7.82 6.32 
13 1680 1658 4.32 - - 7.74 6.32 
14 1620 3297 2.65  4.52  3.44 2.81 3.12 2.00 
15 1622 3293 2.60  4.51  2.90 2.21 3.17 2.11 
'For  easier  comparison  of  spectroscopically  analogous  data,  the  numbering  of  15  (see  
Scheme  2)  were  used  in  the  text  and  Tables.  The  IUPAC  numbering  is  given  in  the  
Experimental.  Assignments  were  proved  by  2D-HSC  (6a,b,  7b,  8a,  9a,b,  14,15),  DNOE  
(6b,  7b,  9b,  14,15)  and  DR  (6b)  experiments.  Further  signals:  CH3(10),  d  {J:  6.5):  1.26  
and  1.28  1.31  (7b),  1.45  (11);  H-2,3(endo),  m (2H):  - 1 . 6  (6a,  7a,  8a,  9a',  15);  H-
2,3(exo)  +  H-12(enrfo),  m (3H):  1.25-1.5 (6a, 7a, 8a, 9a,  15); olcfinic H-2,3  in 6b, 7b,  8b,  
9b  and  14,  2xzW (J:  5.7±0.1  and  3.0±0.1):  6.20  and  6.30,  for  15:  6.09  and  6.31  (2xlH);  
H-5a,  dd  (J:  10.3  and  3.8):  4.08  (14),  4.01  (15);  CH,(6),  m(2H):  2.6±0.5  for 6a,b,  8a,b  
and  9a,b  (in  overlap  with  the H-l  m  for 6a),  3.14  (10),  2.93  (12),  3.0  (13),  2xm  (2xlH):  
2.60 and  2.78  (7a,b  in overlap  with the H-l,4,1 la  m's for 7a),  3.03  and 3.20  (11),  1.2  and  
2.0 (14,15),  CH,(7-9),  m:  1.8-2.05  (2H  for 6a,b  and  10, 4H  for 8a,b  and  12,  6H  for  13),  
1.5-1.9  (6H  for  9*a,'4H  for  14  and  15),  2\m  (2xlH):  1.65  and  2.05  (7a,b),  2.26  (11),  1.9  
and  2.4  (11);  H-12(exo),  id  (1H):  1.18±0.02  (6a,  7a,  8a,  9a,  15);  CH,(12),  2xd  (J:  9,  
further  t  split  of  one  of  the  ds  by  <1  Hz,  due  to  long-range  couplings):  1.32±0."02  (in  
overlap with d o t C H ,  for  7b)  and  1.42±0.02  (for 6b,  7b, 8b  and  9b),  1.40 and  1.62  (14);  
. "vNH  band  for 14,15; 'NCH(IH)  for 7a.b and  11, multiplicity:  dt  (J:  7.5  and  1.0, 6a),  dqi  
(IH)  for 2a,b,  unresolved  m  for 8b,  II  and  13,  2add  for 9a,b  (J:  15.2,  7.8  and  14.5,  7.0)  
for  14 and  15: di  (J:  10,  10, 3.5  and  12,  12, 5) and  dd(  12.2, 2.7  in  both cases),  i  for  12  (J:  
6.0);  'J:  8.7  (6a,b-9a,b),  6.7  (10-13).  7.5  (14,  15); ' 'Overlapping  signals;  '1:1  Mixture  of  
C-10  diastcrcomcrs;  hFurthcr  split  by  1 Hz to dd:  'Doubled  signal  due to  diastcreomcrs.  
Table  2.  , 3C-nnir  chemical  shifts (6T M S  =  0 ppm) for compounds  6a ,b-9a ,b  and  11-15  in CDCI3  solution  at 62.89  MHz*  
Com- CH C-2b C-3b CH(4) CHC C-5ad CH2 CH2  CI-I2  CH2  NCH2E CHC CHJ C = 0 
pound (1) (4a) (6) (7)  (8)  (9)  (10) ( I I a ) (12) (11) 
6a 42.4 29.4 25.6 45.4 65.3 154.3 31.3 18.3 44.1 46.1 34.0 168.4 
6b 48.4 139.0 136.2 52.8 62.1 155.5 31.4 18.9 44.3 41.6 44.1 168.7 
42.4 45.6 65.2 26. l h 52.3 47.1 34.0 
7a r 29.68 26.0h 154.6 29.78 168.3 
43.1 45.9 65.4 26.2h 52.5 47.2 34.2 
7b 48.1 139.0 136.1 51.9 62.0 155.2 29.4 26.7 52.5 42.0 44.2 168.1 
8a 43.9 30.2 26.6 46.5 62.9 150.2 32.1 19.9  22.7  40.6 48.3 34.7 169.6 
8b 49.1 138.8 136.1 52.4 58.5 150.6 31.7 19.2  22.1  40.2 42.1 43.9 169.9 
9a 43.4 29.6 26.0 46.0 62.5 154.6 37.1 28.68 26.2  29.48  41.2 47.0 34.0 169.6 
9b 49.2 138.9 136.2 52.2 58.6 155.0 37.2 28.78 26.1  29.48  41.3' 41.3' 43.7 169.9 
10 - - - - 154.0 161.2 32.4 18.5 46.7 112.5 - 164.7 
11 - - - - 154.0 - 1 6 0 31.1 26.9 56.1 113.3 - 164.4 
12 - - - - 152.5 160.4 31.4 18.9  21.6  42.3 112.2 - 162.3 
13 - - - - 152.3 162.0 37.2 27.18 24.5  29.48  42.4 112.9 - 165.2 
14 45.4 139.2 134.6 48.1 54.5 67.1 33.5 22.1  24.2  40.7 44.5 43.7 172.0 
15 40.2 29.1 26.0 42.8 59.0 66.4 33.6 22.1  24.3  40.7 50.0 34.3 171.5 
'For  easier  comparison  of analogous  spectral  data  tlic  numbering of  15 was  used  for all  compounds  investigated.  Assignments  were  proved  
by DEPT (except  for  10,  12 and  13) and 2D-HSC  measurements  (except  for 7n,  10,  12 and  13).  Further  signals:  CH,:  18.9 and  19.0  (7n).  
19.0  (7b,  11).  kCHj group  Tor 6n-9n  and  15,  olcfmic CH  group  for  6b-9b  and  14;  'Mclhinc  .r//  (,v/r  for  10-13)  carbon  vicinal  i 0  Uic  
niliogcn  (Pos.  4a)  or  tlic carbonyl  (Pos.  1 la);  llN=C-N-typc  quaternary  carbon  or  N-CH-N  group  (14,  15);  'NCH  group  for  7a,b  and  I I ;  
r l : I  Mixture of C-10 diaslcrcomcrs; •'''Interchangeable assignments; 'Two overlapping  lines.  
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Compounds  7a,b  may  exist  in  two  diastereomeric  forms  differing  in  the  C-10  
configurations.  The  NMR  data  suggest  an  approximately  1:1  mixture  of  such  
isomers for 7a,  but a stereohomogeneous  sample for 7b. 
The  free  pseudorotation  of  the  pyrroline  ring  results  in  the  differences  in  the  
spectral  data  on  the  isomers  being  very  small  (hardly  significant)  for  all  the  13C-
NMR shifts, e.g.  <0.3  ppm.  
The  all-c/s  configuration  of  H-4a,5a,lla  in  14  and  15  was  proved  by  DNOE  
measurements.1819  On  saturation  of  one  of  these  signals,  intensity  enhancements  
for  both  of  the  others  were  observed,  confirming  their  steric  proximity.  These  
experiments,  together  with  2D-HSC30  results,  allow  the  firm  assignment  of  close-
lying signals  in the  'H  and  13C-NMR  spectra,  e.g.  the H-1,4  and  C-1,4  singlet  pairs  
or the  exo  and  endo  H-12  doublets.  
EXPERIMENTAL 
The  IR  spectra  were  measured  in  KBr  pellets  on  an  Aspect  2000  computer-
controlled  Bruker IFS-113v vacuum optic FT  spectrometer.  
The  'H-  and  13C-NMR  spectra  were recorded  in  CDC13  solution  in  5 mm tubes  at  
room  temperature  on  a  Bruker  WM-250  FT  spectrometer  at  250.13  ('H)  and  
62.89.MHz  (13C),  respectively,  using the  3H  signal  of  the  solvent  as the  lock  and  
TMS  as  internal  standard.  NOE  difference  (DNOE)  and  two-dimensional  
heteronuclear  shift  correlation  (2D HSC)  measurements  were  carried  out  with  the  
standard  software  written  for  the  Aspect  2000  computer  of  the  Bruker  
spectrometers.  DEPT  spectra31  were  run  in  a  standard  way,33  using  only  the  0  =  
135° pulse to separate  CH/'CH3  and  CH2  lines phased  "up and  down",  respectively.  
Pyrrolo-,  Pyrido-  and  Azepino[2,l-A]quinazoIinones  (6a,b-9a,b);  General  
Procedure: 
A  mixture  of the  azetidinone  la  or  l b  (3.6  mmol)  and  the  corresponding  lactim  
ether  (7.2  mmol)  was  kept  at  100-110  °C  for  8  hours.  The  excess  of  the  lactim  
ether  was  evaporated  off  and  the  residue  was  dissolved  in  diethyl  ether  (20  ml),  
treated  with  charcoal,  filtered  and  left to  stand  at 4  °C.  The product  6a,b-9a,b  that  
separated  out was filtered off (yields: 70-80%)  and  recrystallized.  
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Table 3. Analytical data  on compounds 6a,b-9a,b and 10-15 
No Mp °C 
Solvent 
Formula 
Mw 
Analysis (%) 
C  H  N  
Caled./Found. Calcd./Found. Calcd./Found. 
6a 101-103 C12HI6N2O 70.56 7.90 13.71 
;Pr20 204.28 70.58 8.32 13.72 
6b 122-124 C i 2HuN :0 71.26 6.98 13.85 
;Pr,0 202.26 70.94 6.33 13.59 
7a' 152-160 C13H19CIN,0 61.29 7.52 11.00 
EtOH/EqO 254.76 * 60.89 7.66 11.09 
7b 130-136 C,3Hl6N,0 72.19 7.46 12.95 
iPr20 216.29 71.26 7.94 12.96 
8a 36-40 C,3H18N2O 71.53 8.31 12.83 
EtjO 218.30 71.78 8.40 12.77 
8b 105-106 C13H16N2O 72.19 7.46 12.95 
t'PtjO 216.29 70.68 7.98 13.95 
9a 98-99 72.38 8.68 12.06 
i'Pr20 232.33 71.42 8.83 12.72 
9b 118-120 C14H18N20 73.01 7.88 12.16 
;Pr20 230.31 73.03 8.26 12.64 
10 104b C;H8N,0 61.75 5.92 20.57 
hexane 136.16 60.98 5.88 20.79 
11* 177-179 C8H„C1N20 51.48 5.94 15.01 
EtOH/EtjO 186.64 51.06 6.18 15.49 
12 84-86 C8H10N,O 63.98 6.71 18.65 
hexane 150.18 63.54 6.82 18.39 
13 62-63c 65.83 7.37 17.06 
hexane 164.21 65.39 7.58 17.11 
14 133-135 C13HI8N,0 71.53 8.31 12.83 
hexane 218.30 71.84 8.55 12.61 
15 142-144 C,3H;oN,0 70.87 9.15 12.71 
hexane 220.32 70.47 9.43 12.74 
•Hydrochloride. bLit.9mp  101 °C.cLit.'mp 66-67 °C. 
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Pyrrolo-, Pyrido-  and  Azepino[l,2-a]pyrimidinoncs  (10-13);  General  
Procedure: 
The tetracycles 6b-9b  (1  mmol) were  heated  at  about  110-130  °C for 20  minutes.  
The  crude  product  was  dissolved  in  diethyl  ether  (20  ml),  and  the  solution  was  
treated  with  charcoal,  filtered  and  evaporated.  The  products  were  recrystallized  
from hexane, yields:  70-80%.  
(r-l,c-4,c-4a,c-5a,c-lla)-l,4-Methano-l,414a,5,5a,6,7,8,9,lla-decahydro-
pyrido[2,l-6]quinazolin-l  1-one (14) 
To  a  methanolic  (10  ml)  solution  of  8b  (1  mmol),  sodium  borohydride  (2  mmol,  
76  mg)  in  water  (10  ml)  was  added  dropwise  with  stirring  at  room  temperatute.  
After stirring for 2 hours,  the methanol  was evaporated  off, and  the  aqueous  phase  
was  extracted  with  diethyl  ether  (3x20  ml).  The  combined  organic  extrcts  were  
dried  (Na,S04),  and  the  solvent  was  evaporated  off.  The  residue  crystallized  on  
treatment  with diethyl ether and was recrystallized  from  hexane, yield:  86%.  
(M,c-4,c-4a,c-5a,c-lla)-l,4-Methano-l,2,3,4,4a,5,5a,6,7,8,9,lla-dodecahydro-
pyrido[2,l-Z>]quinazolin-l 1-one (15) 
The reaction was performed similarly as for  14, starting  from 8a, yield:  79%. 
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Ethyl  eis-  and  ira/i.v-2-isothiocyanato-l-cyclopentanecarboxylates  2  and  7  were  prepared  by  the  reaction  
of  the corresponding  alicyclic  ethyl  2-amino-l-carboxylates  and thiophosgene.  The  c/s-isothiocyanato  com-
pound  2  underwent  ring  closure  with  amines  in  one  or  two  steps,  resulting  in  3-subslituted-c/'s-2-thioxo-
cyclopenta[i/]pyrimidin-4-ones  3a-g.  The  trans  isomer  7  failed  to  cyclize,  but  gave  carboxamide  8a,b  or  
thiourea ester derivatives  9a,b.  
J.  Heterocyclic  Chem..  37,  779  (2000).  
In t roduct ion 
Al though  s i x - m e m b e r e d  sa tura ted  1 ,3-he te rocyc les  and  
the i r  b e n z e n e  r i n g - f u s e d  d e r i v a t i v e s  h a v e  been  s tud ied  
t h o r o u g h l y ,  m u c h  l e s s  a t t e n t i o n  h a s  b e e n  p a i d  to  t he  
bicycl ic  sa tura ted  de r iva t ives .  T h e  syn thes i s  and  con fo r -
mat ional  s tudy  of  sa tu ra ted  or  par t ia l ly  sa tura ted  s i x - m e m -
bered  1 ,3-he te rocyc les  cis-  o r  r r a / t s - fused  with  5- ,  6- , 7-  or  
8 - m e m b e r e d  a l icyc les  has  t h e r e f o r e  been  one  of  our  main  
research  top ics  [1],  
I s o c y a n a t o  [2]  and  i s o t h i o c y a n a t o  c o m p o u n d s  [3,4]  a re  
wide ly  used  f o r  the  p r e p a r a t i o n  of  u reas ,  t h iou reas  and  
he te rocyc l i c  d e r i v a t i v e s  [5],  w h i c h  h a v e  a  w i d e  r a n g e  of  
b io log ica l  a c t i v i t i e s .  S o m e  of  t he  i s o t h i o c y a n a t o  c o m -
p o u n d s  h a v e  a l so  f o u n d  a p p l i c a t i o n s  in  the  syn thes i s  of  
a g r i c h e m i c a l s  and  p h a r m a c e u t i c a l s  [6].  T h e y  a re  pa r t i cu-
larly  v a l u a b l e  b u i l d i n g  b l o c k s  f o r  the  s y n t h e s i s  of  d i f f e r -
e n t  h e t e r o c y c l e s  [ 2 , 7 - 1 0 ] .  I s o t h i o c y a n a t o  c o m p o u n d s  
h a v e  m a i n l y  been  p r e p a r e d  b y  the  r e a c t i o n s  of  a m i n e s  
wi th  t h i o c a r b o n y l  r e a g e n t s  s u c h  as  c a r b o n  d i s u l f i d e  or  
t h i o p h o s g e n e  [11],  
Resul ts  and  Di scus s ion  
T h i s  p a p e r  d e s c r i b e s  t he  p repa ra t ion  of  e thyl  cis-  and  
r rans-2- i so th iocyana to- l  - cyc lopen tanecarboxyla tes  2 and  7,  
f r o m  the  co r r e spond ing  e thyl  2 - a m i n o - l  -cyc lopentanecar -
boxylates  1 and  6  with  t h iophosgene  ( S c h e m e s  1 and  2).  
c / i - 2 - A m i n o - 1 - c y c l o p e n t a n e c a r b o x y l i c  a c i d  w a s  
prepared  f r o m  cyc lopen tene  by  addit ion  of  chlorosul fonyl  
isocyanate  and  subsequen t  r ing open ing  of the result ing  aze-
t idinone  with  hydrochlor ic  acid  [12],  T h e  trans  i somer  was  
obtained  by  the  addi t ion  of  a m m o n i a  to  1-cyclopentene-1-
carboxyl ic  acid  [13].  T h e  a m i n o  acids  were  t r ans fo rmed  to  
t he  a m i n o  e s t e r  h y d r o c h l o r i d e s  1  [14]  a n d  6  [15]  wi th  
thionyl  ch lor ide  and  e thanol .  I so th iocyanato  c o m p o u n d s  2  
a n d  7  c a n  b e  p r e p a r e d  t h r o u g h  r e a c t i o n  of  t h e  e s t e r  
hydrochlor ides  1 or  6  wi th  t h iophosgene  in  the  presence  of  
sod ium  hydrogenca rbona te  at 4 0 ° C  and  subsequent  co lumn  
chromatography  of  the c rude  oi ly  products .  
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It  is  i n t e r e s t i n g  t ha t  t he  c h e m i c a l  s h i f t s  of  6  and  7  
h a p p e n  to  be  p r a c t i c a l l y  the  s a m e ,  p r o b a b l y  b e c a u s e  of  
the  m a g n i t u d e s  of  t h e  e l e c t r o n i c  and  a n i s o t r o p i c  e f f e c t s  
of  the  2 - s u b s t i t u e n t .  T h e  d i f f e r e n c e  in  the  mul t ip l i c i t y  
of  2 - H  is  c a u s e d  b y  the  s te r ic  d i f f e r e n c e  b e t w e e n  N H 2  
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Table 1 
Physical  and Analytical  Data for Compounds 2-9 
Compound Yield Method MpCC) Formula Calcd  Found  
(%) (Mw) C(%) H(%) N(%) 
3a 62 B 200-203 C7H|0N2OS 49.39 5.92 16.46 
[a] [b] (170.24) 49.02 6.28 16.64 
3b 60 C 132-135 C8H,2N2OS 52.15 6.56 15.20 
55 D le]  [d]  (184.26) 51.98 6.61 15.10 
65 E 
3c 63 E 131-133 C10H16N2OS 54.90 7.15 7.64 
[c] (222.40) 54.55 7.25 7.99 
3d 69 E 282-284 CI3H14N2OS 63.39 5.73 11.37 
le]  [e]  (246.33) 63.11 5.67 11.05 
3e 67 E 162-165 C14H,6N2OS 64.59 6.19 10.76 
M (260.36) 64.29 6.43 10.93 
3f 75 E 136-137 C15HLGN2OS 65.66 6.61 10.21 
[gl (274.39) 65.35 6.84 10.47 
3g 78 E 292-294 C14H,6N2OS 64.59 6.19 10.76 
[h] (260.36) 64.30 6.28 10.54 
4c 77 F 67-68 C,2H2,N2O2S 55.78 8.58 10.84 
Ig) (258.39) 55.92 8.70 10.61 
4d 69 F 61-64 C15H20N2O2S 61.62 6.89 9.58 
[g] [i] (292.40) 61.87 6.96 9.39 
4e 83 F 80-82 C16H22N2O2S 62.72 7.24 9.14 
Ü1 (306.43) 62.93 7.60 9.50 
4g 72 F 64-68 C16H22N2O2S 62.72 7.24 9.14 
Ü1 (306.43) 62.78 7.48 8.92 
5 74 G 100-104 C9H17N3OS 50.20 7.96 19.52 
[g] (215.32) 50.33 8.09 19.36 
8a 60 G 154-157 C7H,3N3OS 44.90 7.00 22.44 
[c] (187.27) 45.02 7.29 22.78 
8b 61 G 132-138 C9H,7N3OS 50.20 7.96 19.52 
[c] (215.32) 50.36 8.12 19.22 
9a 78 F 78-80 C15H20N2O2S 61.62 6.89 9.58 
[c] [k] (292.40) 61.35 6.99 9.31 
9b 82 F 102-105 C16H22N2O2S 62.72 7.24 9.14 
[c] (306.43) 63.05 7.53 9.12 
[a] From ethyl acetate,  [b] Lit. mp [14]: 205-208°C.  [c] From diethyl ether/methanol.  [d] Lit. mp [16]:  134-137°C. [e] Lit. mp [16]: 285-2878C. [f] From 
ethyl acetate/diethyl  ether,  [g] From diethyl ether/diisopropyl  ether,  [h] From dimethylformamide.  [i] Lit. mp [16]: 66-69°C.  [j] From diisopropyl  ether,  
[k] Lit. mp [16]: 70-73°C. 
and NCS,  which  could  alter  the  geometry  of  the  cyclo-
pentane  ring.  
Isothiocyanates  2  or  7  were  reacted  with  different  
amines  and,  depending  on  the  reagent,  the  ratio  of  the  
reactants  and  the  configuration  of  the  isothiocyanate,  
three different products  were formed. The  cis  2  with  two  
equivalents  of  ammonia  or  methylamine  gave  the  corre-
sponding  cis-2-thioxo- 1,2,3,4a, 5,6,7,7a-octahydrocyclo-
penta[d]pyrimidin-4-ones  3a  and 3b,  respectively.  When  
an excess  of  ammonia  was  used,  the  product  was  again  
3a,  but with  an excess of  methylamine,  the  cis  2 gave  the  
thiourea  5,  the  ester  function  was  amidated  rather  than  
ring closure  occurring.  
Reactions  of  substituted  amines  such  as  isopropylamine,  
benzylamine, phenylethylamine,  aniline and p-toluidine with 
2  resulted  in the corresponding  thioureas 4c-g.  Thiourea 4b 
was prepared from 1 with methyl isothiocyanate as described 
earlier [16]. Thioureas 4 can readily  be cyclized  using either 
acid (HC1) or base (e.g. NH3)  catalysts.  
When the trans  7 (Scheme 2) was reacted with amines, the 
formation  of  the  pyrimidinone  10  was  not  observed,  even  
under  forced  conditions.  But  the  reaction  with  ammonia  or  
methylamine,  leads  to the thiourea-amide  derivatives 8a  and  
8b.  With aniline  or p-toluidine,  the trans  thioureas 9a  and 9b 
were formed in good yields. The cyclization of  trans thioureas 
9a and 9b failed under both acidic and basic conditions. 
It is  noteworthy  that  in  the  ring closures of  the  1,2-di-
substituted-l,3-difunctional  cyclohexane,  cycloheptane  
and  cyclooctane  derivatives,  no  appreciable  differences  
were  found  in  the  reactivities  of  the  cis  and  trans  iso-
mers  in the formation  of  six-membered  1,3-heterocycles  
fused  with  carbocycles  [1,17].  In  contrast,  very  striking  
differences  were  observed  in  the cyclization  reactivities  
of  the  cis-  and  trans-1,2-disubstituted  1,3-difunctional  
cyclopentane  derivatives,  such  as  2-hydroxymethyl-l-
cyclanols  and  alicyclic  2-aminomethyl-l-amines,  or  in  
the  cases  of  cis-  and  trans-2-hydroxy-l-cyclopentane-
carboxamides  or  cis-  and  i/-ans-2-amino-l-cyclopen-
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Table  2  
'H-NMR  Parameters of Compounds 2-9 
Compounds  'H  NMR data 
2  4.35 m,  1  H (1): 4.30-4.16 m, 2 H (Ctf,CH3); 2.92 m,  1  H (2); 2.16 m,  I  H; 2.07-1.90 m, 4 H;  1.75 m,  1  H; 1.321,3 H, J=  7.1  
(CH2C«3) 
3a  8.38 brs,  1  H (NH): 7.13 brs,  1  H (NH); 4.08 m,  1  H (7a); 2.88 m,  1  H (4a); 2.23 m,  1  H; 2.11-1.99 m, 2 H;  1.95-1.72 m, 3 H 
3b  7.83 brs,  I H (NH); 4.00 m,  1  H (7a); 3.56 s, 3 H (NCH3); 2.95 m,  1  H (4a); 2.22 m,  1  11; 2.07-1.86 m, 4 H;  1.75 m,  1  H  
3c  7.16 brs,  1  H (NH); 5.70 sep,  1  H, J=  6.8 (C«(CH3)2);  3.95 m,  I H (7a); 2.85 m,  1  H (4a); 2.20 m,  1  H; 2.02-1.71  m, 5 H;  1.47 d, 
3 H, J=  6.8 (CH(C«3)2);  1.42 d, 3 H, J=  6.8 (CH(CW3)2.) 
3d  9.82 brs,  1  H (NH); 7.39-7.38 m, 2 H (Ar); 7.33-7.31  m,  1  H (Ar); 7.20-7.05 m. 2 H (Ar); 4.05 m,  I H (7a); 3.05 m,  1  H (4a); 
2.11 m,  1  H;  1.98 m. 2 H;  1.85 m,  1  H; 1.72 m,2H 
3c  7.39 d, 2 H, J=  7.3 (Ar); 7.35 brs,  1  H (NH); 7.32-7.21  m, 3 H (Ar); 5.55 d,  1 H, J=  14.6 (PhCH2); 5.49 d.  I H, J=  14.6  
(PhCH,); 3.97 m,  1  H (7a); 2.94 m,  1 H (4a); 2.18 m,  1  H; 2.08-1.70 m. 5 H 
3f  7.53 brs,  1  H (NH); 7.34-7.27 m, 4 H (Ar); 7.24-7.21  m,  1  H (Ar); 4.53-4.39 m, 2 H (ArCH2); 3.95 m,  1  H (7a); 3.05-2.85 m, 3 H 
(NCH2,4a); 2.18 m,  1  H; 2.01-1.70 m, 5 H 
3g  7.26-7.24  m, 2 H (Ar); 7.13 brs,  1  H (NH); 7.04-7.03 m, 2 H (Ar); 4.16-4.15 m,  1  H (7a); 3.06 m,  1  H (4a); 2.39 s, 3 H 
(ArCH3); 2.32 m,  1  H; 2.18 m,  I  H; 2.09-1.80 m. 4 H 
4b  6.64 brs,  1  H (NH): 6.01 brs,  IH (NH); 4.87 m,  IH (2); 4.10-4.17  m, 2H (C«,CH3);  3.10-3.05 dd,  1H, J= 7.64,  14.4 (1); 2.92, 
d, 3H, J= 4.8 (NCH3); 2.16-2.13m,  IH; 2.00-1.9 m, 2H;  1.82-1.61 m, 3H;  1.38-1.25 t, 3H,J=7.64,  14.4 (CH2Ctfj) 
4c  6.59 d,  1  H, J= 4.3 (NH); 5.83 d,  1  H, J=  5.8 (NH); 4.88 m,  1  H (2); 4.20-4.08  m, 2 H (CA/iCH3): 3.9 m,  1 H; 3.08 m, 1  H (I); 
2.19-1.93 m, 3 H;  1.86-1.61 m, 3 H;  1.271,3 H, J= 7.1 (CH-.CH3);  1.23 d, 3 H, J=  6.7 (CH(C.H3)2);  1.21 d, 3 H, J=  6.7  
(CH(C«3)2) 
4d  8.01 brs,  1  H (NH); 7.44-7.39 m, 2 H (Ar); 7.30-7.27  m,  1  H (Ar); 7.20-7.17 m, 2 H (Ar); 6.93 d,  1  H, J=  7.8 (NH); 5.01 m,  1  H  
(1); 4.03 q, 2 H, J=  7.1 (Ctf2CH3); 3.10 m,  1  H (2); 2.13 m,  1  H; 2.04-1.85  m, 2 H;  1.80-1.59 m,3H;  1.17i,3H,J=  7.1  
(CH,Ctf3) 
4e  7.37-7.29 m, 5 H (Ar); 6.63 d.  1  H, J=  8.1 (NH); 6.33 brs,  1  H (NH); 4.85 m,  1 H (1); 4.52 brs, 2 H (PhCH2); 4.13-4.00 m, 2 H 
(C«2CH3); 3.03 m,  I H (2); 2.10-1.85  m, 3 H;  1.74-1.57 m, 3 H;  1.241, 3 H, J=  7.2 (CH2CH3) 
4f  7.34-7.29 m, 2 H (Ar); 7.26-7.21 m, 3 H (Ar); 6.61 brs,  1  H (NH); 5.98 brs,  1  H (NH); 4.80 m,  1  H (2); 4.17-4.05  m, 2 H 
(C«2CH3); 3.67-3.53 m, 2 H; 3.04 m,  IH (1); 2.89 m, 2 H; 2.13-1.92 m, 3 H;  1.84-1.59 m, 3 H; 1.251,3 H, J=  7.1 (CH,C«3) 
4g  8.17 brs,  1 H (NH); 7.23-7.20 d, 2 H. J=  8.3 (Ar); 7.09-7.07 d, 2 H, J=  8.3 (Ar); 6.82 d,  1  H, J=  9.1 (NH); 5.01 m, 1  H (1); 4.03 
q, 2 H, J=  7.1 (CW2CH3); 3.10 m,  1  H (2); 2.35 s, 3 H (Ar-Me); 2.10 m,  1  H; 2.02-1.85 m, 2 H;  1.79-1.58 m, 3 H; 1.181,3 H, J= 
7.1 (CH2CW3) 
5  7.62-7.23 brs,  1 H (NH); 7.14-7.03 brs,  1 H (NH): 6.52-6.36 brs,  1  H (NH); 4.87 m,  1  H (1); 3.18 m,  1  H (2); 3.02 d, 3 H, J=  3.5  
(NCH3); 2.70 d, 3 H, J= 4.8 (NCH3); 2.10-1.89 m, 3 H;  1.83 m,  1  H;  1.66-1.50 m, 2 H 
6  4.30 dl, 1  H, 1= 6.5, 6.5 (1); 4.18 q, 2 H, 1= 7.3 (CW2CH3); 2.93 m,  1  H (2); 2.19-2.07  m, 2H;  1.92-1.70 m, 4 H; 1.251,3 H. J= 
7.3 (CH2C«3) 
7  4.30 dd,  1  H, J=  12.6,6.3 (1); 4.18 q, 2 H, J=  7.0 (CH2CH3);  2.93 m,  1  H (2); 2.19-2.07 m, 2 H;  1.93-1.73 m, 4 H; 1.291,3 H, J= 
7.0 (CH2C tf3) 
8a  7.53 d,  IH, J= 7.4 (NH); 7.20-6.70 m, 4H (NH2, NH2); 3.20 m,  IH (2); 2.54 m,  IH (1);  1.98 m,  IH;  1.88 m, IH;  1.65-1.55 m, 
3H;  1.45 m, IH 
8b  7.7 brs,  1  H (NH); 6.4 brs,  1  H (NH); 4.4 brs,  1 H (NH); 3.07 d, 3 H, J= 4.3 (NCH3); 2.82 d, 3 H, J= 4.8 (NCH3); 2.62 m, 1  H 
(1); 2.18-1.98 m, 2 H; 1.85-1.70 m, 3 H;  1.60 m,  1  H  
9a  7.4 m, 2 H (Ar); 7.35-7.22 m, 3 H (Ar); 6.2 brs, 1 H (NH); 4.8 brs,  1  H (NH); 4.19 q, 2 H, J =  7.1 (CH2CH3); 2.66 m,  1  H (2); 
2.31 m,  1  H (1); 2.06-1.87 m, 2 H;  1.79-1.66 m, 2 H;  1.55-1.44 m, 2 H;  1.28 l, 3 H, J=  7.1 (CH2C«3) 
9b  7.25-7.10 m, 4 H (Ar); 6.0 brs,  1  H (NH); 4.8 brs,  1  H (NH); 4.19 q, 2 H, J=  7.1 (CH2CH3); 2.63 m, 1  H (1); 2.36 s, 3 H 
(ArCH3); 2.32 m,  1  H (2); 2.04-1.88 m, 2 H; 1.80-1.64 m, 2 H;  1.46 m, 1  H;  1.281, 3 H, J=  7.1 (CH2C«3) 
tanecarboxylic  acids  [1].  The  cis  isomers  react  readily,  
while  their  trans  counterparts  do  not  undergo  ring  
closure  in most cases  [1].  
The difference observed in the present study may serve as 
supporting evidence for the difference in the ring closure reac-
tivities  of  cis  and  trans-l,2-disubstituted-l,3-difunctional  
cyclopentane derivatives [1].  
EXPERIMENTAL 
The  1 H-NMR  spectra  were  recorded  in  CDC13  or  DMSO-d6  
solution  in  5 mm  tubes  at room  temperature  at 400.13 MHz  on  a  
Bruker  AVANCE DRX  400  spectrometer,  using  the  2H  signal  of  
the  solvent  as  the  lock  and  TMS  as  internal  standard.  Melting  
points  were  determined  with  a  Kofler  apparatus  and  the  values  
are  not  corrected.  The  physical  and  analytical  data  on  the  com-
pounds prepared  are  listed  in Table  1. The ethyl  cis-  and  trans-2-
amino-l-cyclopentanecarboxylates  1  and  6  and  the  thiourea  4b  
were prepared  according  to literature methods  [12-16].  
Preparation  of Isothiocyanato Compounds  2 and  7 (Method  A).  
To a stirred  mixture of chloroform (150 ml), water (80 ml), thio-
phosgene  (5.75  g,  0.05  mol)  and  sodium  hydrogencarbonate  
(12.6  g,  0.15  mol),  a  solution  of  ethyl  cis-  or  /ra;ir-2-amino-l-
cyclopentanecarboxylate  hydrochloride  1 or  6  (0.05  mol)  in  water  
(80  ml)  was  added  dropwise  during  a  period  of  40  minutes  
(Caution:  thiophosgene  is  volatile  and  highly  toxic  -  use  hood.)  
After stirring  for  3  hours  at 40°C,  the chloroform  layer  was  sepa-
rated  and  dried  over  magnesium  sulfate.  It  was  diluted  with  
n-hexane  (400  ml),  and  purified  by  passing  through  a  silica  gel  
782 M.  Palkó,  F. Evanics,  G.  Bernáth  and  F.  Fülöp  Vol.  37  
passing through  a silica gel column. The  'H-NMR  spectra  indi-
cated  that  the oily  isothiocyanato  compounds  2  and  7  obtained  
had  a purity  > 96%  (Table  2).  
c / j -2 -Th ioxo-1 ,2 ,3 ,4a , 5 ,6 ,7 ,7a-oc tahydrocy clopentafr/J-
pyrimidin-4-one 3a  (Method  B).  
To a methanolic  solution  of  isothiocyanate  2 (398 nig, 2  mniol  
in  10 ml), two equivalents of ammonia (25%, 0.3 ml) in  methanol  
was added  and  the mixture was left to stand  at  ambient  tempera-
lure overnight.  After evaporation  to dryness,  the solid  residue  3a  
was  recrystallized.  
c/'s-3-Methyl-2-thioxo-l,2,3,4a,5,6,7,7a-octahydrocyclopentafi/]-
pyrimidin-4-one (3b) (Method  C).  
To  a  methanolic  (absolute)  solution  of  isothiocyanate  
2  (398  mg,  2 mmol  in  10 ml),  two equivalents  of  methylamine  
(40%,  0.35  ml)  in  methanol  was  added  and  the  mixture  was  
left  to stand  at  ambient  temperature  overnight.  After  evapora-
tion  to dryness,  the  solid  residue 3b  was  recrystallized.  
c/i-3-Methyl-2-thioxo-1,2,3,4a,5,6,7,7a-octahydrocyclopenta-
[</]pyrimidin-4-one 3b  (Method  D).  
The  thiourea  derivative 4b  (253 mg,  1.1 mmol)  was  dissolved  
in  absolute  methanol  (15  ml),  and  ammonia  (25%,  0.2  ml)  in  
methanol  was  added  dropwise. The  mixture  was  left to  stand  at  
ambient  temperature  overnight.  The  solvent  was  evaporated,  
diethyl  ether (5 ml) was added  to the oily residue and  the precip-
itate was collected  by filtration to give 3b. 
c/j-3-Methyl-2-tliioxo-1,2,3,4a,5,6,7,7a-octahydrocyclopenta-
[rf]pyrimidin-4-one 3b (Method  E).  
The  thiourea  derivative  4b  (2  mmol)  was  dissolved  in  
hydrochloric  acid (10%,  15 ml) and the solution  was refluxed for 
12  hours.  After  keeping  for  overnight,  the  crystalline  product  
obta ined  was  separated  by  f i l t ra t ion  and  recrysta l l ized.  
Compounds 3c-g were prepared  as  above.  
Af-Isopropyl-W-(2-ethoxycarbonylcyclopentyl)lhiourea  4c  
(Method  F).  
Isothiocyanato  compound  2  (398  mg,  2  mmol)  was  dis-
solved  in  methanol  (15  ml),  and  the  equivalent  amount  iso-
propylamine  in methanol  (10 ml) was  added. The mixture  was  
left  to  stand  overnight  at  ambient  temperature.  After  evapora-
t ion  to  d r y n e s s ,  the  sol id  r e s i d u e  was  r e c r y s t a l l i z e d .  
Compounds  4d-g  and  9a,b  were  prepared  as  above.  The  oily  
p r o d u c t  4f  was  p u r i f i e d  by  c o l u m n  c h r o m a t o g r a p h y  
(toluene:methanol  =  19:1)  
Al-Methyl-/V'-(2-methylaminocarbonylcyclopentyI)thiourea  5  
(Method  G).  
Isothiocyanate  2  (398  mg,  2  mmol)  was dissolved  in  absolute  
methanol  (15 ml), and  an excess of methylamine  (40%,  10 ml) in 
methanol  was  added  dropwise.  The  mixture  was  left  to  stand  
overnight  at  ambient  temperature.  After evaporation  to  dryness,  
the  solid  residue  was  recrystallized.  Compounds  8a,b  were  pre-
pared as  above.  
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A b s t r a c t 
R a c e m i c  cis-  a n d  Z r a n s - l - a m i n o i n d a n e - 2 - c a r b o x y l i c  a c i d s  (3  a n d  5 )  w e r e  p r e p a r e d  f r o m  i n d e n e  b y  
c h l o r o s u l p h o n y l  i s o c y a n a t e  a d d i t i o n  f o l l o w e d  b y  r i ng  o p e n i n g  a n d  i s o m e r i s a t i o n .  T h e  i n t e r m e d i a t e  
r a c e m i c  h y d r o x y m e t h y l a t e d  P - l a c t a m  6  w a s  r e s o l v e d  t h r o u g h  t h e  l i p a s e - c a t a l y s e d  a s y m m e t r i c  a c y l a t i o n  o f  
t h e  p r i m a r y  h y d r o x y  g r o u p  a t  t h e  ( £ ) - s t e r e o g e n i c  c e n t r e .  H i g h  e n a n t i o s e l e c t i v i t i e s  ( £ > 2 0 0 )  w e r e  o b s e r v e d  
w h e n  t h e  e n z y m a t i c  r e a c t i o n s  w e r e  p e r f o r m e d  w i t h  l ipase  A K  o r  l i p a s e  P S  as  c a t a l y s t  a n d  v inyl  a c e t a t e  
o r  v inyl  b u t y r a t e  a s  a c y l  d o n o r .  T h e  h y d r o l y s i s  a n d  i s o m e r i s a t i o n  r e s u l t e d  in  all  f o u r  e n a n t i o m e r s  (9,  11,  
13  a n d  14)  o f  l - a m i n o i n d a n e - 2 - c a r b o x y l i c  a c i d ,  a  n e w  b e n z o l o g u e  o f  c i s p e n t a c i n .  ©  2000  E l sev ie r  Sc ience  
L t d .  Al l  r i g h t s  r e s e r v e d .  
1.  Introduction  
Although  of  less  importance  than  their  a-analogues,  P-amino  acids  are  also  present  in  
peptides  and  different  heterocycles,  and  their  free  forms  and  derivatives  exhibit  interesting  
pharmacological  effects.1"6  A  decade  ago,  (l£,25')-2-aminocyclopentanecarboxylic  acid  (cis-
pentacin),  an  antifungal  antibiotic,  was  isolated  from  Bacillus  cereus1  and  Streptomyces  setonii.8  
c/s-2-Aminocyclopentanecarboxylic  acid  is  also  a  component  of  the  antibiotic  amipurimycin.9  
The  research  groups  of  Seebach  and  Gellman  recently  reported  oligopeptide  chains  which  can  
fold  into  stable  helical  structures.10,11  Gellman's  group  synthesised  and  investigated12  14  trans-2-
aminocyclopentane-  and  tra«i-2-aminocyclohexanecarboxylic  acid  oligomers  which  display  a  
stable  helical  conformation.  
Besides  the  fact  that  they  themselves  possess  pharmacological  activity,  the  alicyclic  P-amino  
acids  can  be  used  as  building  blocks  for  the  preparation  of  modified  (unnatural)  analogues  of  
* Corresponding  au thor .  Tel:  36  62  545564;  fax:  36  62  545705;  e-mail:  fuIop@pharma.szote .u-szeged.hu  
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biologically  active  peptides.  In  consequence  of  the  natural  occurrence  and  the  novel  biological  
activity,  chemical  interest  in  investigations  of  the  alicyclic  p-amino  acids  has  rapidly  increased.  
Our  present  aim  was  the  synthesis  of  the  title  alicyclic  P-amino  acids.  
2.  Results  and  discussion  
2.1.  Synthesis  of  the  racemic  f  -amino  acid  substrates  
The  pathways  of  the  syntheses  of  the  racemic  amino  acids  3  and  5  are  shown  in  Scheme  1.  
Chlorosulphonyl  isocyanate  addition15"17  to  indene  takes  places  regio-  and  stereoselectively,  in  
accordance  with  the  Markovnikov  orientation,  resulting  in  p-lactam  2.  Treatment  of  2  with  
hydrochloric acid resulted  in amino acid hydrochloride 3, while treatment with ethanolic  hydrogen  
chloride  led  to  ethyl  ester  4.  Sodium  ethoxide  isomerisation  of  4,  followed  by  acidic  hydrolysis,  
resulted  in  the  trans  amino  acid  hydrochloride  5.  The free amino  acids  of  3 and  5 were  liberated  
by  ion-exchange  chromatography.  
The  ,/V-hydroxymethylated  P-lactam  6,  the  starting  substance  of  the  enzymatic  reactions,  was  
prepared  from  2  with  paraformaldehyde  under  sonication.  
l .CS I 
2.  NOjSOJ  
aq.  HCI  
N H 2 - H C I 
•COOH 
<±)-2 (±)-3 
CH2O 
ultra 
sound 
EtOH /  HCl  
J  OH  
(±)-6 
2.2.  Enzymatic  resolutions  
_ N H 2 - H C . 
(±)-4 
Scheme  1.  
1.NaOEt 
2. aq.  HCl  
NH2  •  HCl  
,/V-Hydroxymethylated  P-lactams were earlier readily resolved18 by means of lipase AK- or lipase 
PS-catalysed  asymmetric  acylation  of  the  primary  hydroxy  group  at  the  (S)  stereogenic  centre.  
The  investigated  related  substrates  were:  A-hydroxymethylated  7-azabicyclo[3.2.0]heptan-7-one,  
7-azabicyclo[4.2.0]octan-8-one,  7-azabicyclo[4.2.0]oct-3-en-8-one  and  7-azabicyclo[4.2.0]oct-4-en-
8-one.19,20  The  enantioselectivities  (E)  varied  in  the  range  40-200  when  vinyl  butyrate  was  used  
as  acyl  donor.  Acetone  proved  to  be  the  best  solvent  for  the  transformations.  
At the beginning of this work, we had  some doubt  as to whether  similarly high selectivities would 
be  achieved,  since  the  steric  demand  of  the  benzologue  of  7-azabicyclo[3.2.0]heptan-7-one  is  
increased.  In  the  small-scale  experiments  (Table  1),  it  was  found  that  lipase  AK  and  lipase  PS  
are  each  excellent  catalysts,  both  in  vinyl  acetate-  and  in  vinyl  butyrate-mediated  acylation  
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(£>200).  In  the  present  case,  replacement  of  acetone  by  acetonitrile  or  tetrahydrofuran  did  not  
lead  to  lower  E  values;  excellent  selectivities  were  still  attained  (£>200).  Finally,  for  the  
gram-scale  resolution  of  6,  lipase  AK  and  vinyl  butyrate  in THF  were  used.  With  this  method,  
after  a  reaction  time  of  2.5  hours,  product  8 was  obtained  in  44%  yield,  and  substrate  7  in  42%  
yield,  after  chromatographic  separation,  both  with  ee = 99%. 
Table  1  
Effects  of  vinyl  esters  (0.2  M)  and  solvent  on  the  acylation  of  6  (0.1  M)  in  the  presence  of  lipase  PS"  or  AK"  
(50  mg  m l - 1 )  at  room  temperature  
Solvent Acyl  donor b  Enzyme Time  (h)  Conv.  (%)  Ees  (%)  Eep  (%)  E 
Acetone VA Lipase  AK"  4 49 94 98 > 2 0 0 
Acetone VB Lipase  AK"  7 47 88 99 >200 
Acetone VB Lipase  PS"  7 40 66 99 >200 
T H F VB Lipase  PS"  7 46 85 98 >200 
T H F VB Lipase  AK"  2.5 49 96 99 > 2 0 0 
Acetonitrile VB Lipase  AK"  8 49 93 98 >200 
" Contains  20%  (w/w)  of  lipase  adsorbed  on  Celite  in  the  presence  of  sucrose.  
b V A  =  vinyl  acetate,  VB = vinyl  butyrate.  
kl 
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Enantiomers  7  and  8  were  transformed  to  the  corresponding  P-amino  acids  9  and  11  and  
esters  10  and  12,  similarly  to  the  racemic compounds  (Scheme  2).  Isomerisation  of  esters  10  and 
12,  followed  by  hydrolysis,  resulted  in  the  trans  enantiomers  13  and  14,  respectively,  with  high  
optical  purity  (ee = 99%). 
2.3.  Absolute  configurations  
X-ray  investigation  revealed  the absolute configuration  of  12. Amino  ester  12 was transformed 
to  thiourea  15  by  reacting  it  with  (15',2S')-l,3-diacetoxy-l-(4-nitrophenyl)-2-propyl  isothio-
cyanate  (DANI),  a  newly  developed  chiral  derivatising  agent.21,22  The  X-ray  structure  (Fig.  1)  
clearly  shows  the  (R,R)  configuration  of  the  starting  12.  In  the  early  cases,  S  selectivity  was  
observed19,20  in  the  enzyme-catalysed  acylation  of  hydroxymethylated  P-lactams,  while  in  the  
present  case  R  selectivity  was  found.  It  is  necessary  to  mention  that  in  these  reactions  the  same  
stereochemical  demands  are  fulfilled  around  the  asymmetric  centres,  but  only  the  sequence  of  
priority  of  the  substituents  on  the  substrates  differs.  
Figure  1. O R T E P  plot  of  the  X-ray  structure  of  thiourea  15.  The  thermal  ellipsoids  are  drawn  at  the  25%  probability  
level.  Only  the  main  component  of  the  disordered  ester  chain  is  shown  
3.  Conclusions  
Starting  from  indene,  the  syntheses  of  all  four  enantiomers  of  l-aminoindane-2-carboxylic  
acid  proved  possible  by  a  combination  of  lipase-catalysed  O-acylation  and  some  simple  
synthetic transformations. The  synthesised  P-amino  acids,  all  four enantiomers  (9,  11,  13 and  14)  
of  l-aminoindane-2-carboxylic  acid,  are  promising  compounds  for  the  synthesis  of  partially  
saturated  heterocycles,  peptides  and  peptidomimetics,  as  potential  pharmacons.  
-O 
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4.  Experimental  
4.1. Materials and methods 
Vinyl  acetate  was  purchased  from  Aldrich  Chemical  Co.  and  vinyl  butyrate  from  Fluka.  
Lipase PS and  lipase AK  were obtained from Amano Pharmaceuticals,  and Novozym 435 as an 
immobilised  preparation  from  Novo  Nordisk.  Before  use,  lipase  PS  (5  g)  was  dissolved  in  
Tris-HCl  buffer (0.02  M;  pH  7.8)  in  the  presence  of  sucrose  (3  g),  followed  by  adsorption  on  
Celite  (17  g)  (Sigma).  The  lipase  preparation  thus  obtained  contained  20% (w/w)  of  lipase.  
The  ee values  of  the  unreacted  alcohol  7  and  the  produced  ester  8  and  amino  esters  10 and 
12 were determined  by gas chromatography  on a Chrompack  CP-Chirasil-DEX  CB column (25 
m).  Amino  esters  10  and  12  were  derivatised  with  acetic  anhydride  in  the  presence  of  
4-dimethylaminopyridine  and pyridine before the gas chromatographic analysis. The ee values of 
the  amino  acid  enantiomers  9,  11,  13  and  14  were  determined  by  HPLC  on  an  APEX  ODS  
column  (0.46x25  cm,  Jones  Chromatography  Ltd.),  with  0.1%  aqueous  trifluoroacetic  
acid:methanol  (45:55)  as  eluent.  For  chiral  derivatisation,  (1 <S,2.S)-1,3-diacetoxy-1 -(4-nitro-
phenyl)-2-propyl  isothiocyanate  was  used,  according  to  the  literature.21'22  
Optical rotations were measured  with a Perkin-Elmer  341 polarimeter.  'H NMR  spectra were 
recorded  on  a  Bruker  Avance  DRX  400  spectrometer.  Chemical  shifts  are  given  in  8  (ppm)  
relative to TMS  (CDC13)  or  to TSP (D20)  as internal  standards;  multiplicities  were recorded  as  
s  (singlet),  d  (doublet),  dd  (double  doublet),  t  (triplet),  q  (quartet),  m  (multiplet)  and  om  
(overlapping  multiplet).  Melting  points  were  determined  on  a  Kofler  apparatus.  
4.2. 3,4-Benzo-6-azabicyclo[3.2.0]heptan-7-one,  (±)-2  
A  solution  of  15.57  g  (0.11  mol)  N-chlorosulphonyl  isocyanate  in  dry  diethyl  ether  (50 ml)  
was  added  rapidly  to  11.62 g  (0.10  mol)  freshly  distilled  indene  dissolved  in  dry  diethyl  ether  
(200  ml).  The  resulting  colourless  solution  was  stirred  for  2 hours  at  room  temperature,  after  
which n-hexane  (100 ml)  was  added  and the crystalline product  was filtered off. The  crystalline  
N-chlorosulphonyl  derivative  was  dissolved  in  diethyl  ether  (200 ml)  and  added,  dropwise  and  
with  stirring,  to  a mixture  of Na2S03  (10 g) in  water  (50 ml) and  diethyl  ether  (50 ml).  During  
the  addition,  the  aqueous  phase  was  kept  slightly  alkaline  by  addition  of  10% KOH  solution.  
(±)-2 crystallised  out  and  was filtered off (7.92 g) from the mixture. A second crop  of  (±)-2 was 
obtained  as  follows: from the  above filtrate, the  organic phase was separated,  and  the  aqueous  
part  was extracted  twice with diethyl ether. The combined organic layer was dried (Na2S04)  and 
evaporated.  The  combined  crude  products  were  recrystallised  from  ethyl  acetate-methanol,  
which  afforded  10.03 g  (63%) colourless  crystals  of  (±)-2,  mp  188-189°C,  lit.23  mp  183-184°C.  
'H NMR  (400 MHz,  CDC13) 8 (ppm): 3.07 (1H, dd, 7= 17.5,10.5, CH2), 3.35 (1H, d, 7= 17.4, 
CH2), 4.02 (1H, m, CHCO),  5.03 (1H, d, 7=4.2,  CHN),  6.28 (1H, broad  s, NH),  7.18-7.36 (4H, 
om,  C6HA).  Analysis:  calculated  for  C10H9NO:  C,  75.45; H,  5.70; N,  8.80; found:  C,  75.61; H, 
5.91; N,  8.65.  
4.3. cis-1 -Aminoindane-2-carboxylic  acid hydrochloride,  (±)-3  
The  P-lactam  (±)-2  (1.59  g,  0.01  mol)  was  refluxed in  36% hydrochloric  acid  (10 ml)  for  12  
hours.  After standing  overnight,  the precipitated  crystalline product  was separated  by filtration 
and  recrystallised  from ethanol-diethyl  ether  (1.68  g,  79%),  mp  220-222°C.  
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'H  NMR  (400  MHz,  D20)  5  (ppm):  3.37  (2H,  d, 7=8.9,  CH2),  3.74  (1H,  dd,  7=15.9,  8.7,  
CHCO),  5.01 (1H, d, 7=7.0,  Ci/N),  7.42 (3H, m,  C6H4), 7.53 (1H, d, 7=7.5,  C6i/4).  Analysis:  
calculated  for  CIOH12C1N02:  C,  56.21; H,  5.66; N,  6.56; found:  C,  56.35;  H,  5.56; N,  6.72.  
The free amino  acid  base  was  liberated  by  ion-exchange  chromatography  with  DOWEX  50,  
mp  265-266°C.  
'H  NMR  (400 MHz, D20)  8 (ppm):  3.22 (1H, dd, 7= 16.3, 9.6,  CH2),  3.32 (1H, dd, 7= 16.3,  
8.6, CH2),  3.51 (1H, m,  CHCO),  4.85 (1H, d, 7=6.8,  Ci/N),  7.37  (1H, m, C6i/4),  7.44 (2H, m, 
C6H4),  7.51  (1H,  d, 7=7.5,  C6H4).  Analysis:  calculated  for  C10H,,NO2:  C,  67.78;  H,  6.26;  N,  
7.90; found:  C,  67.49;  H,  6.48; N,  7.97.  
4.4. Ethyl cis-l-aminoindane-2-carboxylate  hydrochloride,  (±)-4  
The  p-lactam  (±)-2  (0.01  mol,  1.59  g)  was  refluxed  in  ethanol  (50  ml)  containing  22% dry 
hydrogen  chloride for 8 hours.  The solvent  was evaporated  off, and  the crystalline product  was  
recrystallised  from ethanol-diethyl  ether  (1.98  g,  82%),  mp  210-211°C.  
'H NMR  (400 MHz,  CDC13) 8 (ppm):  1.27 (3H, t, 7=7.1,  CH3),  3.24 (1H, dd, 7=18.0,  10.8,  
CHCH2), 3.54  (2H,  m,  CHC//2,  CHCO),  4.20  (2H,  q,  7=7.1,  OCH2),  4.81  (1H,  d,  7=6.2,  
C//N),  7.25 (3H, m,  C6H4),  7.80  (1H,  d, 7=7.6,  C6H4). Analysis:  calculated  for  C12HI6C1N02:  
C,  59.63; H,  6.67; N,  5.79; found:  C,  59.82; H,  6.56; N,  5.43.  
4.5. trans-1-Aminoindane-2-carboxylic  acid hydrochloride,  (±)-5  
Sodium  (0.60 g) was dissolved  in dry ethanol  (20 ml),  2.05 g (0.01 mol) base  (±)-4 was added 
to  this  solution  and  the  mixture  was  heated  at  70°C  for  7  hours.  The  yellow  solution  was  
evaporated  and  refluxed  with  10%  hydrochloric  acid  (20  ml)  for  10  hours.  After  standing  
overnight,  the solution  was filtered and evaporated  to dryness.  The residue  was dissolved  in hot 
methanol,  and  the removal  of  solvent  gave  1.80 g crude product,  which was recrystallised from 
ethanol-diethyl  ether  (1.45 g,  60%), mp  220-222°C.  
'H NMR  (400 MHz, D20)  8 (ppm): 3.23 (1H, m, CHf), 3.51 (2H, m, CH2, CHCO),  5.17 (1H, 
d,  7=5.3,  Ci/N),  7.40  (3H,  m,  C6i/4),  7.51  (1H,  d,  7=7.0,  C6H4). Analysis:  calculated  for  
C10H12ClNO2:  C,  56.21;  H,  5.66; N,  6.56;  found: C,  56.44;  H,  5.73; N,  6.40.  
The free amino  acid  base  was liberated  by ion-exchange  chromatography  with  DOWEX  50,  
mp  234-235°C.  
'H NMR  (400 MHz, D20)  8 (ppm):  3.13 (1H, dd, 7= 16.0, 7.0, CHf),  3.22 (1H, m, CH2), 3.46 
(1H,  dd,  7=16.0,  8.7,  CHCO),  5.04  (1H,  d,  7=6.0,  Ci/N),  7.40  (3H,  m,  C6//4),  7.48  (1H,  d,  
7=7.4,  C6H4).  Analysis:  calculated  for  QqHmNOz: C,  67.78; H,  6.26; N,  7.90; found: C,  67.66;  
H,  6.38; N,  7.72.  
4.6. Preparation  of  racemic 3,4-benzo-6-hydroxymethyl-6-azabicyclo[3.2.0]heptan-7-one,  (±)-6  
Compound  2  (6.00  g,  37.69  mmol)  was  dissolved  in  THF  (250  ml),  and  paraformaldehyde  
(1.36  g), potassium carbonate  (0.52 g,  3.77 mmol)  and water  (3.8 ml) were added. The solution 
was sonicated for 5 hours. The solvent was evaporated  off and the residue was dissolved in ethyl 
acetate.  The  solution  was  dried  over  Na2S04,  the  solvent  was  evaporated  off and  the  product  
was  recrystallised  from a  THF-diisopropyl  ether  mixture  to  afford white  crystals  of  6  (5.06 g,  
71%,), mp  112-114°C.  
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'H  NMR  (400  MHz,  CDC13)  5  (ppm):  3.08  (2H,  m,  CHC//2,  OH),  3.33  (1H,  d,  7=17.4,  
CHCH2),  4.01 (1H, m,  CHCO),  4.39 (1H, dd, 7=11.6,  9.0, CH2OH),  4.87 (1H, dd, 7=11.6,  5.8,  
C//2OH),  5.17 (1H, d, 7=4.3, CtfN), 7.28 (3H, m, C6//4),  7.42 (1H, d, 7=7.4,  C6#4).  Analysis:  
calculated  for C„H„N02:  C,  69.83;  H,  5.86; N,  7.40; found:  C,  69.39; H,  6.23; N,  7.30.  
4.7.  General procedure for  small-scale  experiments  
The AMiydroxymethyl-|3-]actam  (±)-6 (0.1 M solution)  in  an organic solvent  (1 ml) was added 
to  lipase  PS  (50  mg ml"1)  or  lipase  AK  (50  mg ml-1).  Vinyl  acetate  or  butyrate  (0.2  M  in  the  
reaction  mixture)  was added  and  the mixture was shaken  at  room temperature. The progress of 
the reaction was followed by taking samples from the reaction mixture at intervals and analysing 
them  by gas  chromatography.  
4.8.  Gram-scale  resolution  of  (±)-6  
Racemic 6 (4.00 g, 21.14 mmol) was dissolved  in THF  (200 ml), lipase AK (10.58 g) and vinyl  
butyrate  (4.83  g,  42.28  mmol)  were  added  and  the  mixture  was  stirred  at  room  temperature.  
After 2.5 hours, a few drops  of triethylamine were added  in order to enhance the stability  of the 
unreacted  acid-labile  7,  and  the  enzyme  was  filtered  off  at  50%  conversion.  The  THF  was  
evaporated  off.  The  residue  was  chromatographed  on  silica,  with  elution  with  
dichloromethane.ethyl  acetate  (9:1)  for  separation  of  the  ester  (lR,5R)-8  (2.43  g,  9.37  mmol;  
[a]o =-91.8 (c=0.51,  CHC13); ee=99%)  as a  colourless oil. Elution  with  dichloromethane:ethyl  
acetate  (1:1) afforded the unreacted  (lS,5S)-7  (1.68 g,  8.88 mmol; [a£5 =+137  (c = 0.36, CHC13); 
ee=99%;  mp  138-140°C)  as  white  crystals.  
•H  NMR  (400  MHz,  CDC13)  5  (ppm)  for  8:  0.96  (3H,  t,  7=7.4,  CH3),  1.66  (2H,  m,  
CH2C//2CH3),  2.30  (2H,  t,  7=7.4,  C//2CH2CH3),  3.09  (1H,  dd,  7=17.4,  10.5,  CHCH2),  3.32  
(1H,  d,  7=17.4,  CHC//2),  4.00  (1H,  m,  CHCO),  4.97  (1H,  d,  7=11.4,  OCH2), 5.07  (1H,  d,  
7=11.4,  OCH2),  5.11  (1H,  d,  7=4.4,  C#N),  7.30  (3H,  m,  C6H4),  7.61  (1H,  d,  7=7.4,  C6/f4).  
Analysis:  calculated  for  C1SH17N03:  C,  69.48;  H,  6.61;  N,  5.40;  found:  C,  69.12;  H,  6.71;  N,  
5.48. 
The 'H NMR  data for 7 are similar  to  those for  (±)-6. Analysis found: C,  69.71; H,  5.91; N, 
7.35. 
4.9. Acid hydrolysis  of  7 and 8 
Compound  7 (0.40 g,  2.11 mmol)  was dissolved in  18% HCl  (14 ml) and  refluxed for 2 hours 
at  70°C. The solvent was evaporated off, and the residue was recrystallised  from ethanol-diethyl 
ether,  which  afforded  white  crystals  of  (lS,25)-9  (0.35  g,  1.64  mmol;  [aß5=+5.7  (c=0.50,  
MeOH);  mp  281-282°C;  ee = 99%). 
The  'H NMR  data  for 9 are  similar  to  those for  (±)-3. Analysis found: C,  56.34; H,  5.58; N, 
6.53. 
Similarly,  8  (1.00  g,  3.86  mmol)  afforded  white  crystals  of  (1R,2R)-11  (0.50  g,  2.34  mmol;  
[aß5 = -5.3 (c=0.50,  MeOH);  mp  273-275°C;  ee = 99%). The  'H  NMR  data  for  11 are  similar  
to  those for 9  and  (±)-3.  Analysis  found: C,  56.29;  H,  5.71; N,  6.60.  
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4.10.  Preparation  of  esters 10 and 12 
Similarly as in Section 4.4, (lS,5S)-7  (0.80 g, 4.23 mmol) afforded white crystals  of (15,25)-10 
(0.73 g,  3.02 mmol;  [a]£>5 = +6.0  (e=0.50,  H20);  mp  208-209°C;  ee = 99%). The  'H  NMR  data  
for  10 are  similar  to  those  for  (±)-4.  Analysis  found:  C,  59.74; H,  6.61;  N,  5.75.  
Similarly,  (1R,5J?>8  (1.00  g,  3.86 mmol)  afforded white  crystals  of  (1/?,2R)-12  (0.70  g,  2.90 
mmol;  [a£s = -6.2  (c = 0.50,  H20);  mp  214-216°C;  ee=99%).  The  'H  NMR  data  for  12  are  
similar  to  those for  10  and  (±)-4.  Analysis  found: C,  59.69;  H,  6.59;  CI,  14.62; N,  5.84.  
4.11.  Preparation  of  trans-1 -aminoindane-2-carboxylic  acid hydrochloride  enantiomers  13 and 
14 
With  the  procedure  described  in  Section  4.5,  (15,2S)-10  (0.40  g,  1.65  mmol)  afforded  
(15,2/?)-13 crude material.  Since the product  contained  ~20%  cis isomer, the isomerisation  was  
carried  out  again,  yielding white crystals  of (15,2i?)-13  (0.13 g, 0.61 mmol;  [a]£>5 = -76.8  (c = 0.5, 
H20);  mp  217-220°C;  ee=99%).  The  'H  NMR  data  for  13  are  similar  to  those  for  (±)-5.  
Analysis  found: C,  56.11; H,  5.69;  CI,  16.47; N,  6.48.  
With  the above procedure,  (1R,2R)-12  (0.40 g,  1.65 mmol)  afforded (1/?,2S)-14  (0.21 g, 0.98 
mmol;  [a]g=+75.8  (c = 0.5,  H20);  mp  220-222°C;  ee=99%).  The  'H  NMR  data  for  14  are  
similar  to  those  for  13  and  (±)-5.  Analysis  found: C,  56.28; H,  5.62;  CI,  16.52; N,  6.61.  
4.12.  Preparation  of  thiourea  derivative IS 
The free base  of ethyl  ester  12 (0.08 g, 0.39 mmol) was dissolved  in  diethyl  ether  (10 ml),  and 
(\S,2S)-1,3-diacetoxy-1 -(4-nitrophenyl)-2-propyl  isothiocyanate  (0.14 g,  0.41 mmol) was added. 
The mixture  was  allowed  to  stand  at  room  temperature  for  a  few hours.  The white  crystals  of  
15  were  separated.  The  product  was  recrystallised  from  diisopropyl  ether-diethyl  ether,  mp  
145-148°C. 
4.13.  X-ray  crystallography  
All  data  were  collected  on  a  Rigaku  AFC5S  diffractometer, with  graphite-monochromated  
Mo  Ka  radiation  (* = 0.71069  A)  in  the  co-20 scan  mode  at  room  temperature.  The  lattice  
parameters  were  calculated  by  least-squares  refinements of  20 reflections. The  weak reflections 
[/<10ff(/)] were rescanned  up to  two times. For  15,  2819 reflections were collected  (20max=5O°).  
The data  were corrected  for  Lorentz  and  polarisation effects. 
4.13.1.  Crystal data for  15  
C26H27N308S,  Mr = 541.57,  orthorhombic,  space  group  P21212,  (no.  19),  lattice  parameters:  
a=  11.127(4),  ¿ = 22.908(3), c=  10.665(4) A, Z=4,  V= 2718.6(14) A3, Dc=  1.323 g cm"3, p.  (Mo  
Ka)=0.172  mm-1,  F(000)=1136,  T= 294 K;  a  colourless  plate,  crystal  dimensions  0.22x0.24x  
0.32 mm. 
The structure was solved  by direct methods (SIR-92)24 and refined by full-matrix least-squares 
techniques (SHELXL-97)25 to  an i?,  value of 0.048 (vt>R2=0.112). These final R  values are based 
on  the  reflections  with  I>2a(I).  The  heavy  atoms  were  refined  anisotropically.  The  hydrogen  
atoms  on the aliphatic carbons (CI,  C2,  C12 and CI3)  and  on  the nitrogen  atoms  were refined 
F.  Fülöp  el  al. /  Tetrahedron:  Asymmetry  11  (2000)  4179-4187  4187 
with  fixed  isotropic  temperature  factors  (1.2 C/eq  of  the  carrying  atom)  and  the  remaining  
hydrogen  atoms  were  included  in  the  calculated  positions  with  fixed  isotropic  temperature  
factors (1.2 or  1.5 times  t/eq  of  the carrying atom). The ester  group at  C8 has  two  orientations.  
The population  of the major component  is 56(5)%. Calculations were performed with teXsan for 
Windows26  crystallographic  software.  Fig.  1 was  drawn  with  ORTEP-3  for  Windows.27  
Acknowledgements 
The authors would  like to thank the OTKA (grant no. T 030452) and MKM (grant no. FKFP 
0535/1999)  for financial support. 
References 
1.  Enantioselective  Synthesis  of  p-Amino  Acids\  Juaristi,  E.,  Ed.;  Wiley-VHC:  New  York,  1997.  
2.  Gademann,  K.;  Hintermann,  T.;  Schreiber,  J.  V.  Curr.  Med.  Chem.  1999,  6,  905.  
3.  Abdel-Magid,  A.  F.;  Cohen,  J.  H.;  Maryanoff,  C.  A.  Curr.  Med.  Chem.  1999,  6,  955.  
4.  Juaristi,  E.;  Lopez-Ruiz,  H.  Curr.  Med.  Chem.  1999,  6,  983.  
5.  Fülöp,  F.  In  Studies  in Natural  Product  Chemistry,  Atta-ur-Rahman,  Ed. The  chemistry  of  2-aminocyclopentane-
carboxylic  acid.  Elsevier  Science:  New  York,  2000;  pp.  273-306.  
6.  Davies,  S.  G.;  Ichihara,  O.;  Walters,  I.  A.  S.  Synlett  1993,  461;  Davies,  S.  G.;  Ichihara,  O.;  Lenoir,  I.;  Walters,  
I.  A.  S.  J.  Chem.  Soc.,  Perkin  Trans.  1  1994,  1411;  Davies,  S.  G.;  Bhalay,  G.  Tetrahedron:  Asymmetry  1996,  7,  
1595. 
7.  Konishi,  M.;  Nishio,  M.;  Saitoh,  K.;  Miyaki,  T.;  Oki,  T.;  Kawaguchi,  H.  J.  Anlibiot.  1989,  42,  1749.  
8.  Iwamoto,  T.;  Tsujii,  E.;  Ezaki,  M.;  Fujie,  A.;  Hashimoto,  S.;  Okuhara,  M.;  Kohsaka,  M.;  Imanaka,  H.;  
Kawabata,  K.;  Inamoto,  Y.;  Sakane,  K.  J.  Antibiot.  1990,  43,  1.  
9.  Knapp,  S.  Chem.  Rev.  1995,  95,  1859.  
10.  Appella, D.  H.;  Christianson,  L.  A.; Klein, D.  A.; Powell,  D.  R.; Huang,  X.;  Barchi, J. J.;  Gellman,  S. H.  Nature  
1997,  387,  381;  Porter,  E.  A.;  Wang,  X.;  Lee,  H.  S.;  Weisblum,  B.;  Gellman,  S.  H.  Nature  2000,  404,  565.  
11.  Seebach,  D.;  Overhand,  M.;  Kühnle,  F. N.  M.;  Martinoni,  B.; Oberer,  L.;  Hommel,  U.; Widmer,  H.  Helv.  Chim.  
Acta  1996,  79,  913.  
12.  Appella,  D.  H.;  Christianson,  L.  A.;  Karle,  I.  L.;  Powell,  D.  R.;  Gellman,  S.  H.  J.  Am.  Chem.  Soc.  1999,  121,  
6206. 
13.  Appella,  D.  H.;  Durell,  S.  L.;  Barchi,  J.  J.;  Gellman,  S.  H.  J.  Am.  Chem.  Soc.  1999,  121,  2309.  
14.  Barchi,  J.  J.;  Huang,  X.;  Appella,  D.  H.;  Christianson,  L.  A.;  Durell,  S.  R.;  Gellman,  S.  H.  J.  Am.  Chem.  Soc.  
2000,  122,  2711.  
15.  Rasmussen,  J.  K.;  Hassner,  A.  Chem.  Rev.  1976,  76,  389.  
16.  Dhar,  D.  N.;  Murthy,  K.  S.  K.  Synthesis  1986,  437;  Kamal,  A.;  Sattur,  P.  B.  Heterocycles  1987,  26,  1051.  
17.  Szakonyi,  Z.;  Fülöp,  F.;  Bernáth,  G.;  Evanics,  F.;  Riddell,  F.  G.  Tetrahedron  1998,  54,  1013.  
18.  Bornscheuer,  U.  T.;  Kazlauskas,  R.  J.  Hydrolases  in  Organic  Chemistry,  Wiley-VHC:  Weinheim,  1999.  
19.  Csomós,  P.;  Kanerva,  L.  T.;  Bernáth,  G.;  Fülöp,  F.  Tetrahedron:  Asymmetry  1996,  7,  1789.  
20.  Kámán,  J.;  Forró,  E.;  Fülöp,  F.  Tetrahedron:  Asymmetry  2000,  11,  1593.  
21.  Péter,  M.;  Péter,  A.;  Fülöp,  F.  Chromatographia  1999,  50,  307.  
22.  Péter,  M.;  Péter,  A.;  Fülöp,  F.  J.  Chromatogr.  A  2000,  871,  115.  
23.  Murray,  R.  J.;  Cromwell,  N.  H.  J.  Heterocyclic  Chem.  1974,  11,  979.  
24.  Ahornare,  A.;  Cascarano,  M.;  Giacovazzo,  C.;  Guagliardi,  A.;  Burla,  M.  C.;  Polidori,  G.;  Camalli,  M.  J.  Appl.  
Crystallogr.  1994,  27,  435.  
25.  Sheldrick,  G.  M.  SHELX-97-  University  of  Göttingen:  Germany,  1997.  
26.  Molecular  Structure  Corporation.  teXsan  for  Windows.  Single  Crystal  Structure  Analysis  Software.  Version  1.01.  
MSC:  3200  Research  Forest  Drive,  The  Woodlands,  TX  77381,  USA,  1997.  
27.  Farrugia,  L.  J.  J.  Appl.  Crystallogr.  1997,  30,  565.  
I V . 
Monatshefte für Chemie  133,  1423-1430  (2002)  Monatshefte  für  Chemie  
Chemical  Monthly  
©  Springer-Verlag  2002  
Printcd  in Austria 
Synthesis  of  Imidazo[l  ,5 : l,2]pyrido 
[3,4-&]indole  Derivatives  
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Summary.  The  reactions  of  l,2,3,4-tetrahydro-/?-carboline-l-carboxylic  acid  and  its  ethyl  ester  with  
alkyl and  aryl  isothiocyanates  under  mild  conditions resulted  in the corresponding  thiohydantoin-fused  
leirahydro-/?-carbolines.  Treatment  of  the  ethyl  ester  with  isocyanates  furnished  ethyl  2-alkyl-  or  
arylcarbamoyl-l,2,3,4-tetrahydro-jS-carholine-l-carboxylates  which  were  transformed  to  hydantoin-
fused tetrahydro-/?-carbolines.  The  structures  of  the  thiohydantoin  compounds,  involving  two  confor-
mera  and  the presence  of  keto-enol  tautomerism,  were  determined  by NMR  spectroscopy.  
Keywords.  /3-Carbolines;  Hydantoins;  Thiohydantoins;  Keto-enol  tautomerism.  
Introduction 
The /3-carboline structure is present  in important natural compounds, and its deriv-
atives exert various pharmacological effects  on the benzodiazepine receptors in the 
mammalian  nervous  system  [1-4].  It  is  also  found  as  a  structural  element  of  
compounds  exerting  anticancer  potential,  analgesic  activity,  or  oxytocin  antago-
nism [5]. In 1994, in a programme with the goal of developing new drugs affecting 
the central  nervous  system, Lopez-Rodriguez  et al. have  studied  the  ring-closure  
possibilities  of the  1,2,3,4-tetrahydro-/3-carboline  skeleton  through the reaction  of  
l,2,3,4-tetrahydro-/3-carboline-l-carboxylic  acid  (1)  with  alkyl  and  aryl  isocya-
nates under vigorous conditions  (refluxing for 40 h in  acetone or DMSO).  In their 
case the corresponding  hydantoin  analogues have been  formed  [6].  Some further 
derivatives  of  the  4-ring  hydantoins  exert  pharmacological  effects on aj-adreno-
receptors  [7].  However,  the  synthesis  of  thiohydantoin  derivatives  remained  un-
solved under the circumstances  applied:  in the reactions  of 1 and isothiocyanates,  
decarboxylation took place, and open-chain thiourea derivatives have been isolated 
instead  of the desired  thiohydantoins  [6].  
Our  present  aim  is  to  attempt  the  synthesis  of  thiohydantoin-fused  imidazo  
[l\5/:l,2]pyrido[3,4-6]indole  derivatives  under  mild  conditions  based  on  the  
results  of  similar  ring  closures  [8-13],  starting  from ethyl  1,2,3,4-tetrahydro-/?-
carboline-l-carboxylate  (2).  
*  Corresponding  author.  E-mail:  fulop@pharma.szote.u-szeged.hu  
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Results  and  Discussion  
1,2,3,4-Tetrahydro-/?-carboline-l-carboxyIic  acid  (1)  was  obtained  from  trypt-
amine  hydrochloride  and  glyoxylic  acid  [14].  Racemic  1  was  esterified  by  two  
methods  (Scheme  1):  refluxing  in  ethanol  with  thionyl  chloride  (method  A)  or  
reaction  with  dry hydrogen  chloride gas in ethanol  (method  B)  [14],  Both  methods  
resulted  besides  2  in  a by-product,  the  hydrochloride  of  1,2,3,4-tetrahydronorhar-
mane  (3)  as a consequence  of  decarboxylation.  This  side-product  could  be filtered 
off from the  hot  ethanolic  solutions.  Method  A gave 2  in  a somewhat  higher  yield  
(A:  76%,  B:  57%).  
When  the  ester  base  2  was  combined  with  alky!  and  aryl  isothiocyanates  at  
room temperature  in methanol,  the corresponding  target  thiohydantoins  4 could  be  
filtered off from the  reaction  mixtures  after stirring  overnight  (Scheme  2).  Gener-
ally,  the  yields  were  fair  to  good  (41-74%),  except  in  the  case  of  4d  where  it  
was  only  16%.  No  decarboxylation  was  observed  during  the  reactions,  and  no  
COOH  COOC2H5  
1  2  3  
Scheme  1  
COOC2H5 
N —C—NH—R 
COOC2H6 
R 
5a:  Ph  
5b:  CH2CH3  
R 
4a  CH3  
4b  CH2CH3  
4c:  CH2CH2CH3  
4d  CH2CH2CH2CH3  
4e:  Ph  
4f:  p-CH3-C6H4  
4g:  p-CI-C6H4  
4h:  p-OCH3-C6H4  
6a:  Ph  
6b:  CH2CH3  
Scheme  2  
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intermediates  or  by-products  could  be  isolated  from the  residues.  From  the  reac-
tions  of  1 and  isothiocyanates  under the same conditions,  but with  sodium  methyl-
ate  as  the  catalyst,  the  thiohydantoins  4  were  obtained  in  rather  low  yields.  
In  the  reactions  of  2  and  ethyl  and  phenyl  isocyanates  under  similarly  mild  
conditions,  the  corresponding  urea  derivatives  5  were  formed  as  crystalline  prod-
ucts.  These  were  cyclized  by  refluxing in  ethanol  for one  day  under  hydrochloric  
acid catalysis.  Hydantoin  compounds  6a  and  6b were formed in  56 and  37% yield;  
and  no  other  products  could  be  isolated.  
The  low solubility  and  susceptibility  to degradation  of 4a-h  made the proof  of  
the  thiohydantoin  structure  by  NMR  spectroscopy  difficult. Hydantoin  derivatives  
can undergo keto-enol  tautomerism  [6],  In addition, the saturated  nitrogen  contain-
ing heterocycles  tend  to populate  more than  one low-energy  conformation  in  solu-
tion  due  to the relative  ease  of  nitrogen  inversion  [15].  Bearing  in  mind the  above  
possible  processes,  the  observed  line  broadening  in  pyridine-d5  at  300 K  was  not  
surprising.  In  order  to  slow  down  the  chemical  exchange  we  decreased  the  tem-
perature to 243 K.  At this temperature  two exchanging  species  were observed.  The 
results  of  'H  and  13C  resonance  assignment  by  means  of  COSY,  HSQC,  and  
HMBC  for  4b  as  an  example  demonstrated  that  the  two  species  have  the  same  
spin  connectivity  and  similar  chemical  shifts.  Concerning  the  constitution,  the  
missing  H-llb  signal  and  the  chemical  shift  values  for  C-l lb  (71.25  and  
67.96 ppm)  pointed  to  the  predominance  of  the  enol  form  for  both  species;  how-
ever,  the  presence  of  the  keto  form  cannot  be  excluded.  In  addition  to  the  argu-
ments  described  above,  the  I3C  chemical  shifts  relating  to  C-l  (170.06  and  
169.03 ppm)  are  between  the  values  for  the  possible  enol  (ca.  90 ppm)  and  keto  
(ca. 220ppm)  forms. The chemical  shifts of C-llb  (71.25  and 67.96ppm)  are also 
Table  1.  'H  and  1 3C  NMR  data  of  the  conformers  4bA  and  4bB  dissolved  in  pyridine-d5  
4bA  ¿ /ppm  4bB  ¿ /ppm  
'H •  , 3 C  'H 13C 
1 _ 170.06 — 169.03 
3 - 182.8 - 184.74 
5 2.52,  4.98  40.46 3.88,  5.44  42.62 
6 2.44,  2.84  20.21 2.76,  2.93  19.94 
6a - 112.45 - 111.65 
6b - 125.85 - 126.21 
6c - 138.24 - 138.30 
7 6.96 112.23 7.35 120.17 
8 7.05 123.36 7.74 119.64 
9 7.17 119.18 7.43 112.8 
10 7.51 118.92 7.33 123.48 
11 12.4 - 13.41 -
11a - 121.94 - 122.75 
l i b _b 71.25a _b 67.96' 
a  6 values  between  those  for  the  enol  (80ppm)  and  keto (56ppm)  forms ( C - l l b )  [5];  b  the  methine  
proton  at C - l l b  is  missing  because  of  the  suggested  keto-enol  tautomerism  and  HD  exchange  
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average values  in both  species between  the chemical  shifts found  in the literature 
[6] for the  enol  (80ppm)  and  keto  (56ppm)  forms. These  observations,  together  
with  the  missing H-llb,  suggest  a rapid  acid-catalyzed  equilibrium  between  the  
two tautomeric forms in both conformers. From these data  we may conclude that 
the  NMR  signals  belong  to  two  exchanging  conformational  isomers  which  are  
predominantly the enol forms  of the thiohydantoin derivatives. The two conformers 
are designated  by  4bA  and  4bB; the chemical  shifts given  in Table 1.  
In  CDC13  solutions  of  4,  broadened  signals  were  obtained  which  would  also  
suggest  the  possibility  of  a  conformational  equilibrium.  The  compounds  4  were  
satisfactorily soluble in DMSO-d6,  where characteristic but still  slightly broadened 
signals  appeared.  The  geometry  of  the  two  conformations  could  not  be  estab-
lished, but the conformational equilibrium  is obviously  due to  nitrogen  inversion  
[15]. 
Conclusions 
It was proven that 2-substituted 5,6,11,11 b-tetrahydro-1 -oxo-1 //-imidazo[ 1 ',5': 1,2] 
pyrido[3,4-£>]indole-3-thiones  4  can  be  prepared  under  mild  conditions  from  
1,2,3,4-tetrahydro-/3-carboline-l-carboxylic  acid (I) and its ethyl ester 2. The struc-
tures of the thiohydantoin  compounds, involving two conformers and the presence 
of keto-enol  tautomerism,  were determined  by  NMR spectroscopy. 
Experimental 
Melting  points were determined  with  a Kofler apparatus  at a heating rate  of 4°C/min;  the values  are  
not corrected.  *H NMR  spectra  were recorded  in  5 mm tubes  in the appropriate  solvents on  a  Bruker  
DRX 400 instrument at 400MHz. IR spectra were measured  in  KBr disks on a Perkin Elmer  Paragon  
1000PC  FT-IR  spectrometer.  Analytical  data  were  obtained  by  a  Heraeus  apparatus;  they  were  in  
favourable  agreement  with  the  calculated  values.  The  cyanates  and  isothiocyanates  used  were  com-
mercial  products  (Aldrich,  Fluka).  Yields  in  parentheses  refer to reactions  starting  from  1.  
Ethyl  1,2,3,4-tetrahydro-B-carboline-l-carboxylate  (2)  
Method  A:  Absolute  EtOH  (18cm3)  was  cooled  below  -  10°C.  SOCl2  (1.59cm3,  21.8mmol)  was  
added  dropwise,  the  temperature being kept below  -  10°C. Then,  1  (4.3 g,  19.8 mmol)  was  added  to  
the mixture,  which  was  first stirred  for 0.5 h  at 0°C and  then  for 3 h  at room  temperature,  and finally 
refluxed  for  1 h. 
Method  B  [14]: A suspension of 7.33 g dried and well-powdered  1 (33.8 mmol)  in  150 cm3  absolute 
EtOH  was saturated  with  dry  HC1 gas  under stirring,  and  the mixture  was  then refluxed  for 2h. 
The  crystalline  product  was  filtered off from the  hot  solution  in  both  cases  and  was  identified  as  
1,2,3,4-tetrahydronorharmane  (3;  A:  1.28 g,  6.1 mmol,  18%;  B:  2.45 g,  11.7 mmol,  35%).  EtOH  was  
evaporated  under reduced  pressure,  and  diethyl  ether  was  added to promote  crystallization.  From  the  
hydrochloride, the free base was obtained by treatment with aqueous NaOH and extraction with CHCI3 
followed by  drying  (Na2S04)  and  evaporation. The product  was purified by  column  chromatography  
on silica gel with a mixture of toluene: MeOH = 4:1 as the eluent. Method A resulted in a yield of 76% 
2,  whereas  method  B  gave  a  yield  of  57%.  
Yellowish  needles;  m.p.:  107-110°C  (Et20;  Ref.  [14]:  m.p.:  110-111°C);  IR  (KBr):  t/ =  3363,  
1715,  1252cm - 1 ;  1H  NMR  (DMSO-ds):  <5=1.25  (t,  7=7.05Hz,  CH3),  2.54-2.63  (m,  H-6a,b),  
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2.95-3.05  (m, H-5a), 3.06-3.16  (m, H-5b), 4.08-4.23  (m, CH2), 4.67  (s, H-l lb),  6.95  (t,  7=7 .30Hz ,  
H-8), 7.04  (t,  7 =  7.30Hz,  H-9), 7.33 (d, 7 = 7 . 8 H z ,  H-7),  7.39  (d, 7 =  7.8Hz,  H-10),  10.64 (s,  H - l l )  
ppm. 
2-Substituted  5,6,11,1  lb-tetrahydro-1  -oxo-1 H-imidazo[l',5':  1,2]pyrido[3,4-b]indole-3-
thiones  (4a-4h);  general  procedure  
The  appropriate  isolhiocyanate  (0.8mmol)  was  added  to  195mg  (O.Smmol)  2  dissolved  in  40 cm3 
MeOH. The  mixture  was  stirred  overnight,  and  the  crystalline  product  was  filtered  off  and  recrystal-
Iized. The  synthesis  was  repeated  from the acid  1 in every case, the same method  being  used  with  the  
application  of  1.6mmol  sodium  methylate  as  catalyst.  The  analytical  data  were  identical.  
2-Methyl-5,6,11,1  lb-tetrahydro-1  -oxo-1 H-imidazo[l',  5':1,2)pyrido[3,4-b]indole-
3-thione  (4a;  C1 4H,3N3OS)  
Light-pink  crystals;  m.p.:  195-200°C  (EtOH/CHCl3);  yield:  66% (16%);  IR  (KBr):  ¡7 =  3447,  3399,  
3373,1742,1728,1311 cm " 1 ;  'H NMR  (DMSO-d6):  6 = 2.68-2.88  (m, H-6a,b), 2.95 (bs, H-5a), 3.21 
(s,  CH3),  4.92  (m,  H-5b),  7.02  (t,  7 =  7.55Hz,  H-8),  7.15  (t, 7=7 .55Hz ,  H-9),  7.46  (d,  7 =  7.55Hz,  
H-7),  7.5  (d,  7 =  7.55Hz,  H-10),  10.52  (s, H - l l )  ppm.  
2-Ethyl-5,6,11,1  lb-tetrahydro-1  -oxo-1 H-imidazo[l',  5':  l,2]pyrido[3,4-b]indole-
3-thione  (4b;  C|5H1 5N3OS)  
White crystals;  m.p.: 203-211°C (EtOH/CHCl3);  yield: 62% (27%); IR (KBr):  ¡7 =  3460,3389,1742,  
1727,  1271 c m " ' ;  'H  NMR  (DMSO-de):  6=  1.19  (t, 7 =  7.30Hz,  CH3),  2.68-2.85  (m, H-6a,b),  2.91  
(bs,  H-5a),  3.72-3.91  (m,  CH2),  4.91  (m,  H-5b),  7.03  (t, 7 =  7.3 Hz,  H-8),  7.16  (t,  7 =  7.30Hz,  H-9),  
7.47  (d,  7 = 7 . 8 H z ,  H-7),  7.52  (d,  7 =  7.8Hz,  H-10),  10.49  (s,  H- l l ) .  
2-Propyl-5,6,11,1  lb-tetrahydro-1-oxo-1  H-imidazo[l',5':],2]pyrido[3,4-b]indole-
3-thione  (4c;  Ci 6H I 7N 3OS)  
White crystals; m.p.:  188-190°C (EtOH/CHCl3);  yield: 41% (19%); IR (KBr):  ¡7 =  3451,  3389,1743,  
1 7 2 7 c m " ' ;  'H  NMR  (DMSO-de):  6 =  0.87  (t,  7 =  7.55Hz,  CH3),  1.66  (m,  CH2),  2.63-2.88  (m,  H-
6a,b),  2.96  (bs,  H-5a),  3.61-3.83  (m,  CH2),  4.92  (m,  H-5b),  7.48  (d,  7 =  8.3 Hz,  H-7),  7.02  (t,  
7 = 7.3Hz,  H-8), 7.15  (t, 7 = 7 . 8 ,  H-9),  7.51  (d, 7 = 7 . 8 ,  H-10),  8.31  (bs, H - l l )  ppm.  
2-Butyl-5,6,ll,llb-tetrahydro-l-oxo-lH-imidazo[l',5':l,2]pyrido[3,4-b)indole-
3-thione  (4d;  C1 7H,9N3OS)  
White  crystals;  m.p.:  186-188°C  (EtOH/CHCl3);  yield:  16% (5%);  IR  (KBr):  ¡7 =  3456,  3387,1743,  
1724cm" ' ;  'H  NMR  (DMSO-rfc):  6 =  0.90 (t, 7=7 .30Hz ,  CH3),  1.23-1.35  (m, CH2),  1.55-1.69  (m,  
CH2),  2.63-2.87  (m,  H-6a,b),  2.96  (bs,  H-5a),  3.66-3.87  (m,  CH2),  4.91  (m,  H-5b),  7.03  (t,  
7 = 7.55Hz,  H-8),  7.15  (t,  7 =  7.55,  H-9),  7.46  (d,  7=8 .06Hz ,  H-7),  7.52  (d,  7=8 .06Hz ,  H-10),  
10.44  (s, H-l  1)  ppm.  
2-Phenyl-5,6,11,1  lb-tetrahydro-1  -oxo-1 H-imidazo  [l',5':l,2]pyrido[3,4-b]indole-3-
thione  (4e;  C1 9H1 5N3OS)  
Light-pink  crystals;  m.p.:  208-214°C  (EtOH/CHCl3);  yield:  57%  (31%);  IR  (KBr):  ¿7 =  3423,  3371,  
3250,1754,  1744,  1285 c m " ' ;  'H  NMR  (DMSO-d6):  6=2 .77-2 .90  (m, H-6a), 2.90-3.02  (m,  H-6b),  
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3.12 (bs, H-5a), 5.12  (bs, H-5b),  7.06 (t,  7 =  7.81, H-8), 7.17  (t, 7 =  7.81, H-9), 7.30-7.37  (m, H-7  and  
H-10),  7 .46-7.58  (m,  phenyl),  10.54  (s,  H-l  1)  ppm.  
2-(p-Tolyl)-5,6,ll,llb-tetrahydro-]-oxo-]H-imidazo[]',5':],2]pyrido[3,4-b]indole-3-
thione  (4f;  C 2 0 H, 7 N 3 OS)  
Light-brown  crystals;  m.p.:  187-189°C (EtOH/CHCl3) ;  yield:  67% (36%); IR  (KBr):  ¿5 =  3442,3408,  
1752,  1736,  1 2 8 4 c m "  ';  ' H  NMR  (DMSO-d6):  <5 =  2.35  (s, CH3), 2 .78-2.88  (m,  H-6a), 2.89-3.00  (m,  
H-6b),  3.10  (s, H-5a),  5.11  (bs, H-5b), 7.05  (t, 7 =  7.55, H-8), 7.12-7.23  (m, H-9, H-7  and  H-10),  7.31  
(d,  7 =  8.06Hz,  phenyl),  7.52  (d, 7 = 7 . 8 1  Hz,  phenyl),  10.51  (s, H - l l )  ppm.  
2-(p-Chlorophenyl)-5,6,  J1,11  b-tetrahydro-1  -oxo-1  H-imidazo[  1' ,5':  l,2]pyrido  
[3,4-b]indole-3-thione  (4g;  Ci9H,4C1N3OS)  
Light-pink  crystals;  m.p.:  202-209°C  (EtOH/CHCl3) ;  yield:  59%  (28%);  IR  (KBr):  ¿/ =  3419,  3396,  
1745,1730,  1281,1253 c m " ' ;  'H NMR  (DM50-d6):  6 =  2.76-3.01  (m,  H-6a,b), 3.08  (bs,  H-5a)  5.09  
(bs,  H-5b),  7.06  (t,  7 =  7.55 Hz,  H-8),  7.17  (t,  7 = 7 . 5 5 Hz,  H-9),  7.39  (d,  7 =  8.56 Hz,  phenyl),  
7 .49-7.56  (m,  H-7  and  H-10),  7.62  (d, 7 =  8.56Hz,  phenyl),  10.56  (s,  H-l  1)  ppm.  
2-(p-Methoxyphenyl)-5,6,l  1,1 lb-tetrahydro-l-oxo-lH-imidazol1',5':  1,2]pyrido  
[3,4-b]indole-3-thione  (4h;  C 2 0 H, 7 N 3 O 2 S)  
Light-brown crystals;  m.p.:  183-185°C(EtOH/CHCl 3 ) ;  yield:  74% (21%); IR  (KBr):  £< =  3363,1715,  
1252,  1246,  1 2 3 6 c m " 1 ;  ' H  NMR  (DM50-d6):  6 =  2.73-3.01  (m,  H-6a,b),  3.10  (bs,  H-5a),  3.32  (s,  
OCH3),  5.10  (bs,  H-5b),  6.95-7.09  (m,  H-8,  H-7  and  H-10),  7.16  (t,  7 =  7.55Hz,  H-9),  7.24  (d,  
7 =  7.81 Hz,  phenyl),  7.53  (d, 7 = 7 . 8 1  Hz,  phenyl),  10.51  (s, H - l l )  ppm.  
2-Substituted  ethyl  carbamoyl-1,2,3,4-tetrahydro-P-carboline-l-carboxylates  
(5a,b);  general  procedure  
The appropriate isocyanate  (0.8 mmol)  was added  to  195 mg (0.8 mmol)  2 dissolved  in 40cm 3  MeOH.  
The  mixture was  stirred  overnight,  and  the crystalline  product  was  filtered off  and  recrystallized  from  
EtOH  and  diethyl  ether.  
Ethyl  2-ethylcarbamoyl-l,2,3,4-tetrahydro-P-carboline-l-carboxylate  (5a;  C ] 7 H 2 i N 3 0 3 )  
Pale-yellow  crystals;  m.p.:  167-170°C  ( E t 0 H / E t 2 0 ) ;  yield:  66%;  IR  (KBr):  ¿< =  3338,  3290,  1726,  
1 6 0 6 c m " 1 ;  ' H  N M R  (CDC13):  6 = 1 . 1 9  (t,  7 =  7.3Hz,  CH3),  1.30  (t,  7 =  7.3Hz,  CH3 ,  ester),  
2.76-2.94  (m,  H-6a,b),  3.30-3.39  (m,  CH2),  3.53  (ddd, 7 = 4 . 5 3 ,  11.33,  13.6 Hz,  H-5a),  3.92  (ddd,  
7 =  1.51,  5.04,  13.6Hz,  H-5b),  4.18-4.31  (m,  CH2 ,  ester),  4.65  (t,  7 =  4 .5Hz,  H - l l b ) ,  5.93  (s,  NH),  
7.11  (t, 7 = 7 . 8 H z ,  H-8), 7.2 (t, 7 =  7.81 Hz, H-9), 7.36 (d, 7 = 7 . 8 H z ,  H-7), 7.49 (d, 7 = 7 . 8 H z ,  H-10),  
8.28  (s, H - l l )  ppm.  
Ethyl  2-phenylcarbamoyl-l,2,3,4-tetrahydro-P-carboline-l-carboxylate  (5b;  C 2 ] H 2 IN 3 0 3 )  
Pale-yellow  crystals;  m.p.:  145-150°C  ( E t 0 H / E t 2 0 ) ;  yield:  61%;  IR  (KBr):  v  =  3386,  3289,  1723,  
1 6 3 0 , 1 6 2 2 c m " ' H  NMR  (CDC13): 6 =  1.31  (t, 7 = 7 . 3 H z ,  CH3), 2 .84-3.03  (m,  H-6a,b),  3.67  (ddd,  
7 =  4.28,  11.83,  13.6Hz,  H-5a), 4.13  (ddd, 7 =  1.02,  5.04,  13.6Hz,  H-5b), 4 .23-4 .32  (m, CH2),  5.99  
(bs, H - l l b ) ,  6.62  (s, NH) ,7 .06 ( t ,  7 = 7 . 5 5 H z ,  phenyl),  7.13  (t,  7 = 7 . 3 H z ,  H-8),  7.21 ( t , 7 =  8.06Hz,  
H-9),  7.31  (t,  7 =  7 .3Hz,  phenyl),  7.36-7.41  (m,  phenyl  and  H-7),  7.51  (d, 7 = 8 . 0 6 H z ,  H-10),  8.31  
(s, H - l l )  ppm.  
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2-Substituted  5,6,11,1  lb-tetrahydro-lH-imidazo[l',5':l,2]pyrido[3,4-b]indole-
l,3(2H)-diones  (6a,b);  general  procedure  
The appropriate carbamoyl  compounds 5a or 5b (50 mg) were refluxed in 25 cm3 EtOH containing 4% 
dry HC1 for one day. The reaction mixture was evaporated,  diethyl ether was added, and the crystalline 
product  was  filtered  off  and  recrystallized.  
2-Ethyl-5,6,11,1  lb-tetrahydro-1  H-iinidazo[T,5':  l,2]pyrido[3,4-b]  
indole-l,3(2H)-dione  (6a)  
Pale-yellow  crystals;  m.p.:  182-184°C  (E t0H/H 2 0;  Ref.  [6]:  m.p.:  184°C);  yield:  56%.  
2-Phenyl-5,6,l  1,11 b-letraliydro-1  H-imidazo[  1' ,5': 1,2]pyrido[3,4-b]indole-l  ,3(2H)-dione  
(6b;  C, 9 H 1 5 N 3 0 2 )  
Pale-yellow  crystals;  m.p.:  239-241°C  (E t0H/H 2 0;  Ref.  [6]:  m.p.:  241°C);  yield:  37%;  IR  (KBr):  
¿7  =  3412,  1772,  1704cm" 1 ;  'H  NMR  (CDC13):  5 =  2.89  (ddd,  7 = 1 . 2 6 ,  4.53,  15.86Hz,  H-6a),  
2.99-3.12  (m,  H-6b),  3.33  (ddd,  7 =  5.04,  11.58,  13.6Hz,  H-5a), 4.64  (dd,  7 =  6.04,  13.6Hz,  H-5b),  
5.39 (t, 7 =  1.76 Hz, H-l lb), 7.16 (t, 7 =  7.55 Hz, H-8), 7.25 (t, 7 =  7.81 Hz, H-9), 7.33-7.48 (m, phenyl 
and  H-7),  7.53  (d,  7 =  7.8Hz,  H-10),  8.51  (s, H - l l )  ppm.  
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A  set  of  structurally  varied  indano[l,2-</][l,3]oxazines  and thiazines,  which  are new ring systems,  were  
prepared  by ring-closure reactions  of  amino alcohols  4-6.  The reactions  of  cis-  and  trans-1  -amino-  and  cis-
l-benzylamino-2-hydroxymethylindane  (4-6)  with  1 equivalent  of  an  aromatic  aldehyde  in  methanol  at  
room  temperature  resulted  in  three-component  equilibria  (15a-g),  or  a Schiff  base  (16),  or  a  ring-closure  
product  alone  (17a-c),  respectively,  depending  on  the  substitution  or  configuration  of  the  starting  amino  
alcohol.  The ring-chain  tautomeric  equilibria  can be described  by  an equation  of  Hammett  type.  
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Introduction. 
Cyclic  /3-amino  acids  can  be  used  as  starting  substances  
for  the  preparation  of  different  heterocycles,  potential  
pharmacons  and  synthons  of  natural  products  or their  ana-
logues,  also  used  as building blocks  in  drug research  [1-4].  
( l / ? , 2 S ) - 2 - A m i n o c y c l o p e n t a n e c a r b o x y l i c  acid  (c i s -
pentacin)  is  an  antifungal  antibiotic  [5-9],  while  many  1,2-
and  1,3-amino  alcohols  and  their  derivatives  play  impor-
tant  roles  in  the  synthesis  of  pharmacologically  active  
compounds  [10-14],  The  applications  of  ct i - l -amino-2-
indanol  in  asymmetric  syntheses  have  been  reviewed  [15],  
and  its  (15,2/?)  enantiomer  is  a key  component  of  an  HIV  
protease  inhibitor,  Indinavir  [16,17].  
Our present  aim  was  to  prepare  cis-  and  frans-l-amino-
2-hydroxymethylindane  from  1 -aminoindane-2-carboxylic 
acid  derivatives  (new  cispentacin  benzologues)  and  to  
examine  the  chemistry  and  stereochemistry  of  indane-
fused  1,3-oxazines  and  thiazines.  
Results  and  Discussion.  
In  our  earlier  work,  racemic  ethyl  cis-  and  trans-1-
aminoindane-2-carboxylate  (1  and  2)  were  prepared  from  
indene  by  chlorosulfonyl  isocyanate  addition,  followed  by  
ring  opening  and  isomerization  [18].  The  cis-  and  trans-
unsubstituted  and c/i-ZV-benzyl-substituted  1,3-amino  alco-
hols 4-6  were  prepared  by LiAlH4  reduction  or by  benzoy-
lation followed  by reduction,  respectively  (Scheme  1).  
For the  preparation  of  2-thioxo-1,3-oxazines  7  and  8  the  
most  common  method  is  the  reaction  of  the  appropriate  
1,3-amino  alcohols  4  and  6 with  carbon  disulfide,  followed  
by  cycl izat ion  of  the  resulting  thiourea  with  lead(II)  
nitrate.  Cyclization  of  the  corresponding  1,3-amino  alco-
hol  4  with  ethyl  p-chlorobenzimidate  resulted  in  the  dihy-
dro-l ,3-oxazine  9.  The  synthesis  of  heterocycles  12-14  
started  from  adducts  of  the  corresponding  amino  alcohols  
4  and  6  with  ethyl  isothiocyanate.  Treatment  of  thioureas  
10  and  11  with  methyl  iodide  followed  by  alkali  treatment  
led  to the elimination  of  methyl  mercaptan,  resulting  in  the  
oxazines  12  and  13  in  good  yields.  Treatment  of  thiourea  
10  with  ethanolic  hydrogen  chloride  under  reflux,  fol-
lowed  by  treatment  with  alkali  provided  thiazine  14  
(Scheme  2).  
The  cis  amino  alcohol  4  was  condensed  in  methanolic  
solution  with  seven  substituted  aromatic  aldehydes  with  
Scheme  I  
PhCOCI /  toluene COOEt 
LiAIIVTHF/A L  65%  
NH, 
OH r >  7  
Li A1H4 /  THF / A 
67% 
NH, 
OH 
LiAlH41  THF / A 
55% 
HN' 9 
OH 
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Scheme  2  
different electronic  characters.  The  reactions  reached  com-
pletion  within  a  few  hours,  even  at  room  temperature.  
After  evaporation  and  purification,  well-defined  products  
15a-g  were  obtained,  which  existed  as  three-component  
tautomeric  mixtures  in  deuteriochloroform  solution.  For  
the  tautomeric  equilibria  to  be  reached,  the  substances  
were  allowed  to  stand  for  24  h  in  deuteriochloroform  
(Scheme  3).  The  relative  configurations  of  the  various  
structures  15A,B,C  were  determined  via  NOESY  spectra,  
on  the  basis  of  observation  of  NOE  correlation's  between  
the NH-C/ /Ar-0  and the NH-C// -CH  hydrogen  atoms.  
oxazines.  When  eq.  (1)  was  applied  to  the  log K x  values,  
good  linear  correlations  were  obtained  vj  the  Hammett-
Brown  parameter  (cr+) of  the  substituent  X  on  the  2-phenyl  
group  for  compounds  15a-g  (Tables  1  and  2,  Figure  1).  
The  tautomeric  ratios  are  based  on  the  integration  of  the  
15B  and  15C  ring  form  NH-C/ZAr-O  and  the  15A  chain  
form N=CH  proton  singlets.  
The  linear regression  analysis  data  in Table  2 show  that,  
as  customary  among  2-aryl-substituted  tetrahydro-1,3-
oxazines,  the  value  of  p  is  positive  in  each  case;  i.e.  an  
e lec tron-wi thdrawing  substituent  on  the  2-aryl  ring  
Scheme  3  
NH, 
OH 
UN 
15Aa-g  ISCa-g  
X = p-N02:  a; m-Br  b; p-d:  c; H: d; p-Mc:e; p-OMe:  f, p-NMe2:  g  
Comparative  studies  were  carried out  earlier on  the  ring-
chain  tautomerism  of  a  wide  range  of  2-aryl-substituted  
tetrahydro-l,3-oxazines  [19-24],  For  all  these  series,  the  
following  equation  is  valid:  
log Kx  = po+  + log K X=H (1) 
where K x  =  [ring]/[chain]  and  p  is  a constant  character-
istic  of  the  ring  system.  In deuteriochloroform  solution  at  
ambient  temperature ,  p  is  0 . 7 6  for  te trahydro-1 ,3 -
favours  the  ring-closed  tautomer.  The  proportion  of  the  
ring  form  for  the  trans-2-aryl-1,3-0,N  heterocycles  15C  
varies  within  a  somewhat  wider  range  (10.7-54%)  than  
that  for the corresponding  cis-2-aryl- l ,3-0,A  heterocycles  
15B  (9.2-41.7%).  The  relative  configuration  of  the  ring-
closed  products  does  not  seem  to influence  the value  of  p:  
cis-  and rranj-2-aryl-l ,3-0,N  heterocycles  have  very  simi-
lar values  of  p  (0.78  and  0.81).  
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Table  1  
Proportions  (%)  of  Ring  Forms  (B  and  C)  in Tautomeric  Equilibria  
for Compounds  15a-g  in  Deuteriochloroform  at 300  K  
Scheme  4  
Compound X 0* B ( % ) C ( % ; 
15a />NO2 0.79 41.7 54.0 
15b mBr 0.05 39.3 49.8 
15c pCl 0.114 35.8 50.5 
15d H 0 35.1 41.5 
15e pMe -0.31 29.6 35.9 
15f p O M e -0.77 22.9 28.2 
15g p N M e 2 -1.7 9.2 10.7 
log K 
1.50 
1 0 0  •  
0.50  •  
000 • 
-0.50  •  
- 1 . 0 0  •  
x-tr  '  --* 
..  I  
Figure  1.  Plots  of  log  Kx  vs  a*  for  Compounds  15a-g:  B  (X),  C  (+)  in  
deuteriochloroform. 
Table  2  
Linear  Regression  Data  for Compounds  15a-g  
NH, 
a io  
V 
OH 
MeOll/r.t. 
ri0% c D  v  OH 
16 
15Ad 16 
Figure  2. Stereoview  of  typical  minimum  energy  molecular  structures  for  
15Ad  and  16.  
Scheme  5  
X =p-N0 2 :  a;  H: b; p-NMe2:  c  
17a-c 
B [20] 
Intercept 
Slope 
Con.  coeff  
No.  of  points  
0.32 
0.78 
0.981 
7 
0.42 
0.81 
0.979 
7 
0.22 
0.72 
0.991 
6 
[20]  The  data  for  the  corresponding  cyclopentane-fused  tetrahydro-1,3-
oxazines 
When  the  trans-ammo  a lcohol  5  was  condensed  in  
methanol  with p-nitrobenzaldehyde  a well-defined  product  
was  obtained,  which  exists  solely  as  the  open,  Schiff  base  
form  16  (Scheme  4).  In  this  case,  the  OH  group  is  too  far  
from  the  N=CH  bond  (4.5  A) ,  and  intramolecular  proton  
transfer is  not  possible  without  energy  transfer (Figure  2).  
When  the N-benzylamino  alcohol  6  was  condensed  with  
aldehydes  in  methanolic  solution  at room  temperature  only  
one  diastereomer  17a-c  was  observed  in  deuteriochloro-
form  of  the  product  at  300  K  (Scheme  5).  The  product  
formed  is  stabil ized  by  aromatic-aromatic  interactions  
(Figure  3).  
17b 
Figure  3.  Stereoview  of  typica]  minimum  energy  molecular  structure  for  
17b 
EXPERIMENTAL 
Melting  points  were  determined  on  a  Kofler  micro  melting  
apparatus  and  are  uncorrected.  Elemental  analyses  were  per-
formed  with  a  Perkin-Elmer  2400  CHNS  elemental  analyser.  
Merck Kieselgel  6OF254 plates  were  used forTLC:  the eluent  was  
toluene-methanol  4:1.  The  'H-  and  1 3C  nmr  spectra  were  
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recorded  in deuleriochloroform  solution  in  5 mm  tubes, at  room 
temperature,  on  a  Bruker  Avarice  DRX  400  spectrometer  at  
400.13 (>H) and  100.61 (13C) MHz,  with the deuterium signal of 
the solvent as the lock and TMS  as internal standard.  Compounds  
1  and  2 were prepared by following literature methods  [18].  
Ethyl c/s- l-Benzoylaminoindane-2-carboxylate  (3).  
Ethyl  c i s-2-aminoindane-1-carboxylate  hydrochloride  (4.84  g,  
20 mmol) was allowed  to react  with benzoyl  chloride (3.0 mL, 24 
mmol)  under  Schotten-Baumann  acylalion  conditions.  After 2  h,  
the toluene phase was separated  and dried (Na2S04) and the solvent 
was evaporated olTto yield a snow-white, crystalline product.  Yield  
5.18 g  (84%), mp  151-153 °C  (n-hexane);  'H  nmr  (deuleriochloro-
form): 61.19 (3H, t, J = 7.1  Hz, COOCH2-C//j),  3.23 (1H, dd, J = 
8 . 6 , 1 6 . 4  Hz ,  3 -H) ,  3.41  (1H,  dd ,  J  =  5.8,  16.4 Hz ,  3 - H ) ,  3 .70  (1H,  
ddd,  J  = 5.8,  8.3 H z , 2 - H ) , 4 .03 -4 .15  (2H, m ,  COOCTF 2 -CH 3 ) ,  6 .05  
(1H,  l,  J  =  8.6 Hz,  1-H), 6.97  (1H,  d,  J  =  9.1  Hz, 4'-H),  7.18-7.25  
(2H,  m,  3 ' -H,  5 ' -H) , 7 .33-7 .53  ( 4 H ,  m ,  4 - H ,  5 - H , 6 - H ,  7-H) ,  7.73-
7.80  (2H,  m,  2'-H,  6'-H);  13C  nmr  (deuteriochloroform):  6  14.3,  
34.8,  48 .0 ,  55 .6 ,  61 .2 ,  124.7,  125.0 ,  127.2,  127.6,  128.7,  128.8,  
131.9,  134.5,  141.1,  1 4 1 . 7 , 1 6 7 . 1 , 1 7 3 . 9 .  
Anal.  Calcd. for C 1 9 H , 9 N 0 3  (309.37):  C,  73.77;  H, 6.19;  N,  
4.53. Found: C, 73.47; H, 6.31; N,  4.71%.  
General Procedure for Amino Alcohols 4-6. 
To a  slurry  of  LiAlH4  (1.7  g, 45  mmol)  in  50  mL  of  dry  THF,  
amino ester  1 or 2  (3.07 g,  15 mmol)  or N-benzoy!  amino  ester  3  
(4.64  g,  15 mmol)  in 20 mL  of THF was  added  dropwise  at 0  °C.  
After  stiiring  and  refluxing for  4  h  (the  end  of  the  reduction  was  
detected  by  means  of TLC),  the  mixture  was  decomposed  with  2  
mL of water under ice cooling. The inorganic material  was filtered 
off and washed with THF. After drying and evaporation,  the result-
ing  oils  were  crystallized  from  n-hexane  and  recrystallized  from  
diisopropyl  ether.  
cis-1 -Amino-2-hydroxymethylindane  (4).  
Compound  4  was  obtained  in  67  % yield  (1.63  g), mp  83-84  
°C, lit. mp [25]: 81-83 °C;  >H nmr (deuteriochloroform):  6 2.67-
2.97  (3H,  m,  2-H,  2  x  3-H),  3.72-3.85  (2H,  m,  CH2-OH),  4.59  
(1H, d, J = 7.1 Hz,  1-H), 7.17-7.24  (3H, m, 4-H, 5-H, 6-H), 7.28-
7.34  (1H, m,  7-H);  I 3 C nmr  (deuteriochloroform);  6  33.3,  44.3,  
58.6,63.7,124.0,125.2,127.1,  128.2,141.8,146.1.  
Anal.  Calcd.  for C ] 0H 1 3NO  (163.22):  C,  73.59;  H,  8.03;  N,  
8.58. Found: C, 73.42; H, 8.21; N,  8.72%.  
trans-1 -Amino-2-hydroxymethy lindane (5). 
Compound  5  was  obtained  in  65%  yield  (1.59  g),  mp  92-93  
°C;  'H  nmr  (deuteriochloroform):  6  2.27-2.39  (1H,  m,  2-H),  
2.52-2.58  (1H,  m,  3-H),  2.94  (1H,  dd,  J  =  8.1,  15.6  Hz,  3-H),  
3.88-4.00 (2H, m, CH2-OH),  4.17 (1H, d, J = 8.8 Hz,  1-H), 7.17-
7.28 (4H, m, 4-H, 5-H, 6-H, 7-H); I 3C nmr  (deuteriochloroform):  
6  33.1,52.7,61.8,66.4,122.9,124.9,126.9,127.6,141.7,146.9.  
Anal.  Calcd.  for C, 0H 1 3NO  (163.22):  C,  73.59;  H,  8.03;  N,  
8.58. Found: C, 73.51; H, 8.11; N,  8.61%.  
cis-1 -Benzy lamino-2-hydroxymelhy lindane (6).  
Compound  6 was  obtained  in  55%  yield  (2.09 g), mp  45-48  
°C;  'H  nmr  (deuteriochloroform):  6  2.68-2.78  (1H,  m,  2-H),  
2.87  (2H,  d,  J  =  7.6 Hz,  2  x  3-H),  3.80  (1H, dd,  J  =  7.6,  11.6  
Hz,  CH2-OH),  3.89  (1H, dd,  J  = 4.3,  11.6 Hz, CH2-OH),  4.00  
(2H, d,  J  =  2.8  Hz, NH-CH2-Ph),  4.34  (1H, d,  J  =  7.1  Hz,  1-H),  
7.17-7.30  (5H,  m,  Ph),  7.31-7.38  (4H,  m,  4-H,  5-H,  6-H,  7-H);  
13C nmr (deuteriochloroform): 6  33.5,44.4,52.9,63.6,65.0,124.2,  
125.5,126.8,127.8,128.3,  128.7,128.9,139.4,143.3,144.2.  
Anal.  Calcd.  for C 1 7H, 9NO  (253.35):  C,  80.60;  H,  7.56;  N,  
5.53. Found: C, 80.52; H, 7.31; N,  5.61%. 
General  Procedure for the Synthesis  of  1,3-Oxazine-2-thiones  7  
and 8.  
Amino alcohol  4  (0.51  g,  3.16 mmol) or  6 (0.8 g, 3.16 mmol) 
in  a solution  (2 mL) of  potassium  hydroxide (0.22 g) was cooled 
to 0 °C, carbon disulfide (0.26 g)  in dioxane (1.6 mL) was added 
and the mixture was stirred for 5 min. Potassium hydroxide  (0.11  
g)  in  water  (2  mL)  and  then  an  aqueous  solution  (6  mL)  of  
lead(II) nitrate  (1.1  g) were added, followed  by  stirring  at 60 °C 
for  10 min. The precipitated  lead sulfide was filtered off, washed 
with  hot  water  and  extracted  with  hot ethanol. The aqueous fil-
trate and  the ethanolic extracts were combined  and evaporated  to  
dryness.  The  crystalline  product  was  recrystallized  from  diiso-
propyl ether-ethyl  acetate.  
e/s-4,4a,5,9b-Tetrahydro-7//-indano[ 1,2-d][ 1,3]oxazine-2-thione (7). 
Compound  7  was obtained  in 62%  yield  (0.4  g),  mp  160-161  
°C;  'H  nmr (deuteriochloroform):  6  2.81  (1H, d, J =  16.1 Hz, 5-
H), 2.96-3.07 (1H, m, 4a-H), 3.21 (1H, q, J = 7.8 Hz, 5-H), 3.88-
3.98 (1H, m, 4-H), 4.41 (1H, dd, J = 4.8,11.3 Hz, 4-H), 4.93 (1H, 
d, J = 7.1 Hz, 9b-H), 7.20-7.30 (3H, m, 6-H, 7-H, 8-H), 7.42-7.48 
(1H, m, 9-H);  I 3C  nmr (deuteriochloroform):  6 32.9,  33.9,  58.9,  
68.7,125.1,125.7,127.9,129.2,139.9,140.5,187.8. 
Anal.  Calcd. for C , , H n N O S  (205.28):  C,  64.36;  H,  5.40;  N,  
6.82. Found: C, 63.42; H, 5.51; N,  6.69%.  
cis-l-Benzyl-4,4a,5,9b-tetrahydro-2-thioxo-7//-indano[l,2-d]-
[l,3]oxazine  (8).  
Compound  8  was obtained  in 56% yield  (0.52 g), mp  133-137  
°C;  'H  nmr (deuteriochloroform):  6  2.81-2.94  (2H, m, 4a-H, 5-
H), 2.97-3.07 (1H, m, 5-H), 3.85 (1H, dd, J = 7.8,11.6 Hz. 4-H), 
3.93-4.01 (2H, m, 4-H, N-CH2-Ph), 4.08 (1H, d, J  =  12.8 Hz, N-
CW2-Ph), 4.67 (1H, d, J = 6.3 Hz, 9b-H), 7.20-7.40 (8H, m, Ph, 6-
H, 7-H,  8-H), 7.48  (1H,  d,  J  =  7.6  Hz,  9-H);  I 3C  nmr  (deuteri-
ochloroform): 6  33.3,43.6,49.5,60.6,63.7,125.9,126.6,127.5,  
129.4,129.5,129.9,130.5,131.0,135.7,144.6,150.2. 
Anal.  Calcd. for C l g H, 7 NOS  (295.41):  C, 73.19; H,  5.80;  N,  
4.74. Found; C, 73.32; H, 5.59; N, 4.85%. 
cis-2-(4-Chlorophenyl)-4,4a,5,9b-tetrahydroindano[l,2-d|[l,3> 
oxazine (9). 
Amino alcohol  4 (0.17 g,  1.02 mmol)  and ethyl p-chlorobenz-
imidate (0.19 g,  1.02 mmol)  were dissolved  in toluene (20  mL),  
one drop of ethanol  saturated  with  hydrogen  chloride was  added  
and  the mixture  was refluxed. The progress  of  the reaction  was  
monitored by TLC. After the reaction  was complete (6-8 h),  the  
mixture was evaporated  to dryness  and the residue was  recrystal-
lized from diethyl ether.  Yield 0.16 g (57%), mp  130-133 °C;  'H  
nmr (deuteriochloroform): 6 2.67 (1H, dd, J = 2.0,16.1  Hz, 5-H), 
2.82-2.91  (1H,  m, 4a-H),  3.20  (1H, dd,  J  =  7.6,  16.1  Hz, 5-H), 
3.70 (1H, t, J  =  10.6 Hz, 4-H), 4.30 (1H, dd, J = 5.5,10.8  Hz, 4-
H), 5.09 (1H, d, J = 6.6 Hz, 9b-H), 7.18-7.26 (3H, m, 6-H, 7-H, 8-
H), 7.33 (2H, d, J = 8.6 Hz, 3'-H, 5'-H), 7.58 (1H, d, J = 6.8 Hz, 9-
H), 7.90 (2H, d, J = 8.6 Hz, 2'-H, 6'-H);  13C nmr  (deuteriochloro-
form): 6 33.6,34.6,60.2,  65.9,125.5,125.9,127.5,128.1,128.6,  
129.2,132.4,136.6,139.3,146.1,155.8 
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Anal.  Calcd. for C17H14C1N0 (283.76): C, 71.96; H, 4.91; CI, 
12.49; N, 4.94. Found: C, 72.12; H, 5.13; CI,  12.41; N, 4.78%. 
General Synthesis for Thioureas  10 and  11.  
• 
Amino alcohol 4  (0.81  g, 5 mmol) or 6 (1.25 g, 5 mmol)  was  
dissolved  in dry diethyl ether (20 mL) and  a  10% excess of  ethyl  
isothiocyanate  was  added  (0.47 g, 5.5  mmol). The mixture  was  
allowed  to stand for 24 h at room temperature. After evaporation, 
the  resulting  crystalline  thiourea  adducts  were  recrystallyzed  
from diisopropyl  ether.  
cis-1 -Ethyl-3-(2-hydroxymethylindan-1 -yl)-lhiourea  (10).  
Compound  10 was obtained  in 85% yield (1.06 g), mp  164-166  
°C;  'H  nmr (deuteriochloroform): 5  1.22 (3H, t, J = 7.3 Hz, NH-
CH 2 -CW j ) ,  2.67  (1H, q,  J  =  8.3, 3-H) , 2.81  (1H, dd,  J  =  6 . 8 , 1 3 . 4  
Hz,  2-H),  2.95  (1H,  q,  J  =  7.8  Hz ,  3 -H) ,  3 .35  (2H,  bs,  NH-CTFR  
CH3), 3.70 (2H, d, J = 6.3 Hz, CFF2-OH), 5.95 (IH, d, J = 6.0 Hz, 
1-H),  7.18-7.25 (3H, m, 4-H, 5 -H , 6 -H) , 7.39 ( I H ,  d,  J  =  6.8  Hz,  
7-H);  l3C  nmr  (deuteriochloroform):  6  14.2,  33.5,  38.8,  46.3,  
61.4,  62.6,  1 2 5 . 1 , 1 2 5 . 4 , 1 2 7 . 5 , 1 2 8 . 9 , 1 4 1 . 0 , 1 4 3 . 5 ,  184.1.  
Anal.  Calcd. for C,3H I8N2OS  (250.37):  C, 62.37; H, 7.25; N, 
11.19. Found: C, 62.22; H, 7.11; N,  11.25%.  
cis-i  -Benzyl-3-elhyl-l -(2-hydroxymethylindan-l  -yl)-thiourea 
(11). 
Compound  11 was obtained  in 88% yield (1.49 g), mp  119-120  
°C; 'H  nmr (deuteriochloroform): 6 0.94 (3H, t, J = 7.3 Hz, NH-
CH2-CW3), 2.66 (IH, dd, J = 13.9,19.1 Hz, 3-H), 2.94-3.09 (2H,  
m, 2-H, 3-H), 3.42-3.67  (3H, m, NH-C//2-CH3,  CH2-OH),  3.75  
(IH, dd, J = 2.8,  11.6 Hz, CW2-OH), 4.09 (IH, d, J =  15.6 Hz, N-
C//2-Ph), 4.28 (IH, d, J =  16.9 Hz, N-CH2-Ph), 5.57 (IH, s, 1-H), 
6.94-7.39  (9H,  m, 4-H,  5-H, 6-H, 7-H,  Ph);  13C  nmr  (deuteri-
ochloroform): 6  14.2,  35.1,  41.5,  47.8,  50.3,  62.4,  66.7,  125.2,  
126.2,  127.0,128.1,2  x 129.0,129.2,134.9,140.6,  144.3,183.0.  
Anal.  Calcd. for C20H24N2OS  (340.49):  C, 70.55; H, 7.10; N, 
8.23. Found: C, 70.29; H, 7.31; N,  8.45%. 
General  Procedure for 2-Ethyliminooxazines  12 and  13.  
Thiourea  compound  10 (0.45  g,  1.8 mmol)  or  11 (0.61 g,  1.8  
mmol) was suspended in methanol (10 mL) and methyl iodide (1 
mL)  was  added.  After stirring  at room  temperature  for  2 h,  the  
reaction  mixture  was evaporated  and  the product  was  dissolved  
in 20 mL of dry THP. This solution was added dropwise to a sus-
pension (55-65% oily dispersion) of NaH (0.7 g,) in 30 mL of dry 
THP under  nitrogen. The reaction  mixture was heated  on  an oil  
bath  (60 °C) for 5 h, until no starting material  could be  observed 
by TLC. A few drops of  water were carefully added to the reac-
tion  mixture  in order to decompose the excess  sodium  hydride,  
and  the solvent  was evaporated  off. Ice-cold  water (25 mL) was 
added  to the residue,  which  was then  extracted  with  chloroform 
(3 x 40 mL). The organic  phase was dried  over Na2S04  and  the  
solvent  was  evaporated  o f f .  The  residue  was  crystallized  from  
diethyl ether and recrystallized  from n-hexane. 
c/j-2-Ethylimino-4,4a,5,9b-tetrahydro-l H-indano[l ,2-a][l ,3]-
oxazine (12). 
Compound  12 was obtained  in 53% yield  (0.22 g), mp 60-63 
°C;  'H  nmr (deuteriochloroform):  6  1.13 (3H,  I, J  =  7.1  Hz,  N-
CH2-Cff3), 2.58 (IH, dd, J = 2.0,  15.9 Hz, 4a-H), 2.72-2.82 (IH, 
m, 5-H), 3.09-3.25 (3H,  m, 5-H, 2 x 4-H),  3.60 (IH,  t, J  =  10.3  
Hz, N-CH2-CH3),  4.07 (IH, dd, J  = 5.3,  10.3 Hz,  N-CH2-CH3),  
4.88 (IH, d, J = 6.8 Hz, 9b-H), 7.16-7.25 (3H, m, 6-H, 7-H, 8-H), 
7.52 (IH,  d,  J  = 7.3  Hz, 9-H);  13C nmr (deuteriochloroform):  6  
15.3,  33.3,  35.3,  36.4,  59.4,  66.0,  125.2,  125.5,  127.2,  127.4,  
139.6,146.3,152.4. 
Anal.  Calcd.  for C1 3H,6N20  (216.29):  C,  72.19;  H, 7.46; N, 
12.95. Found: C, 72.27; H, 7.61; N,  12.75%.  
c/s-l-Benzyl-2-ethylimino-4,4a,5,9b-tetrahydro-l 7iindano[ 1,2-4-
[l,3]oxazine (13). 
Compound  13 was obtained  in 55%  yield  (0.30 g), mp 77-81 
°C;  'H  nmr (deuteriochloroform):  6 0.98 (3H,  t, J  =  7.1  Hz,  N-
CH2-C7/3), 3.00-3.22 (5H, m, 2 x 4-H, 4a-H, 2 x 5-H), 4.08 (IH, 
dd, J = 2.5,  10.8 Hz, N-C//2-CH3),  4.23 (IH,  d, J =  15.6 Hz, N-
CH2-Ph), 4.36 (IH, dd, J = 3.0,10.8 Hz, N-Cff2-CH3), 4.70 (IH, 
d, J = 8.8 Hz, N-CH2-Ph), 5.24 (IH, d, J =  15.4 Hz, 9b-H), 7.13-
7.25  (3H, m, 6-H, 7-H,  8-H), 7.27-7.45  (6H,  m, 9-H,  Ph),  13C  
nmr  (deuteriochloroform):  6  17.0,  34.6,  38.7,  39.9,  50.8,  61.0,  
67.3,  125.3,  125.6,  126.8,  127.3,  128.3,  128.6,  128.8,  138.3,  
141.6,142.8,152.4. 
Anal.  Calcd. for C20H22N2O  (306.48):  C. 78.40;  H, 7.24;  N,  
9.14. Found: C, 78.52; H, 7.52; N, 9.35%. 
c(>2-Ethylimino-4,4a,5,9b-tetrahydro-1 Windanof 1,2-411,3]thi-
azine (14). 
Thiourea  10 (0.63 g, 2.5 mmol) was refluxed for  1  h in ethanol 
(25 mL) containing  10% dry hydrogen chloride. The solvent was 
evaporated  off, and the residue was neutralized  with  10% aque-
ous  sodium  carbonate  and  extracted  with  chloroform  (3  x  30  
mL).  After  drying  and  evaporation  off  the  organic  solution,  a  
crystalline product  was obtained,  which was recrystallized from 
methanol-diisopropyl  ether.  Yield 0.35  g (60%),  mp  82-84  °C;  
•H nmr (deuteriochloroform): 6  1.17 (3H, t, J = 7.3 Hz,  N-CH2-
C f f j ) 2.69-2.81  (4H, m, 4-H, 4a-H, 2 x 5-H), 3.17-3.45 (3H, m, 
4-H, N-Cff2-CH3), 5.14 (IH, d, J = 6.3 Hz, 9b-H), 7.16-7.24 (3H, 
m,  6-H,  7-H,  8-H),  7.50  (IH,  d,  J  =  7.1  Hz,  9-H),  13C  nmr  
Table  3  
Physical Data on Compounds  15a-g  
Comp. M.p. Yield Formula M.W. 6N=CHAr 6N-CHAr-N 6N-CHAr-N 
<°C) (%) chain  (A)  ring  (B)  ring  (C)  
15a 113-115 61 C , 7 H l 6 N 2 0 3 296.33 8.53 5.25 5.10 
15b oil -100 C n H 1 6 B r N O 330.23 8.37 5.14 4.99 
15c 71-74 51 C 1 7H ) 6C1N0 285.78 8.39 5.14 4.70 
15d 83-87 58 C , 7 H ) 7 N 0 251.33 8.45 5.18 5.03 
15e 73-76 52 C 1 8 H I 9 NO 265.36 8.39 5.14 4.99 
15f 103-106 50 C, 8H 1 9NO 2 281.36 8.37 5.13 4.98 
15g 129-133 62 C1 9H2 2N2O 294.40 8.30 5.05 4.90 
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(deuteriochloroform); 6  15.1, 29.0, 36.0, 37.3, 37.4, 63.3,  125.0,  
125.3,126.9,127.4,139.6,146.1,148.5. 
Anal. Calcd.  For C13H,6N2S  (232.35):  C,  67.20;  H,  6.94;  N,  
12.06. Found: C, 67.37; H, 7.01; N,  12.22%.  
General  Procedure  for  the  Reactions  of  Amino  Alcohols  with  
Aromatic Aldehydes to form 15a-g,  16,17a-c.  
To a solution of  the appropriate amino alcohol 4-6 (1.2 mmol) 
in 20 mL of  absolute methanol,  an equivalent amount of aromatic 
aldehyde was added (liquid aldehydes were freshly distilled), and 
the  mixture  was  allowed  to  stand  at  ambient  temperature  for 1 
day. The solvent  was then evaporated off and  the evaporation  was  
repeated  after the addition  of  10 mL of benzene. The  crystalline  
products  were  collected  by  filtration  and  recrystallized  from  
diisopropyl  ether-ethyl  acetate. The oily  product  15b  was  dried  
in a vacuum desiccator for 24 h. 
trans-1 -(4-Nitrobenzylideneamino)indane-2-methanol  (16).  
Compound  16 was obtained  in 60% yield (0.21 g), mp  133-134  
°C;  'H  nmr (deuteriochloroform): 6 2.83-2.92 (2H, m, 2 x 3-H), 
3.20-3.31  (1H, m, 2-H), 3.78-3.88  (2H, m, Ctf2-OH), 4.88  (1H,  
d, J = 6.3 Hz,  1 -H), 7.02 (1H, d, J = 7.6 Hz, 4-H), 7.17-7.32 (3H, 
m, 5-H, 6-H, 7-H), 7.97 (2H, d, J = 8.8 Hz, 2'-H, 6'-H), 8.27 (2H, 
d J = 8.6 Hz, 3'-H, 5'-H), 8.55 (1H, s, N =CH)\ 13C nmr (deuterio-
chloroform): 5 34.3, 50.1,64.3, 77.4,  124.0,  124.5,125.3,  126.9,  
128.3,129.3,141.7,142.5,143.0,149.3,  159.3.  
Anal.  Calcd. For C1 7H1 6N203  (296.33): C, 68.91; H, 5.44; N, 
9.45. Found: C, 68.67; H, 5.21; N,  9.22%. 
(2R*,4aS*,9hS*)-1 -Benzyl-2-(4-nitropheny 1)-1,2,4,4a,5,9b-hexa-
hydroindanoL 1,2-4 [ 1,3]oxazine (17 a). 
Compound  17a  was obtained  in 67% yield  (0.31  g), mp  164-
166 °C; 'H nmr (deuteriochloroform): 5 2.36 (1H, d, J =  15.9 Hz, 
4a-H), 2.84 (1H, dd, J = 6.0,15.6 Hz, 5-H), 3.00-3.09 (1H, m, 5-
H), 3.48 (1H, t, J =  11.6 Hz, N-CH rPh),  3.68 (1H, d, J =  14.6 Hz, 
4-H), 3.86 (1H, d, J =  14.6 Hz, 4-H), 4.26 (1H, dd, J = 7.1,  11.6  
Hz, N-CW2-Ph), 4.49 (1H, d, J = 6.0 Hz, 9b-H), 5.49 (1H, s, 2-H), 
7.17-7.24  (3H, m,  6-H, 7-H, 8-H), 7.26-7.34  (3H, m, 9-H,  Ph),  
7.40 (2H, d, J  = 7.6  Hz, Ph),  7.62 (1H, d,  J  = 7.6 Hz,  Ph),  7.77  
(2H, d, J = 8.56 Hz, 2'-H, 6'-H), 8.21 (2H, d, J = 8.8 Hz, 3'-H, 5'-
H);  l3C nmr (deuteriochloroform): 6  30.3,33.2,50.8,64.5,69.9,  
87.1,  123.6,  124.2,  126.0,  127.3,  127.4,  127.5,  128.0,  128.1,  
128.6,  129.6,141.7,142.0,147.1,147.7.  
Anal. Calcd. For C2 4H2 2N203  (386.45): C, 74.59; H, 5.74; N, 
7.25. Found: C, 74.71; H, 5.62; N, 7.42%. 
(2R*,4aS*,9hS*)-1 -Benzyl-2-phenyl-1,2,4,4a,5,9b-hexahydro-
indano[ 1,2-d][ 1,3]oxazine (17b). 
Compound  17b was obtained  in  54% yield  (0.22 g), mp  117-
119 °C; 'H nmr (deuteriochloroform): 6 2.33 (1H, d, J =  15.9 Hz, 
4a-H), 2.81 (1H, dd, J = 6.6,16.1  Hz, 5-H), 2.97-3.07 (1H, m, 5-
H), 3.46 (IH,  t, J =  11.6 Hz, N-C// rPh),  3.81 (1H, d, J =  14.6 Hz, 
4-H), 3.86 (1H, d, J =  15.1 Hz, 4-H), 4.23 (1H, dd, J = 7.6,  11.8  
Hz, N-Ctf2-Ph), 4.45 (1H, d, J = 6.3 Hz, 9b-H), 5.45 (1H, s, 2-H), 
7.14-7.38  (9H, m, 6-H, 7-H, 8-H, 9-H, Ph), 7.43 (2H, d, J =  8.1  
Hz, 3'-H, 5'-H), 7.56 (2H, d, J  = 7.6 Hz, 2'-H, 6'-H), 7.63 (1H, d, 
J  =  7.3  Hz, 4'-H);  >3C nmr (deuteriochloroform):  5  30.4,  33.2,  
50.5, 64.3, 69.9, 87.8,  124.4,  125.8,  126.4,  126.9,  127.2,  127.6,  
127.7,128.2,128.4,128.5,139.7,140.5,141.7,142.6. 
Anal.  Calcd.  For C24H23NO  (341.46):  C,  84.42;  H,  6.79;  N,  
4.10. Found: C, 84.37; H, 6.91; N, 4.22%. 
(2rtMaS*,9bS*)-l-Benzyl-2(4-dimethylaminophenyl)-
l,2,4,4a,5,9b-hexahydroindano[l,2-<fl[I,3]oxazin  (17c).  
Compound  17c was  obtained  in  59%  yield  (0.27  g),  mp 205-
207 °C;  1H nmr (deuteriochloroform): Ö 2.32 (1H, d, J =  15.6 Hz, 
4a-H), 2.80 (1H, dd, J  = 6.6,  17.1 Hz, 5-H), 2.92 (6H, s, NAfe2) 
2.97-3.03 (1H, m,5-H),  3.45 (1H. t, J =  11.6 Hz, N-CW2-Ph), 3.78 
(1H, d, J =  14.9 Hz, 4-H), 3.94 (1H, d, J =  14.9 Hz, 4-H), 4.20 (IH, 
dd, J =  6.6,  11.3 Hz, N-CH2-Ph),  4.43 (IH, d, J = 5.5 Hz, 9b-H), 
5.39(IH, s, 2-H),7.08-7.65 (13H, m, 6-H, 7-H, 8-H, 9-H,2'-H, 3'-
H,  5'-H,  6'-H,  Ph);  ' 3C  nmr  (deuteriochloroform):  6  30.6,  33.4,  
41.1,50.5, 64.4,70.0,  88.1,112.8,  124.6,125.9,2 x  127.0,127.3,  
127.7,128.4,128.6,  141.0,  141.9,  143.0,  149.3,  154.2.  
Anal.  Calcd.  For C2 6H2 gN20  (384.53):  C,  81.21; H, 7.34;  N,  
7.29. Found: C, 81.34; H, 7.05; N, 7.42%. 
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Facile Regio-  and Diastereoselective  Syntheses  of Hydroxylated 2-
Aminocyclohexanecarboxylic  acids  
Ferenc Fülöp*[a],  Márta  Palkó[a],  Enikő Forró[a],  Máté Dervarics[a],  Tamás  A.  
Martinek[a], 
Reijo  Sillanpaá'11  
Keywords: Amino  acids / Heterocycles  / Diastereoselectivity  /  Structure  elucidation  
By means  of total  regio-  and  diastereoselective  functionalizations of  cis-  and  trans-2-ammo-4-
cyclohexenecarboxylic  acid  derivatives  1,  9,  12  and  16,  isomers  of  2-amino-4-
hydroxycyclohexanecarboxylic  acid  8  and  11,  and  2-amino-5-hydroxycyclohexanecarboxylic  
acid  15  and  19  were  prepared  in  good  yields,  via  1,3-oxazine  or  y-lactone  intermediates.  The  
enantiomers  of  8  and  15  were  also  prepared  by  the  same  pathway,  resulting  in  the  products  
with  ee  >  99%.  The  structures,  stereochemistry  and  relative  configurations  of  the  synthetized  
compounds  were proved  by NMR,  using  some key vicinal  couplings  and characteristic  NOEs.  
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Introduction 
The  continuously  increasing  interest  in  cyclic  P-amino  acids11"31  is  mainly  connected  
with the importance  of the naturally-occurring  cispentacin,141  which  exerts  strong  anticandida  
activity.  A  further  feature  is  the  fact  that  Gellmaif s  group  recently  synthetized  and  
investigated151  ira«s-2-aminocyclopentane-  and  irans-2-aminocyclohexanecarboxylic  acid  
oligomers,  which  clearly  display  a  stable  helical  conformation.  We  have  found  that  by  
inversion of the relative configurations of the cis oligomers, the preferred conformation can be 
switched  from a helix to a single non-polar  strand.161 Cyclic  P-amino acids are widely  used as 
starting substances for the preparation  of heterocycles.  Through their incorporation  in place of 
an a-amino  acid  of a naturally-occurring pharmacologically  active peptide, the activity  or the 
effect can be modified and the stabilities  of the natural peptides  can be increased.  Changes of 
the  configuration and  differences in the ring  size allow modification of the conformations of 
the peptides. They are also applicable in combinatorial  syntheses.17"101  
In  recent  years,  a  number  of  new  syntheses  of  functionalized  derivatives  have  been  
reported  (see  e.g.  ref.  [11]).  Among  them,  hydroxy-substituted  P-amino  acids  are  of  
considerable  importance  because  of  their  occurrence  in  many biologically  active  compounds  
(e.g.  taxol  and  related  molecules).12'71  Our  present  aim  was  to  introduce  an  extra  hydroxy  
group at position 4 or 5 of the cyclohexane ring. For these syntheses, the readily available cis-
and  rmw-2-amino-4-cyclohexenecarboxylic  acids  were  used.  For  the  derivatization,  we  
considered  two  strategies:  cyclization  on  an acylamino  derivative  via  1,3-oxazine formation,  
or cyclization on a carboxylic acid function via lactone formatipn (iodolactonization  protocol).  
Results and  discussion  
The  starting  m-2-amino-4-cyclohexenecarboxylic  acid  was  prepared  by  hypochlorite-
mediated  Hoffman degradation  of  the  carboxamide  obtained  by  ammonolysis  of  cis-1,2,3,6-
tctrahydrophthalic  anhydride.1121  The amino acid was esterified in the presence  of ethanol  and 
thionyl  chloride  than  acylated  with  ieri-butoxy  pyrocarbonate,  acetic  anhydride  or  benzoyl  
chloride, resulting in N-acylated amino esters la-c,  respectively.  
With  N-iodo-  (NIS)  or  JV-bromosuccinimide  (NBS)  (for  a  related  transformation,  see  
e.g.  ref.  [13]),  the  N-Boc  derivative lc  gave  oxazinone  2,  while the  W-acetyl  and  N-benzoyl  
derivatives  la  and  lb  furnished  the  corresponding  methyl-  or  phenyl-substituted  oxazines  
5a,b  and  6a,b  regio-  and  diastereoselectively  (Scheme  1). Not  even traces  of  other  regio-  or  
diastereomers  were  observed  in  the  crude  product.  Iodooxazinone  2  and  bromooxazine  
- 3 -
derivatives  5a,b  and  6a,b  were  dehalogenated  with  tributyltin  hydride  under  an  argon  
atmosphere,  resulting  in compounds  3  and  7a,b,  respectively. Acidic hydrolysis of 3 gave the 
stable  oxazinonecarboxylic  acid  derivative  4,  which  slowly  decomposed  on  further  heating.  
Hydrolysis  of oxazines  7a,b  with  20% aqeous  HC1, and removal  of the  HC1 by  ion-exchange  
chromatography  led to the  all-cis  isomer  of  2-amino-4-hydroxycyclohexanecarboxylic  acid  8  
(Scheme  1).  
Insert  Scheme 1 
The  corresponding  DYWs-2-amino-4-cyclohexenecarboxylic  acid  was  prepared  by  
Hoffman  degradation  of  the  carboxamide  obtained  by  ammonolysis  of  trans-1,2,3,6-
tetrahydrophthalic  anhydride.  The  amino  acid  was  esterified,  and  subsequent  treatment  with  
acetic  anhydride  resulted  in  iV-acetylamino  ester  9.  By a similar transformation as for the  cis  
isomer  la,  the  ira/«-2-acetylamino-4-cyclohexenecarboxylic  acid  9  reacted  via  the  
iodooxazine  intermediate  10  to  furnish  the  corresponding  (r-1,7-2, f-4)-2-amino-4-
hydroxycyclohexanecarboxylic  acid  11 (Scheme 2). 
Insert Scheme 2 
Stereoselective  iodolactonization[71  was  the  key  step  in  the  synthesis  of  2-amino-5-
hydroxycyclohexanecarboxylic  acid.  The reactions  of //-benzoyl-  and //-Boc-protected  cis-2-
amino-4-cyclohexenecarboxylic  acid  12a,b  with  I2/KI  in  slightly  alkaline  medium  yielded  
iodolactones  13a,b  in  fairly  good  yields,  with  excellent  regio-  and  diastereoselectivity;  the  
products were reduced with tributyltin hydride to give lactones  14a,b. The acidic hydrolysis of 
benzoyl derivative  14a did not give the desired amino acid; instead, decomposition took place. 
When  the N-Boc  lactone  14b  was  hydrolysed  after ion exchange  chromatography,  the  all-cis  
isomer  of  2-amino-5-hydroxycyclohexanecarboxylic  acid  15  was  obtained  in  66%  yield  
(Scheme 3).  
Insert  Scheme 3 
By  a  similar  transformation,  from  frans-2-fer/-butoxycarbonylamino-4-
cyclohexenecarboxylic  acid  16 via iodolactone  17, the corresponding  (r-l,f-2,c-5)-2-amino-5-
hydroxycyclohexanecarboxylic  acid  19 was prepared (Scheme 4). 
Insert  Scheme 4 
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The  enantiomeric  cis  compounds  (+)-8  and  (-)-15  were  synthetized  from  rac-1-
azabicyclo[4.2.0]oct-3-en-8-one  by CAL-B treatment with one equivalent  of H2O in isopropyl 
ether,  as  described  earlier.[ 141 The  enantiopure  p-lactam  obtained  was transformed with  18%  
HC1 into  the  (1 S,2i?)-2-amino-4-cyclohexenecarboxylic  acid  hydrochloride.1-141  The  syntheses  
of  the  4-hydroxy-  and  5-hydroxyamino  acid  enantiomers  (+)-8  and  (-)-15  were  carried  out  
similarly  as  for the  racemic  compounds  given  in  Schemes  1 and  3, resulting  in the  products  
with ee > 99%. 
The given stereochemistry  and the relative configurations of the synthetized  compounds  were  
proved  by  using  some  key  vicinal  couplings  and  characteristic  NOEs.  For  8,  there  is  a  low  
V(H-l,H-2)  = 4.1 Hz and a high V(H-l,H-6ax) =13.6 Hz, demonstrating  an axial H-l  and an 
equatorial  H-2.  Unfortunately, the  coupling  pattern  of the H-4  signal  could  not  be  resolved,  
but H-3ax exhibits only a single large coupling of  12.6 Hz, stemming from the geminal H-3eq. 
This  suggests  an  equatorial  H-4,  which,  together  with  the  very  probable  chair  ring  
conformation, proves the relative  stereochemistry.  
For compound  11, H-2 has two large vicinal coupling constants (V=  10.8 and  12.1 Hz), 
indicating  its  diaxial  position  relative to H-3 ax  and H-l. Axial  H-4  is  supported  by the NOE 
interaction  observed  between H-4 and H-2, showing that the NH2 and the  OH are situated  on 
the same side of the ring. 
In  compound  15,  the  cis  orientation  of  the  equatorial  amino  and  the  axial  carboxyl  
group  can  readily  be  concluded  from  the  low  coupling  constants  observed  for H-2  and  the  
single  large  coupling  of  12.1  Hz for H-l.  The  axial  position  of  H-5  can  be  seen  from  the  
multiple  large  couplings  for H-6ax  (1.61  ppm).  The NOE  interaction  between  H-5  and  H-l  
reinforces the cis stereochemistry of the OH and the carboxyl groups. 
The two large couplings for H-2 point to its trans-diaxial  orientation relative to H-l  and  
H-3  in  19.  There  are  two  large  vicinal  couplings  for  H-5  too,  confirming  the  equatorial  
arrangement  of  the  OH  group.  The NOE  observed  between  H-5  and H-l  corroborates  their  
identical orientation relative to the ring. 
X-Ray diffraction studies  confirmed the  structure  of  15.  All  bonding parameters  are in 
the  usual  ranges.  The  molecular  structure  and  extensive  hydrogen  bonding  system  of  15  is  
presented in Figure  1.  
Insert Figure 1 
Experimental  Section  
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General  Procedures:  'H NMR  spectra  were  recorded  at 400 MHz  and  13C NMR  spectra  at  
100  MHz  in  CDCI3  or  in  DMSO-(D6),  at  ambient  temperature,  on  a  Bruker  AM  400  
spectrometer.  Chemical  shifts  are  given  in  8  (ppm)  relative  to  TMS  (CDCI3  or  DMSO)  as  
internal  standards.  Elemental  analyses  were performed with  a Perkin-Elmer  CHNS-2400  Ser  
II Elemental Analyzer. Melting points were measured on a Kofler melting point apparatus and 
are uncorrected. 
The ee values of the synthetized enantiomers were determined by gas chromatography (GC) on a 
Chromopak  Chiralsil-Dex  CB (CCD) or  Chirasil-L-Val  (CLV) columns. (lS,2£)-Ethyl  2-amino-
4-cyclohexenecarboxylate:  CCD  column,  after  derivatization  with  acetic  anhydride  in  the  
presence  of  4-dimethylaminopyridine  and  pyridine  [120  °C  for  2  min  —> 190  °C  (rate  of  
temperature  rise  10 °C/min;  100 kPa),  retention  time  (min):  10.86  (antipode:  10.77)];  (+)-la  
and  (+)-14b:  CCD column,  120  °C for 2 min -»  190  °C (rate  of temperature  rise  10  °C/min;  
100  kPa),  retention  times  (min)  (+)-la:  10.86  (antipode:  10.77),  (+)-14b:  17.48  (antipode:  
17.19);  (+)-l,2b:  CLV  column,  after derivatization  with diazomethane,  100  °C for  10 min  —*  
160 °C (rate of temperature  rise  10 °C/min; 45 kPa), retention time  (+)-12b: 26.61  (antipode:  
26.49).  The  ee  values  of  (+)-8  and  (-)-15  were  detennined  on  a  CCD  column  after  double  
derivatization  with  (/')  diazomethane;  (ii)  acetic  anhydride  in  the  presence  of  4-
dimethylaminopyridine  and pyridine  [120 °C for 2 min  —>  190 °C (rate of temperature  rise  10  
°C/min;  100  kPa),  retention  times  (min):  (+)-8:  20.17  (antipode:  19.59);  (-)-15:  18.34  
(antipode:  17.82)].  
Ethyl  ci£-2-(te/,/-butoxycarbonylamino)-4-cyclohexenecarboxylnte  (la):  Ethyl  cis-2-
amino-4-cyclohexenecarboxylate  hydrochloride  (2.04 g,  10 mmol) was dissolved  in a mixture 
of toluene  (25  mL) and  1 m NaOH  solution  (25 mL), and te/T-butoxypyr0carbonate (2.4 g,  11  
mmol)  was  them  added  with  stirring.  Stirring  was  continued  for  1 h,  after which the toluene 
layer  was  separated  off, and  the  aqueous  layer was  extracted  with  ethyl  acetate  (3 x  20  mL).  
The  combined  organic  phase  was  dried  (Na2S04)  and  evaporated.  The  residue  was  
recrystallized  from n-hexane—diisopropyl  ether:  a white  solid  (1.63 g,  61% yield), mp  70-72  
°C;  'H  NMR  (DMSO)  5  1.17  (t,  J=  7.0 Hz,  3H,  C#3CH2),  1.37  (s,  9H,  OtBu),  2.02  (d,  
J=  17.9 Hz,  1H, H-5),  2.13  (d, J=  17.9 Hz,  1H, H-2),  2.27  (d, J=  17.9 Hz,  1H, H-5),  2.41  
(d, J=  17.9 Hz,  1H, H-2), 2.74-2.80  (m,  1H, H-l),  3.94-4.11  (m, H-6, 3H, CH3C//2),  5.54  (d,  
J=  10.4 Hz,  1H, H-4), 5.61 (d,J=  10.4 Hz,  1H, H-3), 6.49 (d, J=  8.3 Hz,  1H, NH);  13C NMR 
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(DMSO)  <5  14.4,  24.1,  28.5,  30.7,  41.4,  46.1,  60.1,  78.0,  124.4,  125.4,  155.4,  172.9.  Anal.  
Calcd. for C14H23NO4 (269.35): C, 62.43; H, 8.61; N, 5.20. Found: C, 62.84; H, 8.32; N, 5.55. 
Ethyl  cis-2-acetylamino-4-cyclohexenecarboxylate  (lb):  To  a  suspension  of  ethyl  cis-2-
amino-4-cyclohexenecarboxylate  hydrochloride  (2.04  g,  10  mmol)  in  toluene  (40  mL),  
triethylamine  (2.04  g,  20 mmol)  and  acetyl  chloride  (0.94  g,  12 mmol)  were  added,  and the  
mixture  was  stirred  at  room  temperature  for  2  h,  and  washed  with  water ( 2 x 1 0  mL).  The  
aqueous  layer  was  extracted  with  n-hexane  (3  x  20  mL).  The  combined  organic  phase  was  
dried  (Na2S04)  and  evaporated.  The  residue  was  recrystallized  from  «-hexane—diisopropyl  
ether: a white solid (1.15 g, 55% yield), mp 64-67 °C; 'H NMR (DMSO) <51.14 (t, J =  7.0 Hz, 
3H, C//3CH2),  1.77 (s, 3H, COCH3), 2.00 (d, J=  17.6 Hz,  1H, H-5), 2.15 (d, J=  18.6 Hz,  1H,  
H-2),  2.27  (d, J =  17.6 Hz,  1H, H-5),  2.71-2.76  (m,  1H, H-2),  4.28-4.34  (m,  1H, H-6),  5.56  
(d,  J=  10.3 Hz,  1H,  H-4),  5.64  (d,  J=  10.3 Hz,  1H,  H-3),  7.59  (d,  J=  7.6 Hz,  1H,  NH);  
13CNMR  (DMSO) 8  14.9, 23.4, 24.6, 31.1, 41.8,44.8, 60.6,125.9,125.1,  169.8,173.4. Anal. 
Calcd. for CnH17N03 (211.26): C, 62.54; H, 8.11; N, 6.63. Found: C, 62.24; H, 7.82; N, 6.48. 
Ethyl  cis-2-benzoyIamino-4-cyclohexenecarboxyIate  (lc):  Ethyl  cw-2-amino-4-cyclo-
hexenecarboxylate  hydrochloride  (2.04  g,  10  mmol)  was  benzoylated  according  to  the  
Schotten-Baumann  method.  After separation,  drying  and  evaporation  of the toluene  layer, an 
almost white crystalline product was obtained. After recrystallization from w-hexane—EtOAc,  
a white crystalline product,  1.76 g (65%), was obtained. Mp  105-106 °C; 'H NMR (DMSO) 8 
1.13 (t, J=  7.0 Hz,  3H,  C//3CH2), 2.30-2.40  (m,  3H, H-2, H-5),  2.47 (s,  1H, H-2),  2.93-2.99 
(m,  1H, H-l),  3.97-4.1  (m,  2H,  CH3C//2),  4.43-4.50  (m,  1H, H-6),  5.65  (q, .7=9.8 Hz,  2H,  
H-3, H-4),  7.44  (t, J=  7.3 Hz, 2H, w-Ph), 7.52 (t, J=  7.3 Hz,  1H, p-Ph),  7.78 (d, J  = 7.3 Hz, 
2H,  o-Ph),  8.00  (d, .7=7.5 Hz,  1H, NH);  13CNMR  (DMSO)  8  14.4,  25.1,  29.5,  41.3,  45.6,  
60.2,  124.8,  125.3,  127.8,  128.4,  131.4,  135.1,  166.7,  173.0.  Anal.  Calcd.  for  C,6Hi9N03  
(273.34): C, 70.31; H,7.01; N, 5.12. Found: C, 70.44; H, 7.27; N, 5.48. 
Ethyl  t/*fliii-2-acetylamino-4-cyclohexenecarboxylate  (9):  Starting  from  ethyl  trans-2-
amino-4-cyclohexenecarboxylate  hydrochloride, the procedure  described for lb  was followed 
to  prepare  9:  yield  58%, white  solid, mp  68-69  °C;  'H NMR  (DMSO)  <5  1.16 (t, J =  7.0 Hz, 
3H,  C773CH2),  1.76  (s,  3H,  COCH3),  1.87-1.98  (m,  1H, H-5),  2.19  (dt, J=  17.1, 4.3 Hz,  1H,  
H-5),  2.25-2.29  (m,  2H,  H-2,  H-l),  2.55  (dt,  .7=10.1,  7.5 Hz,  1H,  H-2),  4.11-4.19  (m,  
CH3C772,  3H,  H-6),  5.56-5.66  (m,  2H,  H-3,  H-4),  7.85  (d,  .7= 8.3 Hz,  1H,  NT/);  13CNMR  
(DMSO) 8  14.4, 23.0,27.6, 31.1,44.6,45.9,  60.2, 125.2,125.1,  168.7,173.6. Anal. Calcd. for 
C11H17NO3 (211.26): C, 62.54; H, 8.11; N, 6.63. Found: C, 62.63; H, 8.42; N, 6.91. 
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General procedure for the synthesis of iodo- and bromooxazines (2,5a,b, 6a,b and 10): A 
solution  of  Af-acylamino  ester  la-c  or  9  (3  mmol)  in  CH2CI2  (40  mL)  was  treated  with  
equivalent  of  NIS  or  NBS,  and  the  reaction  mixture  was  stirred  for  14  h  at  rt.  When  the  
reaction  was  completed  (monitored  by  TLC),  the  mixture  was  treated  with  10%  aqueous  
NaOH  solution  (3  x  20  mL).  The  aqueous  solution  was  extracted  with  CH2CI2  (3 x  40  mL),  
and  the  combined  organic  layer  was  dried  (Na2S04)  and  evaporated.  The  residue  was  
recrystallized from «-hexane-diisopropyl  ether.  
2:  Yield  80%,  a  white  crystalline  solid,  mp  199-201  °C;  'H  NMR  (DMSO)  8  1.21  (t,  
J =  7.0 Hz,  3H,  C//3CH2),  1.95  (ddt, J =  1.8,  14.1,  4.0 Hz,  1H,  H-9eq),  2.00-2.16  (m,  2H,  
H-7),  2.55 (d, J =  14.1 Hz,  1H, H-9ax), 2.85 (ddd, J =  1.5, 5.5,  11.1 Hz,  1H, H-6),  3.81 (br s, 
1H, H-5), 4.01-4.16  (m, 2H, CH3C//2),  4.58-4.63  (m,  1H, H-l),  4.73-4.79  (m,  1H, H-8), 7.69 
(d, J =  5.0 Hz,  1H, H-4);  ,3C NMR  (DMSO)  <5  14.3,  25.3,  28.1,  28.7,  43.1,  46.6,  60.9,  75.4,  
152.6,  171.6.  Anal.  Calcd.  for  C10H14INO4  (339.13):  C,  35.42;  H,  4.16; N,  4,13.  Found:  C,  
35.13; H, 4.27; N, 3.98. 
5a: This compound was very sensitive to air, and was used in the dehalogenation  step without 
further purification. 
5b:  Yield  80%,  a  white  crystalline  solid,  mp  113-114  °C;  ]H  NMR  (DMSO)  ¿1.21  (t,  
J =  7.05 Hz,  3H,  C//3CH2),  1.83-1.96 (m, 2H, H-7, H-9),  2.04  (d, J =  3.2 Hz,  1H, H-7),  2.62 
(dt, J=  14.1,  1.3 Hz,  1H, H-9), 3.04 (ddd, J=  3.0,4.0,  12.3 Hz,  1H, H-6), 4.12 (q, J=  7.3 Hz, 
2H,  CH3C772), 4.16-4.20 (m,  1H, H-6), 4.74-4.78  (m,  1H, H-l), 4.85-4.89 (m,  1H, H-8), 7.41 
(t,  .7=7.8 Hz,  2H,  m-Ph),  7.48  (t,  .7= 7.0 Hz,  1H, p-Ph),  7.81  (d,  .7=8.1 Hz,  2H,  o-Ph);  
13C NMR (DMSO) 8  14.4, 24.4, 29.0, 29.3, 42.9,48.8,  60.6, 73.3,  127.2,  128.5,  131.2,132.8,  
155.9,  172.0.  Anal.  Calcd  for  C I 6 H I 8 I N 0 3  (399.23):  C ,  48.14;  H,  4.54; N,  3.51.  Found:  C ,  
47.89; H, 4.32; N, 3.87. 
6a:  Yield  83%,  a  white  crystalline  solid,  mp  68-69  °C;  JH  NMR  (DMSO)  8  1.22  (3H,  t,  
J=  7.0 Hz, C/73CH2),  1.70 (ddt, J=  1.5,13.8,4.0 Hz,  1H, H-9),  1.86 (s, 3H, Me-3),  1.99-2.05  
(m, 2H, H-7), 2.35  (dt, J=  13.8,  1.5 Hz,  1H, H-9), 2.93 (ddd, J=  2.8, 6.0,  10.3 Hz,  1H, H-6), 
3.89-3.94  (m,  1H, H-5),  4.00-4.15  (m, 2H, CH3C//2),  4.48-4.52  (m,  1H, H-l),  4.64-4.68  (m,  
1H,  H-8);  13CNMR  (DMSO)  8  16.8,  23.6,  29.5,  38.6,  45.3,  61.7,  63.7,  64.5,  74.9,  172.7,  
174.2. Anal.  Calcd for CnHi6BrN03 (290.17): C, 45.53; H,5.56; N, 4.83. Found: C, 45.89; H, 
5.72; N, 4.37. 
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6b:  Yield  81%,  a  white  crystalline  solid,  mp.  119-120  °C;  'H  NMR  (DMSO)  <5 1.22  (t,  
7=  7.0 Hz,  3H, C#3CH2),  1.86 (ddt, 7=  1.5,  13.8, 3.8 Hz,  1H, H-9),  1.95-2.13 (m, 2H, H-7), 
2.49  (dt, 7=  10.3,  1.5 Hz,  1H,  H-9),  3.07  (ddd, 7=2.8,  4.3,  11.8  Hz,  1H,  H-6),  4.13  (q,  
J =  7.0 Hz, 2H,  CH3C//2), 4.20-4.24 (m,  1H, H-5), 4.47-4.78 (m,  1H, H-l), 4.78-4.83 (m,  1H,  
H-8),  7.41  (t, J  = 7.55 Hz, 2H,  /w-Ph), 7.49 (t, J=  7.3 Hz,  lH,/?-Ph),  7.81 (d, 7=  7.3 Hz, 2H, 
o-Ph);  13C NMR (DMSO) S 14.4, 23.3, 27.6,42.4,48.6,  49.9, 60.6, 72.2,  127.2,  128.5,  131.2,  
132.9,  155.6,  172.1.  Anal.  Calcd  for  CiiHi8BrN03  (252.24):  C,  54.56;  H,  5.15;  N,  3.98.  
Found: C, 54.41; H, 5.49; N, 4.22. 
10: This compound  is sensitive to air, and was used for the next  step without purification.  'H 
NMR  (CDC13)  <5  1.23  (t, 7 =  7.0 Hz,  3H,  C#3CH2),  1.64  (d, 7 =  14.1 Hz,  1H, H-9),  1.90  (s,  
3H, Me),  2.24  (ddd, 7 =  3.5,  7.3,16.4  Hz,  1H, H-7), 2.44  (d, 7 =  16.4 Hz,  1H, H-7), 2.53  (d,  
7=  14.1 Hz,  1H, H-9),  2.73  (d, 7=  6.1 Hz,  1H, H-6),  3.83  (s,  1H, H-5), 4.11  (q, 7=  7.0 Hz, 
2H,  CH3Ci/2),  4.52  (s,  1H, H-l),  4.53  (s,  1H,  H-8);  13CNMR  (DMSO)  <5  14.8,  20.5,  21.6,  
27.5,41.1,46.3,49.5,  61.1,  72.9,158.9,172.8.  
General  procedure  for dehalogenation  of  iodo-  and  bromooxazines  2,  5a,b, 6a,b  and  10  
to  oxazines  3,  7a  and  7:  Tributyltin  hydride  (0.8  mL, 3  mmol)  was  added  to  a  solution  of  
iodo-  or  bromooxazine  2,  5a,b  or  6a,b  (1.48  mmol)  in  dry  CH2CI2 (65  mL) under  an  argon  
atmosphere.  After stirring  for 20  h  at  40  °C, the  solvent  was  evaporated  off and the  residue  
was  purified  by  column  chromatography  on  silica  gel  (eluent:  «-hexane-EtOAc  10:1)  to  
afford the  1,3-oxazine as a white crystalline solid (3,7b)  or as an oil (7a). 
3:  Yield  70%,  a  white  crystalline  solid,  mp  150-153  °C;  'H  NMR  (DMSO)  <5 1.20  (t,  
7=  7.0 Hz, 3H, C/73CH2),  1.53-1.66 (m, 2H, H-7, H-8),  1.71-1.78 (m, III, H-8),  1.86-1.91 (m, 
2H, H-9),  1.91-1.97  (m,  1H, H-7),  2.65  (ddd, 7=  2.0, 4.5,  11.8 Hz,  1H, H-6),  3.79  (br s,  1H,  
H-5),  4.00-4.13  (in,  2H,  CH3CHz),  4.49-4.55  (m,  1H, H-l),  7.37  (d, 7=  5.0 Hz,  1H,  H-4);  
13CNMR  (DMSO)  <5  14.8,  18.7, 29.5,  30.9, 46.5, 47.4,  60.1,  72.6,  154.3,  173.1. Anal.  Calcd  
for C10H,5NO4 (213.24):  C, 56.33; H, 7.09; N, 6.57. Found: C, 55.92; H, 7.22; N, 6.19. 
7a:  Yield  60%,  a colourless  oil,  from  iodooxazine  5a,  and  55% from bromooxazine  5b;  'H  
NMR (DMSO) <51.18 (t, 7 =  7.3 Hz, 3H, CH3CH2),  1.45 (ddt, 7 = 4.8,12.6,4.8  Hz,  1H, H-7), 
1.55  (ddd, 7=  1.5,4.8,  13.3  Hz,  1H,  H-8),  159-1.73  (m,  2H,  H-9),  1.82  (s,  CH3,  3H,  H-8),  
1.93  (d, 7 =  13.3 Hz,  1H,  H-7),  2.67  (dt, 7 =  12.1,  3.0IIz,  1H,  H-6),  3.85  (s,  1H,  H-5),  
3.97-4.11  (m, 2H, CH3C#2),  4.39  (s,  1H, H-l);  13C NMR  (DMSO)  <5  14.1,  17.9, 20.9,  27.8,  
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31.1,45.5,  48.1, 59.7, 59.8,69.2,158.6,  172.6. Anal. Calcd for C,iHi7N03(211.26):  C, 62.54; 
H, 8.11; N, 6.63. Found: C, 63.00; H, 8.24; N, 6.32. 
7b:  Yield  65%  from  iodooxazine  6a,  and  62%  from bromooxazine  6b,  a  white  crystalline  
solid, mp 64-65 °C;  ]H N M R  ( D M S O )  d  1.21 (t, J=  7.0 Hz, 3H, C//3CH2),  1.38-1.52 (m,  1H,  
H-7),  1.63-1.74  (m,  2H,  H-7,  H-8),  1.82-1.89  (m,  1H, H-9),  1.93  (dt, 7=  13.3,  1.8 Hz,  1H,  
H-9),  2.01-2.12  (m,  1H, H-8),  2.82  (dt, 7=  12.1,  3.5 Hz,  1H, H-6),  4.10  (q, J =  7.0 Hz,  2H,  
CH3C#2), 4.17-4.20 (m,  1H, H-5), 4.68-4.72 (m,  1H, H-l), 7.39 (t, 7.5 Hz, 2H, m-Ph), 7.46 (t, 
J=  7.3 Hz,  1H, p-Ph),  7.81  (d, 7=  7.3 Hz, 2H, o-Ph);  l3C N M R  ( D M S O )  S  14.5,  18.2, 28.1, 
31.5,  46.1,  49.0,  60.1,  70.3,  127.1,  128.4,  130.8,  133.8,  156.8,  173.0.  Anal.  Calcd  for  
C , 6 H I 9 N 0 3  (273.34): C, 70.31; H, 7.01; N ,  5.12. Found: C, 70.39; H, 6.87; N ,  5.43.  
General  synthesis  of  stereoisomeric  2-amino-4-hydroxy  acids  8  and  11  and  
oxazinonecarboxylic  acid  4: A solution of ester 3  or  7a,b  (1 mmol  in 20  mL 20% HC1) was 
refluxed  for  30  h.  The  solvent  was  then  evaporated  off  to  afford  the  crude  amino  acid  
hydrochloride.  The free amino acid base was liberated by ion exchange chromatography  with  
Dowex 50. 
(r-6,c-l,c-5)-2-Oxa-3-oxo-4-azabicyclo[3.3.1]nonane-6-carboxylic  acid  (4):  Yield  53%  
from  7a,  and  35% from  7b,  a  white  crystalline  solid, mp  222-226  °C;  "H NMR  (DMSO) 5  
I.52-1.67  (m, 2H, H-5, H-6),  1.69-1.80 (m,  1H, H-6),  1.82-1.98 (m, 3H, H-3, H-5), 2.51-2.59 
(m,  1H,  H-l),  3.79  (brs,  1H,  H-2),  4.51  (brs,  1H,  H-4),  7.28  (d, 7=5.04 Hz,  1H,  OH); 
13CNMR  (DMSO)  <5 18.4,  29.1,  30.1,  46.0,  46.7,  72.1,  153.8,  174.3.  Anal.  Calcd  for  
C8HnN04 (185.18): C, 51.89; H, 5.99; N, 7.56. Found: C, 5.92; H, 5.57; N, 7.92. 
(r-l,c-2,c-4)-2-Amino-4-hydroxycyclohexanecarboxylic  acid  (8):  Yield  52  %,  a  white  
crystalline solid, mp 220-225 °C;  *H NMR (D20)  <51.41 (1H, s, H-5),  1.55-1.67 (m,  1H, H-6), 
1.78-1.91  (m,  2H,  H-3,  H-5),  2.06  (dt, 7=  12.6,  3.5 Hz,  1H,  H-3),  2.10-2.22  (m,  1H, H-6), 
2.58  (q,  7=  4.4 Hz,  1H,  H-2),  3.49  (t,  7=13.6,  4.1Hz,  1H,  H-l),  3.88  (m,  1H,  H-4);  
13CNMR  (D20)  S  22.9,  30.8,  34.7,  42.6,  49.0,  67.5,  180.3.  Anal.  Calcd  for  C7H13N03  
(159.19): C, 52.82; H, 8.23; N, 8.80. Found: C, 52.99; H, 8.48; N, 8.70.  
(r-l,i-27-4)-2-Amino-4-hydroxycyclohexanecarboxylic  acid  (11):  Yield  48%,  a  white  
crystalline  solid,  mp  230-232  °C;  *H  NMR  (D20)  S  1.27-1.5  (m,  3H,  H-3,  H-5,  H-6),  
2.02-2.08  (m,  1H,  H-5),  2.14-2.26  (m,  2H,  H-2,  H-6),  2.28-2.34  (m,  1H,  H-3),  3.35  (ddd,  
7 =  4.0,  10.8,  12.1 Hz,  1H, H-l),  3.76 (tt, 7 =  4.0,10.8 Hz,  1H, H-4); 13C NMR (D20)  S 25 J,  
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35.2, 41.0, 45.8,  50.5, 67.5,  180.5. Anal.  Calcd for  C7H13NO3 (159.19):  C, 52.82; H, 8.23; N, 
8.80. Found: C, 52.54; H, 8.73; N, 8.49. 
cw-2-Benzoylamino-4-cyclohexenecarboxylic  acid  (12a):  2-Amino-4-cyclohexene-
carboxylic  acid  (1.41  g,  10  mmol)  was  dissolved  in  10% NaOH  solution  (15  mL),  benzoyl  
chloride  (1.54  g,  11  mmol)  was  added  dropwise,  and  the  solution  was  stirred  at  room  
temperature  for  1 h.  The  solution  was then  acidified with  aqueous  HCl,  and the  precipitated  
12a  was  filtered  off,  washed  with  water  and  dried.  Yield  2.05  g,  84%,  a  white  crystalline  
solid, mp  188-189  °C (n-hexane-ethyl  acetate);  'H NMR (DMSO)  8 2.30 (m,  1H, H-2), 2.55 
(m,  1H,  H-2),  2.90  (dd,  J =  6.0,9.5  Hz,  1H,  H-l),  4.41-4.48  (m,  1H,  H-6),  5.68  (d,  
J=  10.3 Hz,  1H, H-3),  5.62(d, J=  10.3 Hz,  1H, H-4), 7.52  (t, J=  7.3 Hz,  1H, p-Ph),  7.45 (t,  
J  = 7.3 Hz, 2H, o-Ph),  7.79  (d, J=  7.30 Hz,  2H, m-Ph),  7.97 (d, J=  8.2 Hz,  1H, NH),  12.28  
(br s,  1H, OH);  13C NMR (DMSO) 8 26.1, 30.2,41.6,46.1,  125.4,  126.1,  128.2,129.0,131.9,  
135.6,  167.0,  175.3. Anal.  Calcd for  C14H15NO3  (245.28): C, 68.56; H, 6.16; N, 5.71. Found: 
C, 68.94; H, 7.43; N, 5.39. 
ci5-2-ferf-Butoxycarbonylamino-4-cyclohexenecarboxylic  acid  (12b):  2-Amino-4-
cyclohexenecarboxylic  acid (1.41 g,  10 mmol) was dissolved  in a mixture of dioxane (20 mL) 
and water  (10 mL), feri-butoxypyrocarbonate  (2.4 g,  11 mmol) was added to the solution  at 0 
°C , and the mixture was stirred at room temperature for 4 h. The solvent was then evaporated 
to  down  half  volume,  and  the  mixture  was  diluted  with  ethyl  acetate  (20  mL)  and  next  
acidified with  10%  H2SO4  (pH = 2.5).  The mixture was  extracted  with  ethyl  acetate  (3 x  20  
mL)  and  the  combined  organic  layer  was  dried  (Na2S04)  and  evaporated.  The  residue  was  
recrystallized from diisopropyl  ether to give a white crystalline solid. 'H NMR  (CDCI3) 8 1.44 
(9H, s, OtBu), 2.21 (dd, J =  18.1 Hz,  6.04 Hz,  1H, H-2), 2.36 (d, J =  18.1 Hz, 2H, H-5), 2.54 
(d, J =  18.1 Hz,  1H, H-2), 2.81-2.93 (m,  1H, H-l),  4.11-4.23  (m,  1H, H-6),  5.29 (d, J = 6.04 
Hz,  1H, NH),  5.55-5.70 (m, H-3, 2H, H-4);  ,3C NMR (DMSO) 8 26.8, 28.9, 31.8, 42.6, 46.8, 
80.1,  125.3,  125.7,  156.1,  179.1.Yield  75 %, mp  58-60  °C;  'H NMR  (CDCI3) 8  1.44 (s,  9H,  
OtBu), 2.21 (dd, J =  18.1 Hz,  6.04 Hz,  1H, H-2), 2.36 (d, J =  18.1 Hz, 2H, H-5), 2.54 (d, J = 
18.1 Hz,  1H, H-2), 2.81-2.93 (m,  1H, H-l), 4.11-4.23 (m,  1H, H-6), 5.29 (d, J = 6.04 Hz,  1H,  
NH),  5.55-5.70  (m,  2H,  H-3,  H-4);  ,3CNMR  (DMSO)  8  26.8,  28.9,  31.8,  42.6,  46.8,  80.1,  
125.3,  125.7,  156.1,  179.1. Anal.  Calcd for C,2H,9N04  (241.29):  C,  59.73; II,  7.94; N,  5.80.  
Found: C, 59.42; H, 7.81; N, 5.92.  
/raws-6-te/^Butoxycarbonylaminocyclohcx-3-enc-carboxylic  acid  (16):  The  procedure  
described  for  12b  was  followed to prepare  16  from  fra/w-6-aminocyclohex-3-ene-carboxylic  
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acid.  Yield  74%,  a  white  crystalline  solid,  mp  120-122  °C;  'H  NMR  (DMSO)  S  1.36  (s,  9H,  
OtBu),  1.88-1.97  (m,  1H, H-2), 2.15-2.23  (m, 3H, H-2, H-5), 2.44-2.54  (m,  1H, H-6),  3.6-3.72  
(m,  1H, H-l),  5.55-5.63  (m, 2H,  H-3, H-4),  6.76  (d, J =  8.6 Hz,  1H, NH);  l3C NMR  (DMSO)  
d  28.3,  28.6,  31.5,  44.6,  47.5,  77.8,  126.1,  125.3,  155.2,  175.5.  Anal.  Calcd  for  C I 2Hi9N04  
(241.29):  C,  59.73;  H, 7.94; N,  5.80. Found:  C,  59.39; H, 7.49; N,  5.53.  
General  procedure  for  the  synthesis  of  iodolactones  13a,b  and  17:  To  a  solution  of  
carboxylic  acid  derivative  12a,b  or  16  (5.75  mmol)  in  CH2C12  (50  mL),  0.5  N  NaHC03  
solution  (35  mL),  KI  (5.7  g,  34.5  mmol)  and  I2  (2.9  g,  11.5  mmol)  were  added  at  0  °C.  The  
reaction  mixture  was  stirred  at  room  temperature  for  20  h  and  then  poured  into  100  mL  
saturated  Na2S203  solution.  The  mixture  was  extracted  with  CH2C12  (3  x  50  mL)  and  the  
combined  organic  layer  was  washed  with  saturated  NaCl  solution,  dried  (Na2S04),  and  
evaporated.  The  residue  was  recrystallized  from diisopropyl  ether  to  give  iodolactones  13a,b  
and  17.  
13a:  Yield  78%,  a  white  crystalline  solid,  mp  185-189  °C;  'H  NMR  (DMSO)  d  2.22  (dd,  
7 =  5.3,  15.8  Hz,  1H,  H-3),  2.51-2.80  (m,  3H,  H-8,  H-3),  2.81  (d, 7 =  12.4 Hz,  1H,  H-l),  
4.23-4.31  (1H,  m,  H-2),  4.75  (t,  7 = 4.8 Hz,  1H,  H-4),  4.89  (t, J =  4.8 Hz,  1H,  H-5),  7.48  (t,  
J=  7.3 Hz,  2H,  m-Ph),  7.55  (t,  J=  7.3 Hz,  1H, p-Ph),  7.83-7.87  (d,  J=  7.3 Hz,  2H,  o-Ph),  
8.53  (d,  J  =  7.0 Hz,  1H, NH);  1 3CNMR  (DMSO)  S  23.4,  33.4,  34.6,  43.9,  46.0,  79.3,  127.8,  
128.6,  131.8,  134.3,  166.9,  175.9. Anal.  Calcd  for C14Hi4lN03  (371.18):  C, 45.30; H, 3.80; N, 
3.77. Found:  C, 44.92, H,  3.61; N,  3.87.  
13b:  Yield  84%,  a  white  crystalline  solid,  mp  170-174  °C;  ]H NMR  (DMSO)  d  1.40  (s,  9H,  
OtBu),  2.09  (dd,  7 = 5 . 8 ,  16.1  Hz,  1H,  H-3),  2.27  (ddd, 7 = 5 . 8 ,  12.3,  16.1,  1H,  H-3),  2.46  
(ddd, 7 =  1.5,  5.8,  12.6 Hz,  1H, H-8),  2.55  (d, 7 =  12.6 Hz,  1H, H-8),  2.67  (d, 7 =  6.3 Hz,  1H,  
H-l),  3.69-3.79  (m,  1H,  H-2),  4.66  (t, 7 =  5.3 Hz,  1H,  H-4),  4.82  (dd, 7=4 .3 ,  5.3 Hz,  1H,  
H-5),  7.17  (d, 7 =  7.3 Hz,  1H, N//CO);  I3C NMR  (DMSO)  S 23.2,  28.5,  33.2,  34.9,44.2,46.7,  
78.8,  79.1,  155.2,  175.8.  Anal.  Calcd  for  CI2H18IN04  (367.19):  C,  39.25;  H,  4.94;  N,  3.81.  
Found:  C, 38.93; H, 4.65; N,  3.72.  
17:  Yield  82%,  a  white  crystalline  solid,  mp  125-127  °C;  ]H  NMR  (DMSO)  5  1.41  (s,  9H,  
OtBu),  2.25-2.38  (m,  2H,  H-3,  H-8),  2.41-2.48  (m,  1H,  H-3),  2.75  (t, 7 = 4 . 1  Hz,  1H,  H-8),  
2.88  (d, 7 =  12.8 Hz,  1H, H-l),  3.75  (s,  1H, H-5), 4.42  (s,  1H, H-4),  4.94  (dd, 7 =  3.3,  5.8  Hz,  
1H,  H-2),  6.93  (br  s,  1H, NH);  I 3 CNMR  (DMSO)  S  19.5,  28.0,  28.6,  33.3,  42.4,  46.0,  78.8,  
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81.2,  176.5.  Anal.  Calcd  for  C I 2 H I 8 I N 0 4  (367.19):  C,  39.25;  H ,  4.94;  N ,  3.81.  Found:  C,  
39.37; H, 5.22; N, 3.68. 
Reduction  of iodolactones  13a,b  and  17 to lactones  14a,b  and  18: Tributyltin hydride (2.4 
mL, 9 mmol)  was  added  to  a  solution  of  iodolactone  13a,b  or  17  (4.5 mmol)  in  dry  CH2C12  
(65  mL)  under  an  argon  atmosphere.  After  stirring  for  20  h  at  40  °C,  the  solvent  was  
evaporated off and  the crude lactone  was crystallized  from  w-hexane, and recrystallized from 
isopropyl ether-ethyl  acetate.  
14a: Yield 68%, a white crystalline solid, mp  188-190 °C; 'H NMR (DMSO) <51.79-2.12 (m, 
5H, H-3, H-4, H-8), 2.50-2.57 (m,  1H, H-8), 2.88 (d, J=  5.8 Hz,  1H, H-l),  4.20-4.29 (m,  1H,  
H-5),  4.94  (t, J =  4.8 Hz,  1H,  H-2),  7.60  (t, J =  7.3 Hz,  2H,  m-Ph),  7.67  (t, J =  7.3 Hz,  1H,  
p-Ph),  7.98  (d,  J=  7.3 Hz,  2H,  o-Ph),  8.50  (d,  J=  7.0 Hz,  1H,  NT/);  13C NMR  (DMSO)  8  
23.9,  27.4,  35.6,  43.6,  48.3,  77.0,  127.8,  128.5,  131.7,  134.5,  166.8,  176.9.  Anal.  Calcd for 
C14H15NO3 (245.28): C, 68.56; H, 6.16; N, 5.71. Found: C, 68.49; H, 6.33; N, 5.49. 
14b:  Yield  75%, a white  crystalline  solid, mp  115-119 °C;  'H NMR  (DMSO)  8  1.40 (s,  9H, 
OtBu), 1.45-1.56 (m,  1H, II-3),  1.57-1.65 (m,  1H, H-3),  1.75-1.9 (m, 3H, H-4, H-8), 2.29-2.37 
(m,  1H, H-8), 2.62 (d, J=  4.8 Hz,  1H, H-l),  3.56-3.65  (m,  1H, H-5), 4.73 (t, J=  4.8 Hz,  1H,  
H-2),  6.95  (d, J=  6.5 Hz,  1H,  NT/);  13CNMR  (DMSO)  8  24.3,  27.4,  28.5,  35.5,  43.8,  49.1,  
76.7,  78.3,  155.1,  176.7.  Anal.  Calcd  for  Ci2H19N04  (241.29):  C,  59.73;  H,  7.94; N,  5.80.  
Found: C, 59.92; H, 8.21; N, 5.37. 
18:  Yield  72%,  a  white  crystalline  solid,  mp  82-86  °C;  ]H N M R  ( D M S O )  8  1.40  (s,  9H,  
OtBu),  1.53-1.61  (dd, J =  6.3,14.6  Hz,  1H, H-8),  1.66-1.85  (m, 2H, H-3, H-4), 2.05-2.18 (m,  
2H, H-4, H-8), 2.69  (t, J=  4.3 Hz,  1H, H-l),  3.69-3.78  (m,  1H, H-5), 4.81 (t, J=  4.3 Hz,  1H,  
H-3), 7.48 (1H, br s, NT/) ;  13C N M R  ( D M S O )  8 24.0,24.8,28.6,  31.0,43.1,45.6,  78.1, 78.56, 
177.3.  Anal.  Calcd  for C I 2 H I 9 N 0 4  (241.29):  C,  59.73; H,  7.94; N ,  5.80.  Found:  C, 59.56; H, 
7.83; N ,  5.52.  
General  procedure  for 2-amino-5-hydroxycarboxylic  acids  15  and  19 from lactones  14b  
and  18: Lactone  14b or  18 (0.72 g, 3 mmol) was dissolved  in 20 mL of 20% aqueous HC1 and 
the  solution  was  stirred  at  room  temperature  for  10 h.  The  solvent  was  next  evaporated off, 
and  the  amino  acid  base  was  liberated  from  the  residual  hydrochloride  by  ion-exchange  
chromatography on Dowex 50. 
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(r-l,c-2,c-5)-2-Amino-5-hydroxycyclohexanecarboxylic  acid  (15):  Yield  66%,  a  white  
crystalline  solid,  mp,  255-256  °C;  'H  NMR  (D20)  8  1.43-1.54  (m,  1H,  H-4),  1.61  (q,  
7=  11.8 Hz, 2H, H-6),  1.78 (tt, 7= 4.3,13.6 Hz,  1H, H-3),  1.85-1.93 (m,  1H, H-4), 2.02 (ddt, 
7=  4.3,  14.9, 4.3 Hz,  1H, H-3), 2.15 (d, 7=  13.6 Hz,  1H, H-6), 2.62 (dt, 7=  12.1, 3.8 Hz,  1H,  
H-l),  3.64  (q, 7 =  3.8 Hz,  1H,  H-2),  3.75-3.84  (m,  1H, H-5);  ,3CNMR  (D20)  S 25.5,  27.9,  
32.4, 43.7, 47.9, 68.2,  180.5! Anal.  Calcd for  C7H13NO3 (159.19):  C, 52.82; H, 8.23; N,  8.80.  
Found: C, 52.67; H, 8.49; N, 8.31.  
(r-l,t-2,c-5)-2-Amino-5-hydroxycyclohexanecarboxylic  acid  (19):  Yield  62%,  a  white  
crystalline  solid,  mp  275-280  °C;  'H NMR  (D20)  8  1.32-1.44  (m, 2H, H-4, H-6),  1.53 (ddt,  
7=  3.5,  12.8,  3.5  Hz,  1H, H-3),  2.01-2.14  (m,  2H, H-3,  H-4),  2.31-2.40  (m,  2H, H-l,  H-6),  
3.24  (dt, 7=  3.8,  11.3 Hz,  1H, H-2),  3.73  (tt, 7=4.0,11.1  Hz,  1H, H-5);  13CNMR  (D20)  8 
27.7,  32.0,  36.9,  46.8,  51.5,  68.8,  179.8.  Anal.  Calcd  for C7H,3N03  (159.19):  C,  52.82;  H,  
8.23; N, 8.80. Found: C, 52.55; H, 8.43; N, 8.21. 
(lS,2R,4R)-2-Amino-4-hydroxycycIohexanecarboxylic  acid  (+)-(8):  The  synthesis  was  
carried  out  similarly  as  for  the  racemic  compound  (±)-8,  starting  from  (15,2i?)-2-amino-4-
cyclohexenecarboxylic  acid  hydrochloride,  via  intermediate  5a.  The  'H  NMR  data  on  the  
intermediates and products were similar to those for the racemates. Representative data on the 
enantiomers  isolated:  
(I5',2i?)-Ethyl  2-amino-4-cyclohexenecarboxylate:  Colourless  crystals,  mp  125-128  °C,  
[a]]° +19 (c  1.0, EtOH), ee > 99%. 
(+)-la.. A colourless oil,  [a]»  +58 (c 0.6, MeOH), ee > 99%. 
(+)-7a..  A  colourless oil,  [a]2° +28 (c 0.4, MeOH). 
(+)-(8). Colourless crystals, mp  140-145 °C,  [a]20°  +17 (c 0.23, H20), ee > 99%. 
(lS,2R,5R)-2-Amino-5-hydroxycycIohexanecarboxylic  acid  (-)-(15):  The  synthesis  was  
carried  out  similarly  as  for the  racemic  compound  (±)-15,  starting  from  (15,2£)-2-amino-4-
cyclohexenecarboxylic  acid  hydrochloride,  via  intermediate  13b.  The  *H NMR  data  on  the  
intermediates  and products were similar to those for the racemates. Representative data on the 
enantiomers  isolated:  
(+)-(12b). Colourless crystals, mp  118-123 °C,  [a£°  +19.4 (c 0.5, MeOH), ee > 99%. 
(+)-(13b). Colourless crystals, mp 185-190 °C,  [a£°  +92.5 (c 0.6, MeOH). 
(+)-(14b).  Colourless crystals, mp 135-140 °C,  [aft0  +104 (c 0.1, MeOH), ee > 99%. 
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(-)-(15).  Colourless crystals, mp 247-250 °C,  [a]20  -26 (c 0.15, H20), ee > 99%. 
X-ray  data  collection  and processing:  Crystallographic  data for  15 were collected  at  173 K 
on a Nonius Kappa CCD area-detector diffractometer, using graphite monochromatized  MoKa  
radiation  (A, = 0.71073 A).  The data collection was performed using  <p  and © scans. The data 
were processed  using DENZO-SMN v0.93.0.[151 The structures were solved by direct methods 
with the  SHELXS program^  and  full-matrix least-squares  refinements on F2  were performed, 
using the SHELXL-97  program  [16].  All heavy atoms were refined anisotropically.  The OH and 
NH  hydrogens  were  refined  anisotropically.  The  CH  hydrogen  atoms  were  included  at fixed 
distances  with fixed displacement  parameters from their host  atoms.  Figure  1 was  drawn  with  
Ortep-3 for  Windows[,7].  
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Scheme  3. (i)  KI, I2, NaHC03,  CH2C12, 20 h,  rt; (ii)  Bu3SnH,  CH2C12, 20  h, 40  °C; (Hi) 20% 
HC1, 30 h rt. 
u , 
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Scheme 4.  (/)  KI, I2, NaHC03,  CH2Cl2,  20  h,  rt; (//) Bu3SnH,  CH2C12, 20 h, 40  °C; (Hi)  20% 
HCl, 30 h, rt. 
Figure  1. Crystal  structure of  15, showing  the hydrogen bonding  scheme.  Thermal  ellipsoids  
have been drawn at the 30% probability level.  Symmetry codes:  i =  x+l/2,-y+3/2,-z+2,  
ii = -x+3/2,-y+l,z+l/2  and iii =  x+l/2,-y+3/2,-z+l.  
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1 
Introduction 
During  the past  decade  considerable  attention  has  been  directed  towards  
the  synthesis  of  hydroxy-/?-amino  acids  [1-6].  These  compounds  constitute  an  
important class of amino acids, because of their occurrence in many  biologically  
relevant  compounds,  including  Paclitaxel  (Taxol)  and  Docetaxel  (Taxotere),  
which  are  among  the  most  effective  chemotherapeutic  agents  [7,  8].  The  
alicyclic  hydroxy-/?-amino  acids  can  be  used  as  building  blocks  for  the  
preparation  of  modified  analogues  of  biologically  active  peptides  [9,  10].  
Hydroxylated  alicyclic  /?-amino  acids  and  their  derivatives  can  be  widely  used  
for  the  synthesis  of  various  heterocyclic  compounds  [11-17].  Our  present  aim  
was  the  synthesis  and  structure  analysis  of  the  title  hydroxylated  alicyclic  fi-
amino acids.  
Results and  Discussion  
The  key  step  in  the  synthesis  of  all-endo-3 -amino-6-
hydroxybicyclo[2.2.1]heptane-2-carboxylic  acid  (4)  the  stereoselective  
iodolactonization  [15]  of  /7-Boc-e«c/o-3-aminobicyclo[2.2.1]hept-5-ene-2-
carboxylic  acid derivative  (1). The iodolactonization  was performed under  two-
phase  conditions,  furnishing iodolactone  2, which was reduced  with Bu3SnH to 
give  lactone  3.  The  iV-Boc  lactone  was  converted  to  the  all-endo  isomer  of  
hydroxy-amino acid 4 by acidic hydrolysis (Scheme  1).  
< Scheme  1 > 
2 
When iV-acetylamino  ester  5 was reacted with iV-iodosuccinimide  [16] (NIS)  or  
TV-bromosuccinimide  (NBS)  a  tricyclic  1,3-iodo-  or  -bromooxazine  derivative  
(6a,b)  was obtained  stereoselectively.  When dehalogenated  with Bu3SnH  under  
an  argon  atmosphere,  6a,b  yielded  7.  The  hydrolysis  of  oxazine  7  with  dilute  
hydrochloric  acid  at  room  temperature  gave  /V-acetyl-hydroxy  amino  acid  8.  
When 8 was boiled  in acidic solution,  endo  —» exo  isomerization took place and 
the  forced  conditions  resulted  in  3,5-diendo-2-exo-3-2amrio-5-
hydroxybicyclo[2.2.1]heptane-2-carboxylic  acid  hydrochloride  (9)  as  the  main  
product.  The  mother  liquor  was  treated  with  a  large excess  of propylene  oxide  
and,  after  fractional  crystallisation,  compound  10  was  isolated  as  a  
diastereomerically  enriched  (8:2)  mixture  (Scheme  2).  The  correct  
configurations of hydroxylated  amino acids 9 and  10 were proved indirectly, the 
stereostructures  of  8  and  11  being  demonstrated  with  a  using  DIFFNOE  
technique  and  also  by  chemical  transformation:  esterification  of  9  led  to  
hydroxylated  amino  ester  11,  while  after  acetic  acid  treatment  10  gave  an  N-
acetyl  derivative.  The NMR  spectrum  of the  resulted  compound  was  identical  
with  that  of  0//-e«do-3-acetylamino-5-hydroxybicyclo[2.2.1 ]heptane-2-
carboxylic acid 8. 
< Scheme 2 > 
The constitutions  and  stereostructure  of the new compounds  2-5  and  7-11 were 
determined by IR,  !H and  13C NMR spectroscopy (Tables  1 and 2). The  spectral  
data are self-explanatory; only a few additional remarks  are necessary. It  should  
be  noted  that,  for  easier  comparison  of  analogous  spectral  data,  the  numbering  
of  1 given  in  Scheme  1 will  be  used  for all  compounds  in this  section  and  also  
in Tables  1 and 2. 
< Table  1 > 
< Table 2 > 
3 
1) The  diendo  arrangement  of  the  2,3  substituents  in  compounds  2-5,  7  
and  8 follows from our  "splitting  rule"  [17,  18] In  consequence  of the  dihedral  
angles  of  ca.  90°,  the  1,2-  and  3,4-  vicinal  H,H-couplings  do not  cause  double  
spliting  of  the  H-2  and  H-3  signals  in  the  diexo  compounds,  whereas  these  
couplings  lead  to  a  well-detectable  split  by  2-4  Hz  in  the  case  of  the  diendo  
anellated  molecules,  where  the  dihedral  angles  are  ca.  30°.  Hence,  as  a  
consequence  of the H-2,H-3  interaction, H-2  and  H-3  exhibit  doublets  in  the  
diexo  derivatives  and  double  doublet  signals  in  the  diendo  analogues.  The  
H-2,3  coupling results  in  a 7-11 Hz  split due to the dihedral  angle of 0° for the 
diendo  and  diexo  anellated  compounds  [17],  while  this  coupling  constant  is  
expected  to  be  smaller  (ca.  4-6  Hz)  for  exo-endo  derivatives  [19],  where  the  
dihedral  angle is ca.  109°. Thus, the dd (2-4) ,  dt (5) ,  ddd  (7) or td (8) split of the 
H-2  (2-5)  or  H-3  (7,  8)  signal  confirms  the  2,3 -diendo  configuration.  Higher  
than dd splits are due to couplings with the NH (5) or H-7(exo) (7, 8). 
1Q 
The  similar  C  NMR  chemical  shifts  in  3  and  4  demonstrate  the  
unaltered all-endo  orientation of the three substituents in 4 as compared with 3. 
In the  ]H NMR  spectrum  of  9, the H-2  and H-3  signals  are  ds,  split  by  
4.3  Hz,  and  consequently  this  molecule  must  have  the  endo-exo  configuration.  
In accordance, the C - l  and C-4  chemical  shifts in 9 are dramatically higher (by 
8.0  and  8.6 ppm)  because  of the  absence of  a field effect [20]  causing  opposite  
shifts  to  those  in  8,  due  to  very  strong  hindrance  between  the  three  endo  
substituents. Hence, during the acidic hydrolysis of 8, endo  -> exo  isomerisation  
occurred, probably in position 2, via the enolic form of the carboxyl  group.  
1Q 
The  practically  identical  C NMR  chemical  shifts  of  9  and  11 confirm 
analogous  stereostructures  for  these  molecules.  For  11,  DIFFNOE  
measurements  unambiguously  proved  the  2-exo-3-endo  configuration.  On  
saturation  of the H-2 doublet  (at 2.59 ppm), for example the H-6(exo) signal  (at  
1.24 ppm) responded,  while  for the H-7 (endo)  signal  an  intensity  enhancement  
4 
was  not  observed.  The  DIFFNOE  measurements  together  with the HMQC  and  
HMBC spectra also furnished proof of the assignments.  
I o 
2)  In  the  C NMR  spectrum  of  2 the  very  characteristic upfield-shifted 
line of iodo-substituted  carbon (C-5)  [21] appears  at 24.5  pprn. The /^-effect of 
the  iodo  substituent  [22]  is revealed  in a downfield shift by  7.5  and  8.5 ppm  of  
the  C-4  and  C-6  lines  as  compared  with  3.  An  anisotropic  neighbouring  
deshielding  effect of  the  iodine  atom  is  also  observable  on  the H-7  signals  in  
the 'H NMR spectrum, which are downfield-shifted in 2 (by 0.36 and 0.61 ppm) 
as compared  with 3. This  supports the ab ovo  more probable  exo position  of the 
iodine atom [to avoid the steric interaction between 2(endo)-l  and 0-4(endo)]. 
3) The  ]H NMR  signal  (a singlet of 9H intensity) of the methyl  group and 
I  «j  
its  carbon  line  in  C NMR  spectrum,  together  with  the  line  of the  quaternary  
carbon atom, are proof of the presence of the t-Bu  group in 2 and 3. 
4) The position of the hydroxy group in 4 follows from the structures of 2 
and  3  containing  a y-lactone  ring,  the presence  of which  is proven  by the  high  
IR carbonyl  frequency  [23] (1788 and  1775 cm-1  in 2 and 3, respectively). 
5) In the spectra of 5, 7 and  11, all the IR, !H and  13C NMR signals of the 
COOEt group appear and the rigid  structure of 7 results  in a series of  long-range  
couplings, which lead to higher multiplicities of all signals observed  in this case 
only in the 'H NMR  spectrum.  
6) The downfield shift of the methyl  (Ac)  signal  (by  0.49 ppm)  in the  'H  
NMR spectrum of 8 relative to 5 is noteworthy; this  is caused by the  anisotropic  
effect [24] of the endo-OH  group.  
5 
Experimental 
General  Procedures. Melting points  were determined  on  a Kofler micro  melting  
point  apparatus  and  are uncorrected.  Elemental  analyses  were  conducted  with  a  
Perkin-Elmer  CHNS-2400.Ser  II Elemental  Analyser;  the results  were found to 
be  in  good  agreement  (±0.2%)  with  the  calculated  values.  Merck  Kieselgel  
6OF254 plates were used for TLC: the eluent was toluene:MeOH 4:1. The 'H  and  
l3C  NMR  spectra  were  recorded  in  CDC13  solution  in  5  mm  tubes  at  room  
temperature,  on  a  Bruker  DRX  500  spectrometer  at  500.13  ('H)  and  125.76  
(13C)  MHz,  with  the  deuterium  signal  of  the  solvent  as  the  lock  and  TMS  as  
internal  standard.  DEPT  spectra  were  run  in  a  standard  manner,  using  only  the  
0  =  135° pulse  to  separate  CH/CH3  and  CH2  lines  phased  "up"  and  "down",  
respectively.  The  HMQC  and  HMBC  spectra  were  obtained  by  using  the  
standard Bruker pulse programs.  
(15*,2/?*,35'*,4i?*)-3-ieri-Butoxycarbonylaminobicyclo[2.2.1]hept-5-ene-2-
carboxylic acid (1,  C,2H17NC>4 )  [25]  
1  M NaOH  (20  cm3)  was  added  to  a  solution  of  3-aminobicyclo[2.2.1]hept-5-
ene-2-carboxylic  acid  [26]  (3.1  g,  20  mmol)  in  60  cm  of  a  2:1  dioxane:H20  
mixture.  The  solution  was  cooled  to  0  °C  in  an  ice  bath  and  di-tert-butyl  
dicarbonate (Boc20)  was  added  slowly.  The mixture  was  stirred  at  0 °C for 30 
min and then warmed  to room temperature  and  stirred  for 4 h. The  solvent  was  
concentrated to 20 cm3 on a rotatory evaporator, the pH was then adjusted to 2.5 
with  10% H2S04,  and  the  resulting  solution  was  extracted  with  EtOAc  (3x50  
cm  ). The combined  extracts  were dried (Na2S04),  and evaporated, to give  1 as 
a white solid, which was recrystallized  from zPr20: m.p.  183-187  °C; yield  3.59  
g (75%); lit. m.p.  126-127 °C  [27].  
6 
(1S* ,2 S* ,3 S* ,6 R*  J7^*,95,*)-9-ieri-Butoxycarbonylamino-2-iodo-4-
oxatricyclo[4.2.1.03,7]nonan-5-one  (2 ,  C I 3 H I 8 I N 0 4 )  
To  a  solution  of  /V-Boc-carboxylic  acid  1 (2.75  g,  11.5  mmol)  in  CH2C12  (100  
cm3), NaHC03  solution  (0.5 N,  70 cm3),  KI (11.62  g,  70 mmol)  and  I2  (5.84  g,  
23  mmol)  were  added  at  0  °C.  The  reaction  mixture  was  stirred  at  room  
temperature  for 20  h  and  then  poured  into  10%  aqueous  Na2S203  solution  (50  
cm  ).  The  reaction  mixture  was  extracted  with  CH2C12  (3  x  20  cm  )  and  the  
a 
combined  extract  was  washed  with  brine  (20  cm  ),  dried  (Na2S04),  and  
evaporated.  The  residue  was  recrystallized  from  z'Pr20,  m.p.  183-187  °C;  yield  
3.66 g (84%). 
(lR*,3R*,6R*,7R*,9S*)-9-tert-Butoxycarbonylamino-4-
oxatricyclo[4.2.1.03,7]nonan-5-one  (3 ,  C I 3 H I 9 N 0 4 )  
Bu3SnH (4.8  cm3,  18 mmol) was  added to a solution of iodolactone  2 (4.41 g, 9 
mmol)  in  dry  CH2C12  (65  cm3) under  an argon atmosphere.  After stirring for 20 
h,  at  40  °C,  the  solvent  was  evaporated  off  and  the  lactone  residue  3  was  
crystallized  from w-hexane,  and recrystallized  from  z'Pr20-Et0Ac,  m.p.  145-150  
°C; yield  1.26 g (55%). 
(lR*,2/2*,3iS,*,4i?*,6i?*)-3-Amino-6-hydroxybicyclo[2.2.1]heptane-2-carboxylic 
acid hydrochloride  (4,  C8H14C1N03)  
Compound  3 (1.01 g, 4 mmol) was dissolved  in aqueous HCl (20%, 20 cm3) and 
the  solution  was  stirred  at  room  temperature  for  10  h.  The  solvent  was  next  
evaporated  off and  the  residue  was  recrystallized  from  H20-acetone,  m.p.  220-
222 °C, yield 0.70 g  (84%).  
Ethyl  (IS*,2R*,3S*,4R*)-3-acetylaminobicyclo[2.2.1  ]hept-5-ene-2-carboxylate  
(5 ,  C 1 2 H 1 7 N 0 3 )  
7 
To  a  suspension  of  ethyl  3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylate  
hydrochloride  [28] (2.17 g,  10 mmol) in toluene (40 cm3), triethylamine (2.04 g, 
20  mmol),  and  acetyl  chloride  (0.94  g,  12 mmol)  were  added  and  the  reaction  
mixture was stirred  at room temperature  for 2 h, and then washed with H2O (2 x 
10  cm  ).  The  aqueous  layer  was  extracted  with  EtOAc  (3  x  20  cm  ).  The  
combined  organic  layer  was  dried  (Na2S04)  and  evaporated.  The  residue  was  
recrystallized from w-hexane-z'Pr20, m.p. 64-67 °C; yield  1.67 g (75%). 
Ethyl (IR*,2R*,3R*,7S*,$R*, 10R*)-2-iodo-5-methyl-4-oxa-6-
azatricyclo[5.2.1.03'8]dec-5-ene-10-carboxylate  (6a, C i 2 H i 6 I N 0 3 )  and  
Ethyl  (li?*,2R*,3/?*,7iS'*,8I?*,10I?*)-2-bromo-5-methyl-4-oxa-6-
azatricyclo[5.2.1.03'8]-dec-5-ene-10-carboxylate  (6b,  C,2H16BrN03)  
A  solution  of  5  (1.67  g,  7.5  mmol)  in  CH2C12  (80  cm3)  was  treated  with  N-
iodosuccinimide  (1.68 g,  7.5 mmol)  or N-bromosuccinimide  (1.34 g, 7.5 mmol) 
and  subsequently  stirred  for  14 h  at  room  temperature.  When  the  reaction  was  
completed, the mixture was washed with  10% NaOH solution (3X10  cm3).  The 
aqueous solution was extracted with  CH2CI2 (3 x 40 cm  ), and the organic phase 
was  dried  (Na2S04)  and  evaporated.  The  oily  products  (6a:  1.92  g  ( 73%) ;  6b:  
2 . 0 7  g  ( 9 1 % ) ,  respectively)  were  sensitive  to  the  air;  they  were  therefore  used  
without purification in the next  step.  
Ethyl  (liS,*,35'*,75'*,85,*,10/?*)-5-methyl-4-oxa-6-azatricyclo[5.2.1.0*3,8*]dec-
5-ene-l0-carboxylate  (7,  C12H17NO3)  
Bu3SnH  (2.9  cm3,  11 mmol) was  added to  a solution  of  iodo-  or  bromooxazine  
6a  or  6b  (5.5  mmol)  in  dry  CH2C12  (65  cm3) under  an  argon  atmosphere. After 
stirring  for 20  h  at  40  °C,  the  solvent  was  evaporated  off  and  the  residue  was  
purified  by  column  chromatography  on  silica  gel  (w-hexane:EtOAc  10:1)  to  
afford  1,3-oxazine  7  as  an  oil  (0.82  g  (67%)  from  6a;  and  0.84  g  (69%)  from  
6b). 
8 
(1S * ,2i? * ,35* ,45* ,5.K* )-3 -Acetylamino-5 -hydroxybicyclo [2.2.1 ]heptane-2-
carboxylic acid (8,  CioHisNO^ 
A  solution  of  7 (0.67  g,  3 mmol)  in 20% aqueous HCl  was  stirred  for 2 h.  The  
solvent was then evaporated off to afford crude 8, which was recrystallized  from  
H20:acetone, m.p. 225-235 °C (with decomposition);  yield  0.51 g (80%). 
(15,*,25,*}35'*345,*,5i?*)-3-Amino-5-hydroxybicyclo[2.2.1]heptane-2-carboxylic 
acid hydrochloride  (9 ,  C 8 H I 4 C 1 N 0 3 )  
A  solution  of  8  (0.4  g,  1.8 mmol)  in  20% aqueous  HCl  was  refluxed  for  30 h.  
The solvent was then evaporated  off to afford crude 9, which was  recrystallized  
from Et0H-Et20,  m.p. 240-245 °C (with decomposition); yield 0.21 g (55%). 
(15* ,2R *,3S* ,45* ,5R*)-3 -Amino-5 -hydroxybicyclo [2.2.1 ]heptane-2-carboxylic 
acid (10, C8H13N03) 
The  mother  liquor  of  9  was  evaporated  off  and  the  residue  was  dissolved  in  
absolute EtOH.  To this  solution,  10 equivalents  of propylene  oxide was  added.  
After  stirring  and  refluxing  for  2  h  the  mixture  was  evaporated  to  afford  a  
mixture  of  10:9  =  8:2 as  solid  ciystals,  m.p. 230-235  °C  (with  decomposition);  
yield 0.1 g (32%). 
Ethyl (1 S*,2R*,3S*,4S*,5R*)-3-amino-5-hydroxybicyclo[2.2.  l]heptane-2-
carboxylate hydrochloride  ( 11 ,  C I 0 H I 8 C 1 N O 3 )  
Thionyl  chloride  (0.5  cm3,  7 mmol) was  added  dropwise with  stirring to  5 cm3  
of  dry  EtOH  at  -15  °C.  (15*,25*,35*,45*,5/?*)-3-Amino-5-hydroxybicyclo-
[2.2.1]heptane-2-carboxylic  acid hydrochloride  (9) (0.21  g,  1 mmol) was  added  
in  one portion to the mixture,  which  was then  stirred  for  30  min  at  0  °C. After 
standing for 3 h  at room temperature, the mixture was refluxed for a further  1 h 
9 
and next evaporated. The residue was recrystallized  from Et0H-Et20, m.p. 210-
211 °C, yield 0.22 g (93%). 
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Table  1. Characteristic  IR  frequencies3  and  'H NMR  data1' for compounds  2-5, 7-9  and  l l c  
Com- Amide-I v C = 0 CH3 CH3 CH2 NH H-L  1  H - 2  K H - 3 ' 1 H - 4 ' M H - 5  "  H - 6 ° CH2(7)
P 
pound bandd band e s(9H)f ?(3H) G qa  (2H)G  broad
h norbornane/ene  moiety  
2 1688 1788 1.44 — — 4.15 R 3.24 2.80 4.15  R  2.90 - 4 . 9 5.17 1.94,2.34 
3 1693 1775 1.42 — — 4.81 R 3.24 2.78 4.11 2.56 -  1.75  4.81 R 1.58,  1.73  
4 — 1763 — — — 4.67 3.40 2.95 3.82 2.63 1.82,  1.90  5.01 1.70,  1.77  
5 1654 1730 1.86 1.20 4.04 6.4 3.10  R  3.13 4.72 3.10  R  6.14 6.27 1.35,  1.45  
7 1676 1733 1.86 1.24 4.10 — 2.08 3.02 4.03 2.35 4.55 2.02,  2.19  1.41,  1.48  
8 1680 1732 2.35 — — 12.9 ~2.45R 3.25 4.24 ~2.45R 5.21 1.75,2.20 1.53,  1.64  
9 — 1714 — — — -12.6 2.36 2.54  R  3.76 2.52  R  4.35 1.22,  2.05  1.26,  1.33  
11 — 1732 — 1.21 4.10 -7 .9 2.35 2.59 3.77 2.54 4.35 1.23,  2.07  1.27,  1.33  
a  In KBr discs  (cm"1).  Further bands, vOH band: -3345  (9), 3460  (11), vNH  band: -3230  (2),  3247  (3),  3318  (5),  coalesced  vOH (acidic  & alcoholic)  and  
or vN+H3  bands: 3250-2250  (4),  3600-3250  (8),  3500-2500  (9, l l ) , v C - 0 :  1014(2),  1167  (3),  1108  (4),  1182  and  1047  (5),  1184  and  1060 (7),  1185  
and  1155(11);  
b  In CDC13 solution (D20  for 4  and DMSO-dô for 8, 9 and  11) at 500  MHz.  Chemical  shifts in  ppm (5TMs  =  0  ppm), coupling constants  in Hz; 
0 Assignments  were  supported  by HMQC (except for 2),  for 5, 7,  9 and  11 by HMBC,  and for 8  and  11 also  by DIFFNOE  measurements;  
d Urethane group (2, 3), vC=N  band (7); 
e  COOH (1,  4,  8 and 9),  lactone (2  and 3),  COOEt (5, 7 and  11);  
f 3H (5, 7  and 8); 
8  Ethyl  group, J:  7.1;  
h Intensity  1H  (2,  3,  5  and 9),  2H  (8),  coalesced  signal  of  the  acidic  H's  and  the  solvent  (4),  ©r the  amide-NH  and COOH  (8),  or the  OH  and NH3+  groups  
(11),  , d ( J :  6.5,  5);  
1 - 1  (2,  4  and 7), -5  (9) with coalesced lines,  t (J: 4.7  for 3),  d (J: 4.5  for  11);  
k  dd,  J:  10.3  and 4.7 (2-4), -  dd  (5),  ddd  (7),  td (8)  with coalesced  ines, d, J: 4.3  (9),  5.1  (11);  
1 Broad m (2), - 1  (3), -  d, J: 9.3  (4),  4.3  (9),  dt, J:  8.9  ad 3.5  (5),  m (7,  8  and  11);  
m  Signals with  coalesced  lines,  m (2,  5  and 8),~s (3,  4  and 9), -  t (7  and  11);  
n Broad m (1H)  for 2  and 7-9,  dd, J:  5.6  and 2.9 (5),  m (2H)  for 3, 2xm (2xlH)  for 4,  m  for  11;  
°d(1H),  J\  5.0  (2),  m (2H, 3),  t (1H), J:  6.3  (4),  dd(  1H), J:  5.6  and 3.0 (5),  2xm (2x1 H,  7-9  and  11),  
PAB-type  multiplet,  2xd  (2xlH),  J:  11.8 (2  and 4),  11.2 (3),  9.0 (5),  10.8 (7  and 8),  -  10 (9),  11.5  (11),  further split  by  long-range  couplings of downfield / 
upfield d to  td  (2 / 7),  both d's to dd  (9)  and downfield d  to  m  (7  and 8),  respectively;  
r Overlapping  signals;  
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Table  2.  13C NMR  chemical  shifts3 of compounds  2-5, 7 -9  and  11  b  
Com- CH 3 c CH2 Cquat
 o r  o c = o C = O f C-L C - 2 C - 3 C - 4 C - 5 C - 6 CH2(7) 
pound CH3 d e or  C=N  norbornane/ene  moiety  g  
2 28.7 — 81.0 176.6 155.8 51.4 41.8 54.6 48.2 24.5 89.6 35.6 
3 28.7 — 80.4 178.1 155.9 47.8 43.4 54.1 40.7 32.5 81.1 35.6 
4 — — — 179.9 — 48.4 42.1 53.9 39.7 31.1 83.1 35.3 
5 14.5 60.9 23.8 173.8 170.1 47.6  h  47.7  h  52.5 47.4  h  134.3 137.6 48.0 
7 14.7 60.3 21.9 172.2 156.6 34.5 50.1 50.3 36.8 73.4 33.2 37.9 
8 — — 19.9 172.0 171.1 34.7  h  48.9 46.1 36.9  h  79.3 32.6 36.1 
9 — — — 174.8 — 42.7 51.3 54.7 43.3 72.6 40.2 35.2 
11 14.9 61.5 173.5 42.8 51.2 54.8 43.3 72.5 40.1 35.2 
a  In ppm  ( 5 T M S  =  0  ppm)  at  125.7 MHz.  Solvent:  CDC13 (for 4 D20,  for 8,  9 and  11  DMSO-d6);  
b Assignments  were  supported  by DEPT,  HMQC (except  for 2)  and for 5, 7,  9 and  11 also by HMBC  measurements;  
c  /-Butyl  (2, 3)  or ethyl  (5,  7  and  11);  
d  Quaternary  carbon (/-butyl,  2  and 3),  methyl  (acetyl,  5  and  8  or oxazoline  7);  
e  Lactone (2, 3),  carboxyl  (4,  8  and 9),  ester (5,  7 and  11);  
fCarbamoyl  (2,  3),  amide  (5, 8),  C=N for 7; 
g'For the numbering  used  in the Tables  and  in the spectroscopic  part of the text,  see  1 (Scheme  1);  
h Interchangeable  assignments.  
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Table  3. Physical  and  analytical  data  on compounds  1-11  
Compound M.p. Formula 
(Mw) C  (%)  
Calcd.  /Found  
H  (%)  N  (%)  
1 183-187^ C I3H19N04 61.64 7.56 5.53 
253.10 61.53 7.47 5.58 
2 183-187a C13H18INO4 41.18 4.78 3.69 
379.20 41.23 4.87 3.58 
3 145-150c C13H19N04 61.64 7.56 5.53 
253.30 61.81 7.73 5.37 
4 220-222d C8H14C1N03 46.27 6.80 6.75 
207.70 46.38 6.97 6.69 
5 64-67e Q2H17NO3 64.55 7.67 6.27 
223.27 64.71 7.83 6.12 
6a Oilf C12H I6INO3 41.28 4.62 4.01 
349.10 - - -
6b Oilf C12H17BrN03 47.70 5.34 4.64 
301.20 - - -
7 Oil C12H17N03 64.55 7.67 6.27 
223.27 64.39 7.77 6.43 
8 225-235d'8 C10H15NO4 56.33 7.09 6.57 
213.24 56.49 7.21 6.42 
9 240-245h C8H14CINO3 46.22 6.74 6.74 
207.7 46.32 6.88 6.59 
10 230-235h'' C8H13NO3 56.13 47.65 8.18 
171.20 - - -
11 210-21 lh C10H18CINO3 50.96 7.70 5.94 
235.70 51.13 6.84 6.16 
a  zPr20;  
k  lit.  in.p.  126-127  °C  [27];  
c  zPr20-Et0Ac;  
d  H20-acetone; 
e  «-hexane-/Pr20;  
f sensitive to the  air;  it was therefore used without  purification  in the next step 
8 with  decomposition;  
h  Et0H-Et20; 
1 diastereomerically  enriched  (8:2)  mixture  
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